syndrome	score	normalized_score
DRAVET SYNDROME	2.66916834	100.0
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	2.183276464	81.79613219899049
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.14628166	80.41012729830295
HEMOGLOBIN--BETA LOCUS	2.136743	80.05276280176469
MYASTHENIA GRAVIS	2.078186619	77.85895658420704
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	2.0	74.92970638187624
AUTOIMMUNE HEPATITIS	1.93462592	72.48047607218359
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	1.7851738000000001	66.88127433730912
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	1.6723954490000001	62.656049973978035
OROTIC ACIDURIA	1.643402554	61.56983541922275
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	1.6331731	61.186590426889296
CHILDHOOD ABSENCE EPILEPSY	1.5207408500000001	56.97433268671245
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	1.500545554	56.21771888692489
TETRAGAMETIC CHIMERISM	1.333333	49.95312509963309
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	1.327643269	49.73996016302216
LYSINURIC PROTEIN INTOLERANCE	1.3073542299999998	48.97983429550194
IGG4-RELATED RETROPERITONEAL FIBROSIS	1.2902239	48.33804899693962
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	1.2435071	46.5878109433892
MYOCLONIC-ASTASTIC EPILEPSY	1.2312833539999999	46.12985009405588
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.72157046490368
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	1.1859649	44.43200086810561
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.16386653979269
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	1.13642732	42.576082705971245
AMOEBIC KERATITIS	1.1	41.21133851003193
SARCOIDOSIS	1.0858455999999999	40.681045992026114
MARFAN SYNDROME	1.0712766	40.135220545887336
MOWAT-WILSON SYNDROME; MOWS	1.0627031089999999	39.8140159642385
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	1.0588235	39.668666982615264
TETRASOMY 9P	1.0486634429999997	39.28802193869869
HEPARIN-INDUCED THROMBOCYTOPENIA	1.0449486	39.14884589107631
BLAU SYNDROME	1.04234231	39.05120161885331
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	1.031564619	38.64741700780102
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	1.02867182	38.53903871795512
AORTA COARCTATION	1.02538772	38.41600039359076
MEVALONIC ACIDURIA; MEVA	1.020065344	38.21659835812379
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	1.0188679	38.17173629445942
FOLATE MALABSORPTION, HEREDITARY	1.014941243	38.02462466642324
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	1.011179719	37.88369972198906
LOWRY-MACLEAN SYNDROME	1.011067719	37.879503658431666
PAROXYSMAL KINESIGENIC DYSKINESIA	1.00980392	37.832155614433816
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	1.006569649	37.71098412623911
PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	1.00342466	37.593157575066996
OCULOSKELETODENTAL SYNDROME; OCSKD	1.001197444	37.50971525460249
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	1.001197444	37.50971525460249
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	1.001193309	37.50956033743454
ATRESIA OF SMALL INTESTINE	1.00065189	37.48927615408476
ICHTHYOSIS AND MALE HYPOGONADISM	1.000541419	37.485137374287895
3-METHYLGLUTACONIC ACIDURIA TYPE 7	1.000541419	37.485137374287895
STICKLER SYNDROME, TYPE I	1.0	37.46485319093812
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	1.0	37.46485319093812
LAMBERT-EATON MYASTHENIC SYNDROME	1.0	37.46485319093812
TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD	1.0	37.46485319093812
BARBER-SAY SYNDROME; BBRSAY	1.0	37.46485319093812
ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA	1.0	37.46485319093812
CHROMOSOME 5Q DELETION SYNDROME	1.0	37.46485319093812
MOYAMOYA DISEASE 1; MYMY1	1.0	37.46485319093812
TEMPORAL ARTERITIS	1.0	37.46485319093812
PRIMARY PULMONARY HYPOPLASIA	1.0	37.46485319093812
BNAR SYNDROME	1.0	37.46485319093812
VASCULITIS, LYMPHOCYTIC, NODULAR	1.0	37.46485319093812
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	1.0	37.46485319093812
GRANULOMATOSIS WITH POLYANGIITIS	1.0	37.46485319093812
CHIARI MALFORMATION TYPE II	1.0	37.46485319093812
MYOCLONIC EPILEPSY OF LAFORA	0.96771307	36.255228098502016
LAFORA DISEASE	0.85382841	31.988556030902117
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.87105651792648
FANCONI ANEMIA	0.767400444	28.75054497312072
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.045400988084552
CONGENITAL TRACHEAL STENOSIS	0.7442683999999999	27.883906340654402
AGEL AMYLOIDOSIS	0.742857	27.831028446860717
BLAU SYNDROME	0.7152850099999999	26.798047889328696
EARLY MYOCLONIC ENCEPHALOPATHY	0.708728914	26.552424715183008
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.7	26.22539723365668
PHEOCHROMOCYTOMA	0.7	26.22539723365668
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.676035614	25.32757503035571
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.67357727	25.235473533302887
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.6685339199999999	25.046525165962365
DEXTROCARDIA	0.6674628539999999	25.00639783551456
CHILDHOOD DISINTEGRATIVE DISORDER	0.648192429	24.284434191962575
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.6297218	23.592434788133293
PAROXYSMAL HEMICRANIA	0.61322858	22.97451872218745
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6103603	22.867059033076945
ADDISON DISEASE	0.6076843190000001	22.766803797770212
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.604263379	22.6386387828952
ROLANDIC EPILEPSY	0.60042522	22.49484271943672
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59639105	22.343703132639433
INHERITED CREUTZFELDT-JAKOB DISEASE	0.5893692290000001	22.08063163974139
LEUKOCYTE ADHESION DEFICIENCY	0.5865817090000001	21.976197612174587
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.578550119	21.675295271934775
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.57635427	21.593028111520308
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.81380899340354
DILATED CARDIOMYOPATHY WITH ATAXIA	0.553173019	20.724545946023024
SICKLE CELL ANEMIA	0.54761906	20.51646768745953
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5453812	20.432626591097662
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.5435606	20.364418079378236
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.5416320589999999	20.292165573940526
CREST SYNDROME	0.54103016	20.269615516269763
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.52623536	19.71533050628047
SITOSTEROLEMIA	0.52223601	19.56549544567129
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.52002806	19.48277492306836
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.52002806	19.48277492306836
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.519075659	19.447093359424457
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.517498954	19.388022338074038
ANEURYSM OF SINUS OF VALSALVA	0.5136986	19.245642633390446
LYMPHOID INTERSTITIAL PNEUMONIA	0.512987	19.218982643859768
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.511183854	19.151428043687943
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.5106383	19.130988943170216
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.5106383	19.130988943170216
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50980392	19.09972901896476
THROMBOCYTOPENIA, CYCLIC	0.50714286	19.00003279673248
CYCLIC NEUTROPENIA	0.50714286	19.00003279673248
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.996263457852944
MATTHEW-WOOD SYNDROME	0.50549451	18.938277605975202
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.504195194	18.88959892278656
MULTIPLE SULFATASE DEFICIENCY	0.501738863	18.797572842483216
PALLISTER-HALL SYNDROME	0.501738863	18.797572842483216
TRIGEMINAL NEURALGIA	0.5	18.73242659546906
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.5	18.73242659546906
BRANCHIOOTORENAL SYNDROME 1	0.5	18.73242659546906
INHALATIONAL ANTHRAX	0.5	18.73242659546906
CLUSTER HEADACHE, FAMILIAL	0.5	18.73242659546906
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.73242659546906
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.5	18.73242659546906
NK-CELL ENTEROPATHY	0.5	18.73242659546906
HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION ISUNKNOWN OR UNCERTAIN	0.5	18.73242659546906
PHOCOMELIA, SCHINZEL TYPE	0.5	18.73242659546906
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.5	18.73242659546906
GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD	0.5	18.73242659546906
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.48823819999999996	18.29177248520788
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.46217216000000005	17.315212123338764
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.4586633	17.183753198571207
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.4429828	16.5962855681107
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.43795096899999997	16.407768758414086
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43664070000000005	16.358679722688453
WILLIAMS SYNDROME	0.42545859	15.939743613173532
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.420175039	15.741796150631696
THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA	0.4166663	15.610341759111378
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41513130400000003	15.552833359322701
NEUROMYELITIS OPTICA	0.4102561	15.370184557186828
SPINOCEREBELLAR ATAXIA TYPE 10	0.40889129999999996	15.319052525551832
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.399234773	14.957272159162505
SHEEHAN SYNDROME	0.39560439999999997	14.821260767689157
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.39269791899999995	14.712369883721907
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.38626763999999997	14.471460425010136
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.385638	14.447871054846992
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.38145755000000003	14.291251109324937
FOCAL DERMAL HYPOPLASIA	0.37544414	14.065959586498018
TEMPI SYNDROME	0.37526015	14.059066428159417
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.367208019	13.757394522370214
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.3666667	13.73711408550575
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.3666667	13.73711408550575
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.658183507451612
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.36208931	13.565622841158081
EPIDERMAL NEVUS SYNDROME	0.360194354	13.494628592814792
PGM3-CDG	0.357796809	13.404804921371124
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.394346645067726
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.394346645067726
PLACENTAL INSUFFICIENCY	0.3572261	13.383423392471377
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.35550021	13.318763176997669
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.288817145193624
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.35463122	13.286206594223279
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.35383147299999995	13.256244190278382
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.35285309	13.219589214818875
MALIGNANT ATROPHIC PAPULOSIS	0.351254439	13.159695989800326
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.350867364	13.145194281751445
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.350541419	13.132982800178125
PARAGANGLIOMAS 1	0.35	13.11269861682834
PARAGANGLIOMAS 3	0.35	13.11269861682834
PARAGANGLIOMAS 4	0.35	13.11269861682834
CARNEY COMPLEX	0.35	13.11269861682834
141700 HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES	0.35	13.11269861682834
HEINZ BODY ANEMIAS	0.35	13.11269861682834
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.34626999	12.972954339777608
COG4-CDG	0.345926754	12.960095053427764
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.345372854	12.939343271245304
CHÉDIAK-HIGASHI SYNDROME	0.344757723	12.916297478637109
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.344263504	12.897781636357935
ESOPHAGEAL ATRESIA	0.3438593	12.882638192838748
MAJEED SYNDROME	0.34354254	12.870770825941985
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34324414999999997	12.85959168839834
HEMOLYTIC ANEMIA DUE TO RED CELL PYRUVATE KINASE DEFICIENCY	0.34285699999999997	12.84508717048547
POTOCKI-SHAFFER SYNDROME	0.34103952299999996	12.77699566150256
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.75210877107886
ZIMMERMANN-LABAND SYNDROME	0.339368929	12.7144071025509
FAMILIAL PSEUDOHYPERKALEMIA	0.33675766	12.616576292823853
MALT LYMPHOMA	0.33652789	12.607967993506172
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.33507186299999997	12.553418155709128
ATAXIA-PANCYTOPENIA SYNDROME	0.33488595	12.546452952457843
KAPOSI SARCOMA	0.334656	12.537837909466587
HEREDITARY ACROKERATOTIC POIKILODERMA	0.33398489	12.512694871841616
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.333874419	12.50855609204476
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.333874419	12.50855609204476
DEHYDRATED HEREDITARY STOMATOCYTOSIS	0.33333330000000005	12.488283148150934
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.488271908694974
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.488271908694974
HEREDITARY SPHEROCYTOSIS	0.333333	12.488271908694974
WAGR 11P13 DELETION SYNDROME	0.333333	12.488271908694974
ENCEPHALOMALACIA, MULTILOCULAR	0.333333	12.488271908694974
XK APROSENCEPHALY SYNDROME	0.333333	12.488271908694974
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.488271908694974
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.333333	12.488271908694974
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.333333	12.488271908694974
PULMONARY EDEMA OF MOUNTAINEERS	0.333333	12.488271908694974
FAMILIAL DILATED CARDIOMYOPATHY	0.333333	12.488271908694974
BIRDSHOT CHORIORETINOPATHY	0.333333	12.488271908694974
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.32936450999999994	12.339593013455268
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.32582436	12.206961813431368
PITUITARY APOPLEXY	0.32485326000000003	12.17057969449765
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.31675640000000005	11.867232023290072
ACQUIRED VON WILLEBRAND SYNDROME	0.31610041	11.842655454245348
AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	0.311111	11.65572794108595
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.303177154	11.358487565456436
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.3026316	11.338048464938707
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 3	0.3022207	11.322654156762551
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.30170260000000004	11.303243616324329
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.287463944668247
NON-FUNCTIONING PARAGANGLIOMA	0.30000000000000004	11.239455957281438
SICKLE CELL ANEMIA	0.29888810999999993	11.19779916166696
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.298164554	11.170691242351541
TAKAYASU ARTERITIS	0.29798529900000004	11.1639754800928
ISOLATED AGAMMAGLOBULINEMIA	0.29684689	11.121325154036557
H SYNDROME	0.29495819	11.050565285814832
FAMILIAL AORTIC DISSECTION	0.29256760000000004	10.961002182425107
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.28846150000000004	10.807167748737797
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.28625975400000003	10.724679658084062
NEUROFIBROMATOSIS TYPE 1	0.28389100899999997	10.63593497441229
MENINGIOMA	0.28315414	10.608328285506339
PEDIATRIC-ONSET GRAVES DISEASE	0.280893314	10.523626771326082
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.28022189000000003	10.49847196973721
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.2772361	10.386609785728238
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.2745725	10.286818402768857
POEMS SYNDROME	0.26778827	10.032648221805298
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.267416194	10.018708449089427
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 4	0.26650640000000003	9.984623150445431
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.26424946000000005	9.900067224684676
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.262589619	9.837881525299375
WT LIMB-BLOOD SYNDROME	0.2620482	9.81759734194959
PALLISTER-HALL SYNDROME	0.261723744	9.80544164554267
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.25930812000000003	9.714940647018166
CARTILAGE-HAIR HYPOPLASIA; CHH	0.25899466000000004	9.703196914136933
6P22 MICRODELETION SYNDROME	0.2588235	9.696784429864772
CHILBLAIN LUPUS	0.2567986	9.62092184863844
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.577138697816267
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25549451	9.57206430824067
KIKUCHI-FUJIMOTO DISEASE	0.25415625	9.521926593809365
USHER SYNDROME	0.25364964	9.502946524534304
TRANSALDOLASE DEFICIENCY	0.253341944	9.491418739066864
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.25185456	9.435694115868316
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.251680264	9.429164141816546
POLYARTERITIS NODOSA	0.25128496	9.414354135490758
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.2511215	9.408230130588166
SCHIZOPHRENIA 1; SCZD1	0.25065189	9.39063626088117
SIX2-RELATED FRONTONASAL DYSPLASIA	0.25065189	9.39063626088117
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.250545554	9.386652398252258
INSULINOMA	0.250541419	9.386497481084314
TUBERCULOSIS	0.25	9.36621329773453
PLEURAL MESOTHELIOMA	0.25	9.36621329773453
ASCITES, CHYLOUS	0.25	9.36621329773453
HYPERPARATHYROIDISM 2	0.25	9.36621329773453
FRONTOMETAPHYSEAL DYSPLASIA	0.25	9.36621329773453
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.25	9.36621329773453
RADIATION PROCTITIS	0.25	9.36621329773453
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.25	9.36621329773453
250700 METHEMOGLOBIN REDUCTASE DEFICIENCY;;NADPH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY;;TPNH-METHEMOGLOBIN REDUCTASE DEFICIENCY	0.25	9.36621329773453
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.25	9.36621329773453
NARCOLEPSY TYPE 1	0.25	9.36621329773453
SCHIZOPHRENIA	0.25	9.36621329773453
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.36621329773453
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.36621329773453
ATR-16 SYNDROME	0.25	9.36621329773453
DYSTONIA 6, TORSION	0.25	9.36621329773453
TAKAYASU ARTERITIS	0.25	9.36621329773453
HYPEREKPLEXIA 1; HKPX1	0.25	9.36621329773453
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.25	9.36621329773453
INFANTILE MYOFIBROMATOSIS	0.2478603	9.286049751361878
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.24709744000000003	9.25746931345664
LENNOX-GASTAUT SYNDROME	0.24461950999999998	9.164634029789218
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.24357002	9.125315041013861
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	9.105651013378948
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.24285720000000002	9.098609344362298
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.23910542899999998	8.958049794641276
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.2381579	8.922550759762121
BENIGN SCHWANNOMA	0.237037	8.880556405820398
GAMMA-HEAVY CHAIN DISEASE	0.23680549999999997	8.871883292306695
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.2366162	8.864791195597652
PERIPARTUM CARDIOMYOPATHY	0.23637521	8.855762540627167
AICARDI-GOUTIÈRES SYNDROME	0.23431311300000002	8.778506379256694
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.23333330000000002	8.741797829057122
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.23327009999999998	8.739430050335454
CRI-DU-CHAT SYNDROME	0.23252151000000001	8.71138423588525
BETA-THALASSEMIA	0.23225810000000002	8.701515618906225
RELAPSING POLYCHONDRITIS	0.23123151000000003	8.66305457526894
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.22961429	8.60246566539149
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.22943254000000002	8.595656428324038
CONGENITAL ENTEROVIRUS INFECTION	0.22920565	8.587156027783545
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.22761426	8.527534835064019
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.464402436303438
ENTHESITIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.225	8.429591967961077
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.22301546300000002	8.355241580604092
COGAN SYNDROME	0.22206309000000002	8.31956106597608
NEUROLEPTIC MALIGNANT SYNDROME	0.220888	8.275536491639938
WILLIAMS-BEUREN SYNDROME; WBS	0.21945564999999997	8.221873709171899
DIAMOND-BLACKFAN ANEMIA 1	0.21832105000000002	8.17936608674146
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.21749895400000002	8.148566380792603
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.214831554	8.048632631391095
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.2140845	8.020644362955391
MELIOIDOSIS	0.21388890000000002	8.013316237671244
CONGENITAL AORTIC VALVE STENOSIS	0.212987	7.979526686578336
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2127187	7.969474866467207
MALARIA	0.21222087000000003	7.950823738603165
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.21204820000000002	7.944354682402685
DISTAL TRISOMY 14Q	0.20965852999999998	7.8548260466778945
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.208532629	7.812644331005364
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.20832339000000002	7.804805222588547
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.20714286	7.760576839451049
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.20704225	7.756807500571508
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.206581483	7.739544932561279
NIEMANN-PICK DISEASE, TYPE C2	0.206581483	7.739544932561279
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2061464	7.723244611840406
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.20612591	7.7224769569985225
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424822	7.652129576810431
POLYCYSTIC KIDNEYS	0.20342466	7.621275022316501
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.2030294	7.606466664444252
TUBEROUS SCLEROSIS COMPLEX	0.20127066	7.540575728543221
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.201086973	7.5336939220551375
STICKLER SYNDROME	0.20065219	7.517404840790222
VASCULAR EHLERS-DANLOS SYNDROME	0.20036530400000002	7.506656698917687
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.492970638187623
ACQUIRED PURPURA FULMINANS	0.2	7.492970638187623
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5	0.2	7.492970638187623
HEREDITARY ELLIPTOCYTOSIS	0.2	7.492970638187623
ANEURYSM, INTRACRANIAL BERRY, 2	0.2	7.492970638187623
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.492970638187623
ANEURYSM, INTRACRANIAL BERRY, 3	0.2	7.492970638187623
JUVENILE HYALINE FIBROMATOSIS	0.2	7.492970638187623
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.2	7.492970638187623
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.492970638187623
HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS	0.2	7.492970638187623
PAROXYSMAL COLD HEMOGLOBINURIA	0.19982114	7.486269674545892
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.1989247	7.452684681551408
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.197917	7.4149313489908995
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.197917	7.4149313489908995
WALDENSTRÖM MACROGLOBULINEMIA	0.19750813000000003	7.399613094466721
SNEDDON SYNDROME	0.19579720900000003	7.335513690380428
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.19482519	7.299097141246626
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	7.284827153314728
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	7.284827153314728
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	7.284827153314728
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	7.284827153314728
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	7.284827153314728
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	7.284827153314728
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	7.284827153314728
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.193334014	7.243230451324774
MYOCLONIC EPILEPSY OF INFANCY	0.193334014	7.243230451324774
CRISS-CROSS HEART	0.192857	7.225359191844752
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.19148626000000002	7.174004618981806
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.19087177399999997	7.150982991203918
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.19004364	7.119957072471495
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	0.1888892	7.076706147353748
NEONATAL LUPUS ERYTHEMATOSUS	0.18462666	6.917010712033246
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.18379026	6.885675108824346
REFRACTORY ANEMIA	0.18333336000000003	6.868557417401408
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.855142752067859
UNILATERAL POLYMICROGYRIA	0.1817003	6.807375064249413
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.18162100400000003	6.804404251250785
PANNICULITIS-INDUCED LOCALIZED LIPODYSTROPHY	0.1813185	6.793070983301113
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.18120235999999998	6.7887198152515165
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.179894	6.739702299930621
IMMUNODEFICIENCY 16	0.17871520000000002	6.695538730989144
PULMONARY ARTERIOVENOUS MALFORMATION	0.17856649900000002	6.6899676698547985
CLASSIC MYCOSIS FUNGOIDES	0.17777769999999998	6.660415431122639
SUPRAVALVULAR AORTIC STENOSIS	0.1773398	6.644009571910327
FELTY SYNDROME	0.17730796	6.642816690984728
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.176143563	6.599192728323759
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.17315999999999998	6.487413978542842
COWDEN SYNDROME	0.172055503	6.446034160588013
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.17176456	6.435134023806081
SYSTEMIC SCLEROSIS	0.171495509	6.425054067590207
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.171403613	6.421611197441372
MICROSPORIDIOSIS	0.170382719	6.383363553607863
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.17031664000000002	6.380887913573859
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.170307979	6.380563430480371
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.170082364	6.372110797627699
HYDRANENCEPHALY	0.167753973	6.284877970641596
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.167753973	6.284877970641596
MUCOLIPIDOSIS TYPE II	0.16731889	6.268577649920723
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.264438870123867
PSEUDOXANTHOMA ELASTICUM; PXE	0.16712326	6.26124840069098
CEREBROOCULONASAL SYNDROME	0.166667	6.244154686774083
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.166667	6.244154686774083
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.244154686774083
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	0.166667	6.244154686774083
DERMATOLEUKODYSTROPHY	0.166667	6.244154686774083
STICKLER SYNDROME TYPE 1	0.166667	6.244154686774083
STICKLER SYNDROME TYPE 2	0.166667	6.244154686774083
ULBRIGHT-HODES SYNDROME	0.166667	6.244154686774083
CAUDAL DUPLICATION	0.166667	6.244154686774083
STICKLER SYNDROME, TYPE II	0.166667	6.244154686774083
CONGENITAL PRIMARY MEGAURETER	0.166667	6.244154686774083
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.1666667	6.244143447318126
FRONTOTEMPORAL DEMENTIA; FTD	0.1666667	6.244143447318126
IMMUNODEFICIENCY 23; IMD23	0.165822954	6.212532627297684
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.164156114	6.150084711404901
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.1634615	6.124061099870532
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.1634615	6.124061099870532
PSEUDOXANTHOMA ELASTICUM	0.16139346000000002	6.046582284877545
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.16116350000000002	6.037966867237755
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.16115016999999998	6.037467460744719
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.1607143	6.021137655184386
OGDEN SYNDROME	0.160028354	5.995438788997475
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.975857633617819
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.975857633617819
SANDHOFF DISEASE	0.159364919	5.970583294120744
ACERULOPLASMINEMIA	0.15898980999999998	5.956529890505144
SLC35A2-CDG	0.158977244	5.956059107159947
JEJUNAL NEUROENDOCRINE TUMOR	0.1583333	5.931933839736763
ILEAL NEUROENDOCRINE TUMOR	0.1583333	5.931933839736763
DUODENAL NEUROENDOCRINE TUMOR	0.1583333	5.931933839736763
NEUROENDOCRINE TUMOR OF STOMACH	0.1583333	5.931933839736763
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.15810009	5.923196661324103
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.157504479	5.900882182650196
VON HIPPEL-LINDAU DISEASE	0.15538538000000002	5.821490449718132
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.1549052	5.803500576512906
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.8031878948481745
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.719452449372301
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.719452449372301
GITELMAN SYNDROME	0.15220174000000003	5.702215844505335
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.151852749	5.689140947925376
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.6793532924940955
BURKITT LYMPHOMA	0.1513227	5.669282739956372
ADENOHYPOPHYSITIS	0.15098074000000003	5.656471258759199
PANHYPOPHYSITIS	0.15098074000000003	5.656471258759199
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.15065538299999998	5.644281806519553
MELAS	0.14947458	5.600043195477135
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.14900339999999998	5.582390505950627
STEINERT MYOTONIC DYSTROPHY	0.14835151	5.557967542803988
WOLFRAM-LIKE SYNDROME	0.14835151	5.557967542803988
NORMAL PRESSURE HYDROCEPHALUS	0.14835151	5.557967542803988
GIANT CELL ARTERITIS	0.14822364999999998	5.553177286674995
GRANULOMATOSIS WITH POLYANGIITIS	0.14816871900000003	5.551119304824365
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.1479991	5.544764553890969
RHEUMATOID ARTHRITIS	0.14734160000000002	5.520131412917928
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.14715852999999998	5.513272722244262
ARTERIAL TORTUOSITY SYNDROME	0.146626114	5.493325834967757
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14650664	5.488849759097621
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.14605721000000002	5.472011930128019
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.14605189	5.471812617109043
CHRONIC GRANULOMATOUS DISEASE	0.1458333	5.463623174850035
ACUTE MONOBLASTIC LEUKEMIA	0.1458333	5.463623174850035
COLCHICINE POISONING	0.1438679	5.389989752388566
AUTOIMMUNE HYPOPARATHYROIDISM	0.1435898	5.379570776716166
JUVENILE POLYPOSIS OF INFANCY	0.14350888999999997	5.376539495444486
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.372555632815575
RHESUS BLOOD GROUP, CCEE ANTIGENS; RHCE	0.14285699999999998	5.3521165322978455
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.14285699999999998	5.3521165322978455
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3521165322978455
SUPRAVALVULAR AORTIC STENOSIS	0.14285699999999998	5.3521165322978455
ERYTHEMA ELEVATUM DIUTINUM	0.14285699999999998	5.3521165322978455
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.14285699999999998	5.3521165322978455
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.14285699999999998	5.3521165322978455
ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2	0.14285699999999998	5.3521165322978455
HEREDITARY MIXED POLYPOSIS SYNDROME	0.14285699999999998	5.3521165322978455
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.14285699999999998	5.3521165322978455
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3521165322978455
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.14285699999999998	5.3521165322978455
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	5.3521165322978455
BLACKFAN-DIAMOND ANEMIA	0.14261261000000003	5.342960496826514
ATYPICAL WERNER SYNDROME	0.14255374999999998	5.340755315567694
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.14215680000000003	5.325883642093553
CHOPS SYNDROME; CHOPS	0.142106544	5.324000808431588
ARTERIAL TORTUOSITY SYNDROME	0.14180356000000002	5.312649557352386
OMENN SYNDROME	0.14135269	5.2957577789941865
AUTOIMMUNE HEMOLYTIC ANEMIA	0.14127314	5.292777449922847
TURNER SYNDROME	0.14122625	5.291020722956724
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.14122625	5.291020722956724
MOSAIC MONOSOMY X	0.14122625	5.291020722956724
MONOSOMY X	0.14122625	5.291020722956724
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.141017619	5.283204393170646
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089110999999999	5.278464752058313
1P36 DELETION SYNDROME	0.140266963	5.255081176333749
MUCKLE-WELLS SYNDROME	0.13978809	5.237140269691644
BRONCHIAL NEUROENDOCRINE TUMOR	0.1388889	5.203452248350885
LYSOSOMAL ACID LIPASE DEFICIENCY	0.138184614	5.177066276756452
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.153916369321239
CHRONIC GRAFT VERSUS HOST DISEASE	0.13729243000000002	5.143640734177149
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.13705187300000002	5.134628301488096
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.124778079751987
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.13672527299999998	5.1223922804359345
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.13617971899999998	5.101953179918206
NASU-HAKOLA DISEASE	0.13617971899999998	5.101953179918206
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.13604833400000002	5.097030860181715
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.1359649	5.093905017620582
EVANS SYNDROME	0.1359509	5.093380509675909
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.13589679999999998	5.091353661118279
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.13560496	5.080419918363035
22Q11.2 DELETION SYNDROME	0.13501677299999998	5.058383578759217
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.13489375	5.053774540125109
BEHCET SYNDROME	0.13400901	5.020627885912958
SECONDARY POLYCYTHEMIA	0.1336106	5.005701513753156
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.9632950464263335
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.13210975	4.949472388841537
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.13036414400000002	4.884073516322316
ALSTRÖM SYNDROME	0.129611123	4.855861695107622
SMITH-MAGENIS SYNDROME; SMS	0.129276773	4.8433353214432335
DIABETIC EMBRYOPATHY	0.1291667	4.839211452657946
CINCA SYNDROME	0.128245564	4.804701227649058
KABUKI SYNDROME 1	0.126571663	4.741988772427893
RAMON SYNDROME	0.126193309	4.72781379536369
DOORS SYNDROME	0.125523904	4.702734635313409
NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE	0.1254902	4.701471919901462
AAPOAIV AMYLOIDOSIS	0.1254902	4.701471919901462
YOUNG-ONSET PARKINSON DISEASE	0.125	4.683106648867265
CARIBBEAN PARKINSONISM	0.125	4.683106648867265
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.12477223900000001	4.674573616439644
PHACE ASSOCIATION	0.12465609300000001	4.670222223600929
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.12456896	4.666957798547842
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.1245155	4.664954927496255
INSULIN-RESISTANCE SYNDROME TYPE B	0.12432009999999999	4.657634295182745
INTERMEDIATE UVEITIS	0.12272730000000001	4.597960277020221
ZIMMERMANN-LABAND SYNDROME 1	0.12270051900000001	4.596956930786914
BETA-THALASSEMIA INTERMEDIA	0.12251386000000003	4.589963778755147
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.121974154	4.569743772698877
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.121907154	4.567233627535085
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.12180288999999998	4.563327392081984
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.5300932199727795
CHARGE SYNDROME	0.12067794400000001	4.5211814553442515
NON-HISTAMINIC ANGIOEDEMA	0.12063480999999998	4.5195654463667125
ATRANSFERRINEMIA	0.12037030000000001	4.509655618049179
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.119952919	4.494018500159492
GRAFT VERSUS HOST DISEASE	0.11827941	4.431320731160778
FAMILIAL BICUSPID AORTIC VALVE	0.11784706000000002	4.415122801883677
AICARDI SYNDROME; AIC	0.1177712	4.412280718120611
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.117647	4.407627583354297
EISENMENGER SYNDROME	0.11745177000000001	4.40031332006583
DOWN SYNDROME	0.11739921	4.398344167382114
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.11712576300000002	4.3880995156716125
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.11689349	4.379397441826393
BILATERAL POLYMICROGYRIA	0.116708964	4.372484202326481
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.11667837300000002	4.371338115002518
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.116674229	4.371182860650895
HAMAMY SYNDROME; HMMS	0.11559140000000001	4.330614831135005
HOYERAAL-HREIDARSSON SYNDROME	0.11550333399999999	4.327315451373891
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.11495777999999998	4.306876350856161
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.11491896	4.30542196525529
HOLOPROSENCEPHALY	0.114855613	4.303048679200203
SECKEL SYNDROME 10; SCKL10	0.11453565999999998	4.291061687027202
GOOD SYNDROME	0.11430589	4.282453387709522
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.1138486	4.265321084993837
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.11369860000000001	4.259701357015197
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.1134408	4.250042917862572
AL AMYLOIDOSIS	0.11338956	4.248123218785069
HUGHES-STOVIN SYNDROME	0.11329120000000001	4.244438175825209
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.237098811085104
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.112882339	4.229120258484708
HASHIMOTO THYROIDITIS	0.11263740000000001	4.219943654808973
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.11230430899999999	4.20746444939475
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.1122428	4.205160023739829
SANDHOFF DISEASE	0.11204820000000001	4.197869363308873
SNEDDON SYNDROME	0.11201231900000003	4.196525086911529
CAREY-FINEMAN-ZITER SYNDROME	0.11176288999999999	4.187180266044965
MICROVILLUS INCLUSION DISEASE	0.11165655399999999	4.183196403416053
JOUBERT SYNDROME 2	0.11165655399999999	4.183196403416053
ACUTE INTERMITTENT PORPHYRIA	0.11165241899999999	4.183041486248109
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.1111285	4.163412937829166
REFSUM DISEASE	0.11111099999999999	4.162757302898325
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	4.162757302898325
LOEYS-DIETZ SYNDROME 3; LDS3	0.11111099999999999	4.162757302898325
WELL-DIFFERENTIATED LIPOSARCOMA	0.11111099999999999	4.162757302898325
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.11111099999999999	4.162757302898325
JESSNER LYMPHOCYTIC INFILTRATION OF THE SKIN	0.11111099999999999	4.162757302898325
NEUTROPHIL CHEMOTACTIC RESPONSE	0.11111099999999999	4.162757302898325
AORTIC ANEURYSM, ABDOMINAL	0.11111099999999999	4.162757302898325
INTERSTITIAL GRANULOMATOUS DERMATITIS WITH ARTHRITIS	0.11111099999999999	4.162757302898325
GREENBERG DYSPLASIA	0.11111099999999999	4.162757302898325
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.11111099999999999	4.162757302898325
SÉZARY SYNDROME	0.11111099999999999	4.162757302898325
RING CHROMOSOME 13 SYNDROME	0.11111099999999999	4.162757302898325
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.11111099999999999	4.162757302898325
PAGOD SYNDROME	0.11077089000000001	4.150015131679555
KAWASAKI DISEASE	0.11040813	4.13642438153601
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.109945	4.119073284077691
YUNIS-VARON SYNDROME	0.10946190400000001	4.100974163360562
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.10918121	4.090458003858984
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.10909864000000001	4.087364530931009
KLIPPEL-TRÉNAUNAY SYNDROME	0.10844861	4.063011252411304
WISKOTT-ALDRICH SYNDROME	0.10797127000000001	4.045127779389142
INSULIN AUTOIMMUNE SYNDROME	0.1072261	4.01721009473685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.106758864	3.9997051665913284
FONTAINE PROGEROID SYNDROME; FPS	0.10666075000000001	3.9960293399853533
ELLIS VAN CREVELD SYNDROME	0.1064618	3.9885757074430153
SCRUB TYPHUS	0.105917759	3.968193291248164
ALAGILLE SYNDROME 1; ALGS1	0.1052706	3.94394757432197
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.10470090000000001	3.922603847459093
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.10394717	3.8943654636634872
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.103888364	3.8921623055067402
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.10382638999999999	3.8898404586950845
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.103574954	3.8804204458681686
GAUCHER DISEASE, TYPE II	0.103488263	3.877172580280193
KINDLER SYNDROME	0.10319489000000001	3.8661814039050086
MARFAN SYNDROME; MFS	0.1025266	3.8411440171660356
NEONATAL MARFAN SYNDROME	0.1025266	3.8411440171660356
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.10220120000000002	3.8289529539377054
RENPENNING SYNDROME 1; RENS1	0.10119330900000001	3.791192465590237
6Q TERMINAL DELETION SYNDROME	0.10108697300000001	3.7872086029613254
COMMON VARIABLE IMMUNODEFICIENCY	0.10077069999999999	3.775359481448067
9Q31.1Q31.3 MICRODELETION SYNDROME	0.10065189000000001	3.7709082822404523
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.10054555400000001	3.7669244196115415
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.100541419	3.766769502443596
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.10023214900000002	3.7551827472972352
GRANGE SYNDROME; GRNG	0.1	3.7464853190938117
CRYPTOSPORIDIOSIS	0.1	3.7464853190938117
ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO	0.1	3.7464853190938117
NEUROTROPHIC KERATOPATHY	0.1	3.7464853190938117
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.1	3.7464853190938117
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.1	3.7464853190938117
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.1	3.7464853190938117
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.1	3.7464853190938117
IMMUNODEFICIENCY 15A; IMD15A	0.1	3.7464853190938117
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.1	3.7464853190938117
ARNOLD-CHIARI MALFORMATION TYPE I	0.1	3.7464853190938117
PEROXISOME BIOGENESIS DISORDER 11B	0.1	3.7464853190938117
KINDLER SYNDROME; KNDLRS	0.1	3.7464853190938117
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.1	3.7464853190938117
MENKES DISEASE	0.09968671900000001	3.734748292421301
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.09957260000000001	3.7304728408400054
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.09913806000000001	3.714192863534415
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7072635141476318
ACUTE ADRENAL INSUFFICIENCY	0.098826519	3.7025210257064565
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.09882350000000001	3.702407919314673
8P23.1 MICRODELETION SYNDROME	0.09872166299999999	3.698592611060267
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.6863112950005994
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.09814247300000001	3.676893342740608
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.6761207050732514
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.6761207050732514
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.6761207050732514
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.6761207050732514
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.6761207050732514
3M SYNDROME	0.09793689	3.6691912058270555
PLAGUE	0.09771865000000002	3.661014876266665
WERNER SYNDROME	0.09738284999999999	3.648434178565148
STORMORKEN SYNDROME; STRMK	0.09698400000000001	3.633491321869943
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.096945029	3.632031279076238
TAY-SACHS DISEASE; TSD	0.096945029	3.632031279076238
FAMILIAL CERVICAL ARTERY DISSECTION	0.09656188000000002	3.6176766580409843
NODULAR NON-SUPPURATIVE PANNICULITIS	0.09649120000000001	3.6150286422174487
MOHR-TRANEBJAERG SYNDROME	0.09640361	3.6117470957264537
MIRAGE SYNDROME; MIRAGE	0.095842853	3.590738417045663
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.09564571300000001	3.583352595887602
MUCOPOLYSACCHARIDOSIS TYPE 2	0.095441323	3.575695154543905
OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS	0.09496120000000001	3.557707416835313
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.094875179	3.554484652698975
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.094745569	3.5496288330768975
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.09432294000000001	3.533795099637665
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.0942983	3.53287196565504
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.09427282000000001	3.5319173611957346
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.09426257900000001	3.5315336836342066
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.09374142999999999	3.512008912858602
WAARDENBURG SYNDROME TYPE 2	0.09369369999999999	3.510220715415798
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.093527439	3.50399177145942
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.489407266084986
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.09313722000000002	3.489372273912106
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.09285711000000002	3.478877993884792
INTESTINAL LYMPHANGIECTASIA	0.09285711000000002	3.478877993884792
PELIZAEUS-MERZBACHER DISEASE	0.09264796300000001	3.471042332234467
TAY-SACHS DISEASE	0.09199607300000001	3.446619369087826
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.09199607300000001	3.446619369087826
PMM2-CDG	0.09199607300000001	3.446619369087826
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.09199607300000001	3.446619369087826
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.09193871	3.4444702727142347
CHROMOSOME 1P36 DELETION SYNDROME	0.091622073	3.432607513994415
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.09145051900000001	3.426180268570097
HUNTINGTON DISEASE-LIKE 3	0.09145051900000001	3.426180268570097
WIEDEMANN-STEINER SYNDROME	0.09145051900000001	3.426180268570097
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0914352	3.4256063444840645
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.09113168300000002	3.414235124638112
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0910714	3.4119766308932014
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.09104495900000001	3.4109860227099804
ALG12-CDG	0.09104454	3.410970324936493
X-LINKED DYSTONIA-PARKINSONISM	0.0909091	3.405896085220313
AUTOSOMAL DOMINANT COARCTATION OF AORTA	0.0909091	3.405896085220313
CLEFT VELUM	0.0909091	3.405896085220313
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.09063796900000001	3.3957382021098006
KRABBE DISEASE	0.090614919	3.394874637243749
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.090086344	3.3750716524683493
KEARNS-SAYRE SYNDROME; KSS	0.09002111900000001	3.37262800741897
SIALIDOSIS TYPE 2	0.089977573	3.370996562921918
FABRY DISEASE	0.08951060900000002	3.353501825216465
NON-FUNCTIONING PITUITARY ADENOMA	0.08925105900000002	3.343777822570757
X SMALL RINGS	0.08883780399999999	3.328295284665335
CLASSICAL EHLERS-DANLOS SYNDROME	0.08880671000000001	3.327130352520216
MULTIPLE CARBOXYLASE DEFICIENCY	0.08806991300000001	3.2995263610836925
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.087451019	3.27633958823294
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.08729937900000001	3.270658417895066
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0866013	3.2445049906443897
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.086582199	3.243789374483589
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.086480314	3.2399722679162304
PLUMMER-VINSON SYNDROME	0.08596490000000001	3.220662358073677
SCHINZEL-GIEDION SYNDROME	0.08551310000000001	3.20373573740201
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.08520094	3.1920407088299267
RFT1-CDG	0.08507216300000002	3.1872160974305586
SJÖGREN-LARSSON SYNDROME	0.08452660900000002	3.166776996912829
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.084491644	3.1654670383210077
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08442027300000002	3.162793134283918
KEUTEL SYNDROME; KTLS	0.08406617899999999	3.1495270545581247
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.08403317	3.1482903772191455
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08398519000000002	3.1464928135630448
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.08387885400000002	3.142508950934133
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08387471900000001	3.1423540337661886
HISTIOCYTOID CARDIOMYOPATHY	0.08387471900000001	3.1423540337661886
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08387471900000001	3.1423540337661886
603529 DYSERYTHROPOIESIS, CONGENITAL, WITH ULTRASTRUCTURALLY NORMAL ERYTHROBLASTHETEROCHROMATIN	0.08333330000000001	3.1220698504164037
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.08333330000000001	3.1220698504164037
ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	0.08333330000000001	3.1220698504164037
DPM3-CDG	0.08333330000000001	3.1220698504164037
MYCETOMA	0.08333330000000001	3.1220698504164037
BULLOUS IMPETIGO	0.08333330000000001	3.1220698504164037
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.08333330000000001	3.1220698504164037
UVEAL MELANOMA	0.08333330000000001	3.1220698504164037
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.08333330000000001	3.1220698504164037
BIRDSHOT CHORIORETINOPATHY	0.08333330000000001	3.1220698504164037
FAMILIAL MELANOMA	0.08333330000000001	3.1220698504164037
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.08333330000000001	3.1220698504164037
MARSHALL-SMITH SYNDROME; MRSHSS	0.08311772	3.113993177365501
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.0830565	3.111699579053152
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0829801	3.108837264269364
NOONAN SYNDROME	0.08275369	3.1003548468584037
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.082451209	3.0890224406003552
AMERICAN TRYPANOSOMIASIS	0.08229944	3.08333643729642
MU-HEAVY CHAIN DISEASE	0.08190979000000001	3.0687382572505713
DENT DISEASE	0.0810457	3.036365252256813
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0810457	3.036365252256813
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.08099965	3.0346399957673706
VIPOMA	0.08095241	3.0328701561026308
GLUCAGONOMA	0.08095241	3.0328701561026308
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.08078009	3.026414212600768
GLYCOGEN STORAGE DISEASE IV	0.08039551	3.0120059793605973
GRANGE SYNDROME	0.08034776	3.01021703262073
ACQUIRED HEMOPHILIA	0.08011799000000001	3.0016087333030486
IDIOPATHIC BRONCHIECTASIS	0.08010010000000001	3.000938487079462
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.079492954	2.9781918513239973
DUBOWITZ SYNDROME	0.07909411899999999	2.963249556601589
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9613272724492155
PACHYDERMOPERIOSTOSIS	0.0788706	2.954875450081204
OCULORENOCEREBELLAR SYNDROME	0.0787149	2.9490421724393747
KASABACH-MERRITT SYNDROME	0.07857146000000001	2.943668213897667
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.07841032	2.9376311274544786
MICROSCOPIC POLYANGIITIS	0.07822751	2.9307821776426435
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.07810364	2.926141406277882
GAPO SYNDROME	0.07799389	2.9220296386401765
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.07798160000000001	2.9215691955944605
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.07784329000000001	2.9163874317496217
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.07774309	2.912633453459889
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.9023517490095814
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.9023517490095814
FADD-RELATED IMMUNODEFICIENCY	0.07746451900000001	2.902196831841637
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.07735301900000001	2.898019500710847
NIEMANN-PICK DISEASE TYPE B	0.07713028999999999	2.889674991424482
POTOCKI-LUPSKI SYNDROME	0.077097763	2.888456372144741
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.07703760399999998	2.8862025240416265
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.07692310000000001	2.881912648491852
PEMPHIGUS VULGARIS, FAMILIAL	0.07692310000000001	2.881912648491852
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.881912648491852
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.881912648491852
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.07692310000000001	2.881912648491852
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.07692310000000001	2.881912648491852
AUTOIMMUNE DISEASE	0.07692310000000001	2.881912648491852
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.07688535	2.880498350283894
JUVENILE XANTHOGRANULOMA	0.07681160000000001	2.8777353173610623
HELLP SYNDROME	0.07680494000000002	2.8774858014388114
MEDULLOBLASTOMA	0.07623823399999999	2.856254244346386
ACQUIRED PARTIAL LIPODYSTROPHY	0.076199319	2.8547962995844616
TYROSINEMIA, TYPE I; TYRSN1	0.07619050999999999	2.854466271692702
ALPHA-THALASSEMIA	0.07610704	2.851339080396855
BUSCHKE-OLLENDORFF SYNDROME	0.07558556	2.8318019087548443
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.07540010999999999	2.8248540517305845
RHOMBENCEPHALOSYNAPSIS	0.0753589	2.8233101251305865
ALKAPTONURIA	0.07532480999999999	2.822032948285307
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.075138154	2.8150399086480995
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.07464605	2.7966033045334266
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.07461872	2.7955793900957175
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.07454820000000001	2.7929373686486936
MIXED CONNECTIVE TISSUE DISEASE	0.07425668900000001	2.78201595183015
WHIM SYNDROME	0.07380956	2.765264329487738
REVESZ SYNDROME	0.073777854	2.7640764688524664
GRISCELLI SYNDROME	0.073762673	2.763507714916175
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.07357727	2.7565616187400153
KOOLEN-DE VRIES SYNDROME; KDVS	0.073549173	2.7555089687599095
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.073391543	2.7496033839514222
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.07337811	2.749100118578508
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.07336580000000001	2.748638926235728
SCLERODERMA	0.07326708900000001	2.7449407331123976
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7309483972074986
CRYPTOCOCCOSIS	0.072796159	2.7272974097991884
DERMATOMYOSITIS	0.07276647	2.726185115772803
OROFACIODIGITAL SYNDROME IX; OFD9	0.07262604400000001	2.7209240762986124
OROFACIODIGITAL SYNDROME VIII; OFD8	0.07262604400000001	2.7209240762986124
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0719814	2.696772583478193
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.07197415400000001	2.696501113151972
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.696501113151972
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.696501113151972
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.071830223	2.6911087593673466
ATYPICAL HEMOLYTIC UREMIC SYNDROME	0.07142860000000001	2.6760620126342425
DIAMOND-BLACKFAN ANEMIA 13; DBA13	0.07142860000000001	2.6760620126342425
OCULOPHARYNGODISTAL MYOPATHY	0.07142860000000001	2.6760620126342425
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.6760620126342425
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.6760620126342425
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.07142860000000001	2.6760620126342425
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.0713074	2.671521272427501
BRONCHOPULMONARY DYSPLASIA	0.0712766	2.6703673549492195
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.07125146	2.6694254885399995
MEACHAM SYNDROME	0.07113230000000001	2.664961176633768
CONGENITAL RUBELLA SYNDROME	0.07105489899999999	2.662061359531935
FANCONI-LIKE SYNDROME	0.07087170000000001	2.6551978358922095
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.651739829942685
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.07074325	2.650385475499833
CLASSIC PHENYLKETONURIA	0.070548773	2.6430994232458187
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.07054724400000001	2.6430421394852903
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07051348	2.6417771761821514
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.07051347999999999	2.6417771761821505
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.07019114000000001	2.6297007554045844
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.06986159	2.6173542130355103
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.06921141	2.592995314787826
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.06921141	2.592995314787826
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.06916125	2.5911160777517686
ACROOSTEOLYSIS DOMINANT TYPE	0.06901523000000001	2.5856454598888283
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5735993856423454
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.068405563	2.5628043752384686
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.068405563	2.5628043752384686
IMMUNODEFICIENCY 52; IMD52	0.06833931	2.5603222163200092
JEUNE SYNDROME	0.06825559	2.5571856588108637
PRIMARY SCLEROSING CHOLANGITIS	0.06806321000000001	2.5499781703539917
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.06785990900000001	2.5423615282354204
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0677778	2.5392853266047655
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.067633514	2.5338796727972577
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.06735561400000001	2.5234681900954965
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.06734583	2.523101633971876
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.06731859	2.5220810913709544
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06731859	2.5220810913709544
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.06731859	2.5220810913709544
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.06731859	2.5220810913709544
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.067212254	2.518097228742043
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.067212254	2.518097228742043
PETERS PLUS SYNDROME	0.067212254	2.518097228742043
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5179423115740986
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.06708796	2.5134405722795288
ICF SYNDROME	0.066892334	2.5061114729091982
DYSKERATOSIS CONGENITA	0.066892334	2.5061114729091982
SYNDROMIC DIARRHEA	0.06673235400000001	2.5001178456957125
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.4976581282243138
MANTLE CELL LYMPHOMA	0.0666667	2.4976581282243138
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.0666667	2.4976581282243138
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.4976581282243138
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.4976581282243138
CONGENITAL UNILATERAL PULMONARY HYPOPLASIA	0.0666667	2.4976581282243138
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0666667	2.4976581282243138
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.4976581282243138
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.4976581282243138
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.4976581282243138
DUODENAL ATRESIA	0.0666667	2.4976581282243138
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.066466414	2.490154442638114
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.06625974400000001	2.482411581429143
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.06614964	2.4782865512334076
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0660173	2.473328452562119
BARE LYMPHOCYTE SYNDROME, TYPE II	0.06596636	2.4714199929405725
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.06592466	2.46985770856251
GOODPASTURE SYNDROME	0.0657895	2.4647939590052235
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.06571419	2.461972480911414
RETICULAR DYSGENESIS	0.06569489	2.4612494092448287
UMBILICAL CORD ULCERATION-INTESTINAL ATRESIA SYNDROME	0.06569489	2.4612494092448287
STEVENS-JOHNSON SYNDROME	0.06569489	2.4612494092448287
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.06567971	2.46068069277339
RETT SYNDROME; RTT	0.065511319	2.4543719486797144
NEPHRONOPHTHISIS 1	0.06544305	2.4518142606172226
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.065411554	2.450634267601121
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.0650623	2.437549517764773
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.0650623	2.437549517764773
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.0650623	2.437549517764773
CAT-EYE SYNDROME	0.0649699	2.43408776532993
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0648604	2.4299853639055224
ACROCEPHALOPOLYDACTYLY	0.06467980000000001	2.4232192114192395
MONOSOMY 22	0.06467980000000001	2.4232192114192395
POLYMYOSITIS	0.06450201	2.4165583351704223
JUVENILE DERMATOMYOSITIS	0.06450201	2.4165583351704223
INIENCEPHALY	0.06431801	2.4096648021832894
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.4094246524743355
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.0642595	2.407472733623088
MATERNAL PHENYLKETONURIA	0.064244873	2.4069247352154637
2Q37 MICRODELETION SYNDROME	0.064238863	2.406699571447786
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.06418444400000001	2.404660771601989
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.06418444400000001	2.404660771601989
CHROMOSOME 18Q DELETION SYNDROME	0.064180309	2.4045058544340447
CYSTIC FIBROSIS	0.0640845	2.4009163843146735
MUCOLIPIDOSIS IV; ML4	0.06403765400000001	2.3991613058020915
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.064030564	2.3988956799929673
MYELOPEROXIDASE DEFICIENCY	0.0638946	2.3938018086937145
COMPLEMENT COMPONENT C1R DEFICIENCY	0.06383360999999999	2.3915168272975986
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.063703454	2.3866405518656797
SHWACHMAN-DIAMOND SYNDROME	0.063701104	2.3865525094606808
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.06349210000000001	2.378722205284362
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.06349210000000001	2.378722205284362
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.06345742	2.3774229241757006
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.06345714	2.3774124340168066
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.06322340900000001	2.368655736415636
OSLAM SYNDROME	0.06315189	2.365976287580273
STORM SYNDROME	0.062987	2.3597987079376193
AORTIC VALVE DISEASE 1; AOVD1	0.062987	2.3597987079376193
COCAINE EMBRYOFETOPATHY	0.0627273	2.3500690855639323
RECOMBINANT 8 SYNDROME	0.062596773	2.345178910671479
GAUCHER DISEASE, TYPE IIIC	0.062589619	2.3449108871117508
HOLT-ORAM SYNDROME	0.0625	2.3415533244336326
BARTH SYNDROME	0.0625	2.3415533244336326
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.0625	2.3415533244336326
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0625	2.3415533244336326
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.0625	2.3415533244336326
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.0625	2.3415533244336326
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0625	2.3415533244336326
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.062455790000000004	2.339897003274061
COACH SYNDROME	0.062448133	2.339610134893178
DISTAL MONOSOMY 15Q	0.062265163000000005	2.332755190704832
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.062248160000000004	2.3321181758060265
ALAGILLE SYNDROME	0.062248160000000004	2.3321181758060265
ALAGILLE SYNDROME 2	0.062248160000000004	2.3321181758060265
WHITE-SUTTON SYNDROME; WHSUS	0.062247554000000004	2.332095472104993
SOMATOSTATINOMA	0.06215541	2.328643310672567
NEPHRONOPHTHISIS 4	0.06201839	2.3235098764883446
NOONAN SYNDROME 2; NS2	0.061723744000000004	2.3124710073550476
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.061723744000000004	2.3124710073550476
NOONAN SYNDROME 10; NS10	0.06117819000000001	2.2920319068373187
ACROCARDIOFACIAL SYNDROME	0.061067719000000006	2.2878931270404625
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.060805453999999995	2.278067407318341
HEREDITARY FOLATE MALABSORPTION	0.060754173	2.2761461721818566
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.060562363	2.2689600386913025
ALSTROM SYNDROME; ALMS	0.060373303999999996	2.2618769710118767
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.060360300000000006	2.261389778060982
ADAMS-OLIVER SYNDROME 1; AOS1	0.06024589300000001	2.2571035366019667
GAUCHER DISEASE	0.060068750000000004	2.2504669001131643
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0600359	2.249236179685842
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.059910473	2.244537075544662
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.05980392	2.240545083042608
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.05947539	2.228236754823789
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.05947539	2.228236754823789
CRANIOECTODERMAL DYSPLASIA 3	0.05947539	2.228236754823789
ANE SYNDROME	0.05947539	2.228236754823789
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.059402380000000005	2.2255014458923186
ARIMA SYNDROME	0.059369054	2.224252892194877
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.059369054	2.224252892194877
OCULOFACIOCARDIODENTAL SYNDROME	0.059369054	2.224252892194877
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.059364919	2.224097975026933
TRISOMY 8P	0.059364919	2.224097975026933
MOYAMOYA DISEASE	0.059364919	2.224097975026933
ZUNICH NEUROECTODERMAL SYNDROME	0.059364919	2.224097975026933
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.059364919	2.224097975026933
GAPO SYNDROME; GAPOS	0.059364919	2.224097975026933
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.059364919	2.224097975026933
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.059364919	2.224097975026933
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.05934724999999999	2.2234360085359017
PARTIAL ATRIOVENTRICULAR CANAL	0.059227600000000005	2.2189533388516067
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.05917476900000001	2.2169740331926766
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.059027800000000005	2.211467861184057
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.059027800000000005	2.211467861184057
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.0588235	2.2038137916771485
JUNG SYNDROME	0.0588235	2.2038137916771485
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.0588235	2.2038137916771485
SPINOCEREBELLAR ATAXIA TYPE 4	0.0588235	2.2038137916771485
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0588235	2.2038137916771485
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	2.2038137916771485
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.0588235	2.2038137916771485
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	2.2038137916771485
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0588235	2.2038137916771485
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0588235	2.2038137916771485
AFRICAN IRON OVERLOAD	0.0588235	2.2038137916771485
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	2.2038137916771485
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	2.2038137916771485
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0588235	2.2038137916771485
CONGENITAL ANALBUMINEMIA	0.0588235	2.2038137916771485
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0588235	2.2038137916771485
LYME DISEASE	0.05835695	2.1863345644209162
NEONATAL ACUTE RESPIRATORY DISTRESS DUE TO SP-B DEFICIENCY	0.058264460000000004	2.182869440149286
ANTLEY-BIXLER SYNDROME	0.05812611	2.17768617771032
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.0580808	2.1759886452122386
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1646409158292355
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0574407	2.152007392684719
LICHTENSTEIN SYNDROME	0.057332570000000006	2.147956318109183
FAMILIAL ATRIAL MYXOMA	0.05714281	2.1408469875676706
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056753044	2.1262444615988514
LIGNEOUS CONJUNCTIVITIS	0.05629675399999999	2.1091496237363576
SCIMITAR SYNDROME	0.05582776	2.0915788323789273
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0557029	2.0869009708095065
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.081382397934482
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.081382397934482
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.081382397934482
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.081382397934482
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.081382397934482
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.081382397934482
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.081382397934482
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.081382397934482
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.081382397934482
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.081382397934482
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.081382397934482
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.081382397934482
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	2.081382397934482
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.081382397934482
JUVENILE IDIOPATHIC ARTHRITIS	0.05550021	2.0793072197162354
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.05497831	2.059754312835885
NIJMEGEN BREAKAGE SYNDROME	0.05456239	2.04417193109671
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.054437673	2.039499427001296
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.054370463	2.036981414218333
TUFTSIN DEFICIENCY	0.05433041	2.0354808344534763
CUTIS LAXA	0.054328944	2.0354259109786983
COG2-CDG	0.05426045399999999	2.0328599431836505
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.054232800000000005	2.031823890133509
PERIVENTRICULAR NODULAR HETEROTOPIA	0.054093600000000006	2.02660878256933
PSEUDOTRISOMY 13 SYNDROME	0.0540046	2.0232744106353366
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.053824909000000004	2.016542313700604
SCHNITZLER SYNDROME	0.053799099999999996	2.0155753833045984
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.053718573	2.0125584510716923
MYH9-RELATED DISEASE	0.053714899999999996	2.0124208426659216
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	0.053714899999999996	2.0124208426659216
NAIL-PATELLA SYNDROME	0.05328349	1.9962581303508193
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.05328349	1.9962581303508193
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.05327356	1.9958861043586331
48,XYYY SYNDROME	0.053177154	1.9922742677219076
KLEEFSTRA SYNDROME	0.053173019	1.9921193505539632
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.053173019	1.9921193505539632
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.053173019	1.9921193505539632
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.05311351	1.9898898546054236
MEGALOBLASTIC ANEMIA 1	0.05311351	1.9898898546054236
GAUCHER DISEASE, PERINATAL LETHAL	0.053086119	1.9888636548116705
INTERNAL CAROTID AGENESIS	0.05299534	1.9854626329038505
PULMONARY HEMOSIDEROSIS	0.052941100000000005	1.9834305392667742
BEHÇET DISEASE	0.052719949	1.9751451495187449
MÉNÉTRIER DISEASE	0.0526316	1.9718351672041785
CONGENITAL BILATERAL ABSENCE OF VAS DEFERENS	0.0526316	1.9718351672041785
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.0526316	1.9718351672041785
BETA-THALASSEMIA	0.0526316	1.9718351672041785
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.0526316	1.9718351672041785
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.0526316	1.9718351672041785
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0526316	1.9718351672041785
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.0526316	1.9718351672041785
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.0526316	1.9718351672041785
ACRORENAL SYNDROME	0.0526316	1.9718351672041785
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0526316	1.9718351672041785
IRON-REFRACTORY IRON DEFICIENCY ANEMIA	0.0526316	1.9718351672041785
CONGENITAL MEMBRANOUS NEPHROPATHY DUE TO FETOMATERNAL ANTI-NEUTRAL ENDOPEPTIDASE ALLOIMMUNIZATION	0.0526316	1.9718351672041785
GLOMUVENOUS MALFORMATION	0.0526316	1.9718351672041785
IMMUNODEFICIENCY 21; IMD21	0.05259736	1.9705523706309207
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.05230499999999999	1.959599146152018
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.05230499999999999	1.959599146152018
PROGRESSIVE NON-FLUENT APHASIA	0.05230499999999999	1.959599146152018
DUBOWITZ SYNDROME	0.05216591	1.9543881597216908
AMYLOIDOSIS	0.052139099999999994	1.9533837270076415
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9212431539630803
CONGENITAL DISORDER OF GLYCOSYLATION	0.051230383000000004	1.919338778010532
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9174931094829335
POLYCYSTIC KIDNEY DISEASE 3	0.051043660000000005	1.9123432282281603
OSTEOGENESIS IMPERFECTA, TYPE X	0.050651890000000005	1.8976656226935464
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0505747	1.894773710675738
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.050545554	1.8936817600646347
FRAGILE X SYNDROME	0.050541419000000004	1.8935268428966905
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.050541419000000004	1.8935268428966905
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.050360373	1.8867439810858837
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.05028479	1.883912275087153
IMMUNODEFICIENCY 57; IMD57	0.05	1.8732426595469058
HYPOPLASTIC LEFT HEART SYNDROME	0.05	1.8732426595469058
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.05	1.8732426595469058
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.05	1.8732426595469058
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.05	1.8732426595469058
BLOOM SYNDROME	0.05	1.8732426595469058
FAMILIAL PAPILLARY OR FOLLICULAR THYROID CARCINOMA	0.05	1.8732426595469058
RESTRICTIVE DERMOPATHY	0.05	1.8732426595469058
FAMILIAL PAPILLARY THYROID CARCINOMA WITH RENAL PAPILLARY NEOPLASIA	0.05	1.8732426595469058
FAMILIAL THROMBOCYTOSIS	0.04989651900000001	1.8693657590738548
CONGENITAL LOBAR EMPHYSEMA	0.049848	1.8675480018618833
NON-DISTAL TRISOMY 10Q	0.04979604	1.8656013280900818
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.049718703	1.8627039087388546
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.049492509999999997	1.8542296212010363
RIDDLE SYNDROME	0.049275094	1.8460841626796756
MCLEOD SYNDROME; MCLDS	0.0490852	1.838969811847836
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.838657130183104
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.04902515	1.8367200474137197
12Q14 MICRODELETION SYNDROME	0.048816444	1.8289009077636518
RETINAL VENOUS BEADING	0.048809559999999995	1.828642999714285
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.048705973	1.8247621279667958
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.048705973	1.8247621279667958
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.048705973	1.8247621279667958
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.8192786596592105
FEINGOLD SYNDROME	0.048270890000000004	1.8084618072459229
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.048270890000000004	1.8084618072459229
LESCH-NYHAN SYNDROME; LNS	0.048270890000000004	1.8084618072459229
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.048164554	1.8044779446170112
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.048160419	1.8043230274490667
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.048140339000000004	1.8035707331969928
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.048089099999999996	1.801651071584342
PRIMARY BILIARY CHOLANGITIS	0.04798531	1.7977625944716549
COCKAYNE SYNDROME A; CSA	0.047922089	1.7953940289880705
TRICHOTHIODYSTROPHY	0.047920304	1.7953271542251243
GAUCHER DISEASE, TYPE I	0.047765510000000004	1.7895278197402866
BETA-THALASSEMIA MAJOR	0.04766542	1.7857779625844055
EOSINOPHILOPENIA	0.0476407	1.7848518314135258
ANEURYSM, INTRACRANIAL BERRY, 1	0.047619	1.784038844099282
BODY SKIN HYPERLAXITY DUE TO VITAMIN K-DEPENDENT COAGULATION FACTOR DEFICIENCY	0.047619	1.784038844099282
CEPHALIN LIPIDOSIS	0.047619	1.784038844099282
FORMIMINOTRANSFERASE DEFICIENCY	0.047619	1.784038844099282
PERNICIOUS ANEMIA	0.047619	1.784038844099282
ACROCEPHALOSYNDACTYLY	0.047619	1.784038844099282
PANCREATIC COLIPASE DEFICIENCY	0.047619	1.784038844099282
CEROID STORAGE DISEASE	0.047619	1.784038844099282
GLYCOGEN STORAGE DISEASE II	0.047619	1.784038844099282
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.047619	1.784038844099282
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.047619	1.784038844099282
MEESTER-LOEYS SYNDROME; MRLS	0.047619	1.784038844099282
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0475924	1.7830422790044032
AUTOSOMAL DOMINANT CUTIS LAXA	0.0475924	1.7830422790044032
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.0474093	1.7761824643851427
OCULOECTODERMAL SYNDROME; OES	0.047327573000000005	1.7731205743284069
X-LINKED AGAMMAGLOBULINEMIA	0.04724105	1.769879002835767
JUVENILE POLYPOSIS SYNDROME	0.047173650000000004	1.767353871730698
INCONTINENTIA PIGMENTI	0.046986263	1.7603334452858075
KLEEFSTRA SYNDROME	0.046747963000000003	1.751405570770407
TRISOMY 12P	0.046691954	1.7493072018080358
OVARIAN HYPERSTIMULATION SYNDROME	0.04656081	1.7443939111011633
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.04656081	1.7443939111011633
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.046363313999999996	1.7369947524553657
AMISH INFANTILE EPILEPSY SYNDROME	0.046314350000000004	1.7351603233837247
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.046312040000000006	1.735073779572854
PRIMARY MYELOFIBROSIS	0.04615919	1.7293472767626188
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.04611745	1.7277834937904288
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.04611745	1.7277834937904288
ACETOPHENETIDIN SENSITIVITY	0.046110700000000004	1.7275306060313904
WHIPPLE DISEASE	0.046078619	1.7263286960761717
GALLOWAY-MOWAT SYNDROME	0.046008103	1.7236868244885597
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.046000054	1.7233852698852254
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.04594215	1.7212159050260574
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.0454545	1.7029461693674968
CHLORAMPHENICOL TOXICITY	0.0454545	1.7029461693674968
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.0454545	1.7029461693674968
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0454545	1.7029461693674968
DERMATITIS HERPETIFORMIS	0.045416	1.7015037725196456
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.04528169900000001	1.6964722052712495
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.045238110000000005	1.6948391497855098
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.04509136	1.6893411825797393
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.04509136	1.6893411825797393
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.04509136	1.6893411825797393
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.04509136	1.6893411825797393
ALPORT SYNDROME, X-LINKED; ATS	0.04509136	1.6893411825797393
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.045090873000000004	1.6893229371962355
HARDIKAR SYNDROME	0.045009099999999996	1.6862593237562526
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.683127636678022
FAMILIAL MEDITERRANEAN FEVER	0.044840729	1.6799513289596415
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.044607900000000006	1.6712284246560485
KEUTEL SYNDROME	0.044486123	1.6666660672290157
HYPERLYSINEMIA, TYPE I	0.044422949	1.6642992625935313
MASP2 DEFICIENCY	0.044387499999999996	1.6629711710127657
PINEOBLASTOMA	0.044333859	1.6609615188227507
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.65961634326893
SLC39A8-CDG	0.044289829	1.6593119413367534
AORTIC VALVE DISEASE 3; AOVD3	0.044237	1.6573327106075293
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.04413019000000001	1.6533310896382054
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.04413019000000001	1.6533310896382054
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04413019000000001	1.6533310896382054
CHOREOACANTHOCYTOSIS	0.044082719	1.6515525955923784
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.04407655	1.6513214749130434
HYDROXYKYNURENINURIA	0.044023854	1.649347227009294
CADASIL	0.043987309	1.647978073949431
BETA-THALASSEMIA ASSOCIATED WITH ANOTHER HEMOGLOBIN ANOMALY	0.043885999999999994	1.6441825471375098
PREPAPILLARY VASCULAR LOOPS	0.0435606	1.6319914839091787
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	1.6289081264915648
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.6289081264915648
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.6289081264915648
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.6289081264915648
HYPOPLASMINOGENEMIA	0.043478300000000004	1.6289081264915648
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.6289081264915648
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	1.6289081264915648
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.043424660000000004	1.6268985117664028
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.04335084	1.6241328563038477
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.620982961306966
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6203082193009977
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.04320929	1.6188297063346704
BRAIN-LUNG-THYROID SYNDROME	0.043154204	1.6167659174317945
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.042933073	1.608481276980829
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.042923214	1.6081119109932196
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04292174	1.6080566877996163
DISTAL MONOSOMY 12Q	0.04286414399999999	1.6058988621152306
PHACE SYNDROME	0.042863273	1.6058662302281017
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.601867868701005
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.601867868701005
ADULT-ONSET DYSTONIA-PARKINSONISM	0.04275367299999999	1.6017600823183744
YUNIS-VARON SYNDROME	0.04274726	1.6015198202148615
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042673844	1.5987693005529955
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.042627203	1.5970219023353172
MYASTHENIA GRAVIS; MG	0.0425697	1.5948675608822782
NIJMEGEN BREAKAGE SYNDROME	0.04251419	1.5927878868816494
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.042425710000000005	1.5894729966713155
OGDEN SYNDROME; OGDNS	0.042391654	1.5881970936310446
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.042318589999999996	1.5854597615975015
THYROCEREBRORENAL SYNDROME	0.042208118999999995	1.5813209818006455
THYROCEREBRORETINAL SYNDROME	0.042208118999999995	1.5813209818006455
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.042208118999999995	1.5813209818006455
IMMUNOGLOBULIN A VASCULITIS	0.042081649	1.5765828018175876
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.04192304399999999	1.5706406887772386
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.041761160000000005	1.5645757284832775
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.041735629	1.5636192133164595
ALG1-CDG	0.041706573000000004	1.5625306345421437
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.041666699999999994	1.561036798450861
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.041666699999999994	1.561036798450861
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.041666699999999994	1.561036798450861
AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22	0.041666699999999994	1.561036798450861
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.041666699999999994	1.561036798450861
DYSCHONDROSTEOSIS AND NEPHRITIS	0.041666699999999994	1.561036798450861
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.041666699999999994	1.561036798450861
PERRY SYNDROME	0.041666699999999994	1.561036798450861
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.041666699999999994	1.561036798450861
FECHTNER SYNDROME	0.041666699999999994	1.561036798450861
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.041666699999999994	1.561036798450861
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.041666699999999994	1.561036798450861
CONGENITAL ATRANSFERRINEMIA	0.04164261	1.5601342701374914
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.0415952	1.558358061447709
LETTERER-SIWE DISEASE	0.04125385	1.5455694338109824
ACUTE PROMYELOCYTIC LEUKEMIA	0.04125385	1.5455694338109824
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.041232194	1.5447580949502795
PELIZAEUS-MERZBACHER DISEASE	0.041193309	1.5433012741339498
DIAMOND-BLACKFAN ANEMIA 8	0.041128050000000006	1.5408563552795627
DIAMOND-BLACKFAN ANEMIA 4	0.041128050000000006	1.5408563552795627
NOCARDIOSIS	0.041083259	1.539178267040287
MONOSOMY 18Q	0.041041663	1.5376198790069568
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.04103016	1.5371889208007017
ANTISYNTHETASE SYNDROME	0.04103016	1.5371889208007017
HURLER SYNDROME	0.041023444000000006	1.5369373068466714
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.04065189	1.5230170907841654
KAPUR-TORIELLO SYNDROME	0.040541419	1.5188783109873092
7Q11.23 MICRODUPLICATION SYNDROME	0.040496109	1.517180778489228
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.040476160000000004	1.5164333921329218
NEPHROSIALIDOSIS	0.04043991	1.5150752912047503
RECURRENT ACUTE PANCREATITIS	0.040368229	1.5123897730631706
GASTROINTESTINAL STROMAL TUMOR	0.04023189	1.5072818524439713
APOLIPOPROTEIN A-I DEFICIENCY	0.04023189	1.5072818524439713
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0400144	1.499133621523474
OSTEOGENESIS IMPERFECTA, TYPE V	0.040003689999999995	1.498732372945799
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.04	1.4985941276375248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.04	1.4985941276375248
3Q13 MICRODELETION SYNDROME	0.04	1.4985941276375248
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.04	1.4985941276375248
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.04	1.4985941276375248
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.04	1.4985941276375248
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.04	1.4985941276375248
MECKEL SYNDROME, TYPE 5	0.04	1.4985941276375248
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.039826	1.4920752431823014
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.03979085	1.49075835359264
LINEAR VERRUCOUS NEVUS SYNDROME	0.039616619000000006	1.48423081475633
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.03940096	1.476151181982025
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.03940096	1.476151181982025
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.039369229000000006	1.4749623847254236
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.0393028	1.4724736319928025
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.4723818431024847
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4723818431024847
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.039272100000000004	1.471323460999841
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.039113390000000005	1.4653774141499072
CRANIOFACIOFRONTODIGITAL SYNDROME	0.039113390000000005	1.4653774141499072
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.039113390000000005	1.4653774141499072
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.039113390000000005	1.4653774141499072
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.039007054	1.4613935515209955
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.039002919000000004	1.461238634353051
NORRIE DISEASE	0.038916739000000006	1.4580099133050561
SRD5A3-CDG	0.038839583	1.4551192750922557
HALLERMANN-STREIFF SYNDROME	0.038827810000000004	1.4546782013756392
ADIPOSIS DOLOROSA	0.038722969	1.450750348702248
LEPTOSPIROSIS	0.038709640000000003	1.450250979674066
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.038709640000000003	1.450250979674066
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.038674700000000006	1.4489419577035745
GANGLIOCYTOMA	0.03864865	1.4479659982779505
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4431948492240843
THORACOLARYNGOPELVIC DYSPLASIA	0.0384615	1.4409544510032666
KNIEST DYSPLASIA	0.0384615	1.4409544510032666
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.0384615	1.4409544510032666
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0384615	1.4409544510032666
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0384615	1.4409544510032666
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0384615	1.4409544510032666
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.0384615	1.4409544510032666
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.0384615	1.4409544510032666
FACIOCARDIOMELIC SYNDROME	0.0384615	1.4409544510032666
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0384615	1.4409544510032666
CHILBLAIN LUPUS 1	0.0384615	1.4409544510032666
GAUCHER DISEASE TYPE 3	0.03826132	1.4334547366915045
TETRASOMY X	0.038261104	1.433446644283215
16P13.11 MICRODELETION SYNDROME	0.038234444	1.4324478312971447
NEONATAL ADRENOLEUKODYSTROPHY	0.038230309000000004	1.4322929141292005
NAIL-PATELLA SYNDROME	0.03820016	1.4311633862703466
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.4264630457890117
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.037907460000000004	1.420197423741359
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.419290774294138
TRANSALDOLASE DEFICIENCY	0.037817590000000005	1.4168304573850896
INFANTILE LIVER FAILURE SYNDROME 1	0.03761516300000001	1.4092465595482078
LISSENCEPHALY 2; LIS2	0.037582554	1.408024868150504
300270 ADRENOMYODYSTROPHY	0.037582554	1.408024868150504
VISCERAL STEATOSIS, CONGENITAL	0.037578419	1.4078699509825596
SCHWARTZ-JAMPEL SYNDROME	0.03748775	1.4044730502085905
DIAMOND-BLACKFAN ANEMIA 10	0.037180080000000004	1.3929462388273346
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3875857676327752
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.3875857676327752
CHRISTIANSON SYNDROME	0.037037	1.3875857676327752
RHYNS SYNDROME	0.037037	1.3875857676327752
ADENOMYOSIS	0.037037	1.3875857676327752
TESTICULAR TORSION	0.037037	1.3875857676327752
RCAD (RENAL CYSTS AND DIABETES)	0.037037	1.3875857676327752
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.037037	1.3875857676327752
PEYRONIE DISEASE	0.037037	1.3875857676327752
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	1.3875857676327752
GALACTORRHEA	0.037037	1.3875857676327752
NATHALIE SYNDROME	0.037037	1.3875857676327752
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.3875857676327752
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	1.3875857676327752
DK PHOCOMELIA SYNDROME	0.037037	1.3875857676327752
URINARY BLADDER, ATONY OF	0.037037	1.3875857676327752
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.3875857676327752
FRYNS MICROPHTHALMIA SYNDROME	0.037037	1.3875857676327752
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.037037	1.3875857676327752
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3875857676327752
CONGENITAL RESPIRATORY-BILIARY FISTULA	0.037037	1.3875857676327752
CANAVAN DISEASE	0.037037	1.3875857676327752
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.3875857676327752
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.3875857676327752
GENITOURINARY TRACT ANOMALIES	0.037037	1.3875857676327752
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.3875857676327752
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3875857676327752
POLAND SYNDROME	0.037037	1.3875857676327752
BUTYRYLCHOLINESTERASE DEFICIENCY	0.037037	1.3875857676327752
MYOCLONUS AND ATAXIA	0.037037	1.3875857676327752
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.3875857676327752
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.3875857676327752
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.036933299999999995	1.3837006623568746
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.036911744	1.382893069981491
AORTIC VALVE DISEASE 2; AOVD2	0.0368421	1.3802838677458613
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.036801273	1.3787542901846348
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765932999999994	1.3774302822728668
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.036646299	1.3729482120262224
MUSCULAR HYPERTONIA, LETHAL	0.0366162	1.3718205574100284
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.036559629999999996	1.3697011706650168
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.03636619000000001	1.362453969463762
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.03636619000000001	1.362453969463762
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.036259854	1.3584701068348504
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.036255719000000006	1.358315189666906
THUMBS, CONGENITAL CLASPED	0.0361093	1.3528296233275416
ALG13-CDG	0.03590774	1.3452782075183762
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.035832879	1.3424735511436494
PRIMARY HYPEROXALURIA TYPE 1	0.03576139	1.3397952262538824
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	1.3380310063171212
COWDEN SYNDROME 7; CWS7	0.035714300000000004	1.3380310063171212
HYPOALPHALIPOPROTEINEMIA	0.035714300000000004	1.3380310063171212
THYROID LYMPHOMA	0.035714300000000004	1.3380310063171212
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.035714300000000004	1.3380310063171212
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.3380310063171212
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.3380310063171212
219400 CYANOSIS AND HEPATIC DISEASE	0.035714300000000004	1.3380310063171212
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.035714300000000004	1.3380310063171212
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.035714300000000004	1.3380310063171212
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.3380310063171212
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.3380310063171212
GASTRIC SNEEZING	0.035714300000000004	1.3380310063171212
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.3380310063171212
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.3380310063171212
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1	0.035714300000000004	1.3380310063171212
TERATOMA, PINEAL	0.035714300000000004	1.3380310063171212
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	1.3380310063171212
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.3380310063171212
METHANE PRODUCTION	0.035714300000000004	1.3380310063171212
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.3380310063171212
BLUE DIAPER SYNDROME	0.035714300000000004	1.3380310063171212
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.3380310063171212
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.035714300000000004	1.3380310063171212
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.3380310063171212
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.035714300000000004	1.3380310063171212
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.035676109	1.336600186108906
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.035676109	1.336600186108906
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3362308201212965
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3362308201212965
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03566625	1.3362308201212965
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3362308201212965
IMMUNODEFICIENCY 49; IMD49	0.035569773	1.3326163234799944
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.3249671618688539
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.035357373000000004	1.3246587886622394
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.03532655	1.323504009492335
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.03532655	1.323504009492335
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.03532655	1.323504009492335
MILLER-DIEKER SYNDROME	0.035316919	1.3231431854912532
C SYNDROME	0.035259219	1.320981463462136
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0352092	1.3191075089703785
COCKAYNE SYNDROME	0.035184669	1.3181884586567514
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0351655	1.3174702948859343
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.03513469	1.3163160027591216
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.035108763999999994	1.315344688975293
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.035024219	1.3121772229622655
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.035024219	1.3121772229622655
LYMPHANGIOLEIOMYOMATOSIS	0.034991469	1.310950249020262
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.034931199999999996	1.3086922797832974
CHROMOSOME 16P13.3 DELETION SYNDROME	0.034825383	1.304727861413192
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.304528061351125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.034803472999999994	1.3039070064797784
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.03467466	1.2990810463456943
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03461480399999999	1.296838550093097
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.034594454	1.2960761403306618
CHROMOSOME 15Q25 DELETION SYNDROME	0.034530744	1.2936892545338674
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.034530744	1.2936892545338674
DIAMOND-BLACKFAN ANEMIA 5	0.034530744	1.2936892545338674
INCONTINENTIA PIGMENTI; IP	0.034526609	1.2935343373659227
PANNER DISEASE	0.0344828	1.2918930396124808
FLOOD FACTOR DEFICIENCY	0.0344828	1.2918930396124808
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.0344828	1.2918930396124808
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.0344828	1.2918930396124808
COUMARIN RESISTANCE	0.0344828	1.2918930396124808
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.0344828	1.2918930396124808
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.0344828	1.2918930396124808
CHANARIN-DORFMAN SYNDROME	0.0344828	1.2918930396124808
HEMOPOIETIC PROLIFERATION	0.0344828	1.2918930396124808
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.0344828	1.2918930396124808
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0344828	1.2918930396124808
MACROCYTOSIS, FAMILIAL	0.0344828	1.2918930396124808
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.0344828	1.2918930396124808
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.0344828	1.2918930396124808
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.0344828	1.2918930396124808
MYELOMA, MULTIPLE	0.0344828	1.2918930396124808
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0344828	1.2918930396124808
OMODYSPLASIA 1; OMOD1	0.0344828	1.2918930396124808
GIANT NEUTROPHIL LEUKOCYTES	0.0344828	1.2918930396124808
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.0344828	1.2918930396124808
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.0344828	1.2918930396124808
SULFHEMOGLOBINEMIA, CONGENITAL	0.0344828	1.2918930396124808
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.034420273	1.289550474737011
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.034270400000000006	1.2839355047947258
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.03411099	1.277963232547558
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.03401585	1.2743988264149724
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.03391132	1.2704826253109236
TRANSKETOLASE DEFICIENCY	0.033878854	1.2692662913872266
JERVELL AND LANGE-NIELSEN SYNDROME	0.033874719000000005	1.269111374219282
HYPERCALCEMIA, INFANTILE, 1	0.0338203	1.2670725743734843
TRICHOHEPATOENTERIC SYNDROME 1	0.03371333	1.2630649590276497
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.033695559	1.2623991711215936
BOHRING-OPITZ SYNDROME	0.033608483	1.2591368815651396
NIEMANN-PICK DISEASE, TYPE A	0.033455544	1.2534070443829703
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.033451409	1.253252127215026
GLYCOGEN STORAGE DISEASE IB	0.033441610000000004	1.2528850091186083
FETAL ALCOHOL SYNDROME	0.033418484	1.2520185969237143
PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A	0.0333333	1.2488271908694974
GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS; GURDP	0.0333333	1.2488271908694974
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0333333	1.2488271908694974
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.0333333	1.2488271908694974
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.0333333	1.2488271908694974
BREATH-HOLDING SPELLS	0.0333333	1.2488271908694974
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0333333	1.2488271908694974
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.0333333	1.2488271908694974
PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2	0.0333333	1.2488271908694974
PEUTZ-JEGHERS SYNDROME	0.0333333	1.2488271908694974
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q) CHROMOSOME ABNORMALITY	0.0333333	1.2488271908694974
DIAMOND-BLACKFAN ANEMIA 3	0.0333333	1.2488271908694974
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.0333333	1.2488271908694974
RETINOBLASTOMA	0.0333333	1.2488271908694974
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0333333	1.2488271908694974
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.03327231	1.2465422094733822
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.03327231	1.2465422094733822
HYPER-IGD SYNDROME	0.03325325	1.2458281293715627
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.03319991	1.2438297541023582
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.03315414	1.242114987771809
GAUCHER DISEASE TYPE 1	0.03303136	1.2375150530970258
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.032988863	1.2359229092309705
TRACHEOPATHIA OSTEOPLASTICA	0.0329524	1.234556828289069
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.03290999	1.2329679438652414
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.032864733	1.2312723970043793
HALLERMANN-STREIFF SYNDROME; HSS	0.03281587	1.2294417518829104
PEHO SYNDROME	0.032803653999999995	1.2289840812363295
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2289840812363295
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2288291640683853
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2288291640683853
TUBEROUS SCLEROSIS-1	0.032799519	1.2288291640683853
MECKEL SYNDROME, TYPE 1; MKS1	0.0327485	1.226917744723437
ROIFMAN-CHITAYAT SYNDROME	0.032702724	1.2252027536037686
THYMOMA	0.03268511	1.2245428476796634
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.032490420000000006	1.2172488154119199
BENIGN OCCIPITAL EPILEPSY	0.03240334	1.2139863759960527
REACTIVE ARTHRITIS	0.03226645	1.2088578122427454
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.0322581	1.2085449807186006
DOMINANT BETA-THALASSEMIA	0.0322581	1.2085449807186006
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2085449807186006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0322581	1.2085449807186006
HEMOGLOBIN C-BETA-THALASSEMIA SYNDROME	0.0322581	1.2085449807186006
WEST SYNDROME	0.0322581	1.2085449807186006
ACATALASEMIA	0.0322581	1.2085449807186006
DELTA-BETA-THALASSEMIA	0.0322581	1.2085449807186006
NAKAJO-NISHIMURA SYNDROME	0.0322581	1.2085449807186006
AICARDI SYNDROME	0.0322581	1.2085449807186006
MAJEED SYNDROME	0.0322581	1.2085449807186006
BLUE RUBBER BLEB NEVUS	0.0322581	1.2085449807186006
HEMORRHAGIC FEVER-RENAL SYNDROME	0.03209648	1.2024899111458813
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0320258	1.199841895322346
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.031972994	1.1978635262847452
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.03190189	1.195199625363457
EHLERS-DANLOS SYNDROME, TYPE I	0.03190189	1.195199625363457
THANATOPHORIC DYSPLASIA TYPE 2	0.031869949	1.1940029604876852
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.031795554	1.1912157627345452
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.031791419	1.1910608455666005
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.03173631	1.188996194972101
SAPHO SYNDROME	0.03173631	1.188996194972101
CRYOGLOBULINEMIC VASCULITIS	0.03173631	1.188996194972101
PULMONARY FIBROSIS-HEPATIC HYPERPLASIA-BONE MARROW HYPOPLASIA SYNDROME	0.031656000000000004	1.185987392612337
LIG4 SYNDROME	0.031461654000000006	1.178706248254091
MARFANOID HABITUS WITH SITUS INVERSUS	0.03125	1.1707766622168163
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.03125	1.1707766622168163
AORTO-VENTRICULAR TUNNEL	0.03125	1.1707766622168163
IMMUNODEFICIENCY 62; IMD62	0.03125	1.1707766622168163
CAP MYOPATHY	0.03125	1.1707766622168163
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.03125	1.1707766622168163
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.169911598756637
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.169911598756637
ENCEPHALITIS LETHARGICA	0.031123859000000004	1.1660508081704581
BARDET-BIEDL SYNDROME 1; BBS1	0.030997214	1.1613060718380914
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.030916100000000002	1.158267147736362
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.030676639999999998	1.14929581399126
BARDET-BIEDL SYNDROME 12; BBS12	0.030676639999999998	1.14929581399126
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.030617329999999998	1.1470737735485053
NAVAJO NEUROHEPATOPATHY	0.030609243999999997	1.1467708327456032
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.030498773	1.1426320529487473
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.030310263	1.1355695534737236
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.030302999999999997	1.1352974462449976
COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF	0.030302999999999997	1.1352974462449976
COMPLEMENT COMPONENT 2 DEFICIENCY	0.030302999999999997	1.1352974462449976
SUBCORNEAL PUSTULAR DERMATOSIS	0.030302999999999997	1.1352974462449976
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.030302999999999997	1.1352974462449976
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.030294804000000005	1.1349903843082452
COLD AGGLUTININ DISEASE	0.03016214	1.1300201470245221
RIN2 SYNDROME	0.02996544	1.1226508104018647
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.029957354	1.1223478695989628
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.02990553	1.1204062910471955
ABETA AMYLOIDOSIS, IOWA TYPE	0.02983141	1.1176293961286832
PENTASOMY X	0.029768844	1.1152853701239391
COFS SYNDROME	0.029764709	1.1151304529559944
DISTAL MONOSOMY 7Q36	0.029764709	1.1151304529559944
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.1131172416049262
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.029674064	1.111734451338502
22Q11.2 MICRODUPLICATION SYNDROME	0.029658373000000002	1.111146590327083
SOTOS SYNDROME	0.029658373000000002	1.111146590327083
ABETAL34V AMYLOIDOSIS	0.029542584	1.1068085724409573
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.02954106	1.1067514760046944
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.029538449	1.1066536552730128
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.1019087690812337
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.1019087690812337
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	1.1019087690812337
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.1019087690812337
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0294118	1.1019087690812337
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.1019087690812337
IMMUNE SUPPRESSION	0.0294118	1.1019087690812337
MONOMELIC AMYOTROPHY	0.0294118	1.1019087690812337
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0294118	1.1019087690812337
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.1019087690812337
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.1019087690812337
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	1.1019087690812337
RAGWEED SENSITIVITY	0.0294118	1.1019087690812337
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.1019087690812337
SHORT SYNDROME	0.0294118	1.1019087690812337
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.1019087690812337
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.1019087690812337
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.1019087690812337
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	1.1019087690812337
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.1019087690812337
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.02922329	1.09484626960621
ACRODYSOSTOSIS	0.02922329	1.09484626960621
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.02922329	1.09484626960621
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.02922329	1.09484626960621
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.02917146	1.0929044662653236
PROPIONIC ACIDEMIA	0.029116954	1.0908624069772983
IDIOPATHIC APLASTIC ANEMIA	0.029097360000000003	1.0901283206438752
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.029077904000000005	1.0893994044601922
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.028933610000000002	1.0839934509338591
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.028864773000000003	1.0814144828347545
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.028864773000000003	1.0814144828347545
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.028864773000000003	1.0814144828347545
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.028864773000000003	1.0814144828347545
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.028864773000000003	1.0814144828347545
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.028864773000000003	1.0814144828347545
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.028864773000000003	1.0814144828347545
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.028864773000000003	1.0814144828347545
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.02884175	1.0805519295197394
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.028784944	1.078423701069375
WYBURN-MASON SYNDROME	0.028685513000000003	1.074698533251747
MYHRE SYNDROME	0.028676823	1.0743729636775177
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0723939577374126
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0723939577374126
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.0704233064595694
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0704233064595694
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	1.0704233064595694
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0285714	1.0704233064595694
CHEILITIS GLANDULARIS	0.0285714	1.0704233064595694
COG7-CDG	0.0285714	1.0704233064595694
FANCONI ANEMIA	0.028532350000000005	1.0689603039424633
BRADDOCK SYNDROME	0.028524149999999998	1.0686530921462973
CYSTINOSIS, NEPHROPATHIC; CTNS	0.02842969	1.0651141621138815
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.02840099	1.0640389208273016
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0618050414909386
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0618050414909386
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.028323354000000002	1.0611302994849698
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0611302994849698
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.028319219000000003	1.0609753823170254
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.028319219000000003	1.0609753823170254
GRISCELLI SYNDROME, TYPE 2; GS2	0.028319219000000003	1.0609753823170254
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.028319219000000003	1.0609753823170254
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.028319219000000003	1.0609753823170254
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.028319219000000003	1.0609753823170254
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.028319219000000003	1.0609753823170254
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.028224443999999998	1.0574246508558542
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.028220309	1.0572697336879096
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.028181010000000003	1.055797402422359
WOLF-HIRSCHHORN SYNDROME	0.028113973	1.053285871058998
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.028113973	1.053285871058998
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.028054663	1.0510638306162434
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.027973400000000002	1.0480193242513884
FAMILIAL MEDITERRANEAN FEVER; FMF	0.027876909999999998	1.0444043405669945
ADULT-ONSET STILL DISEASE	0.027876909999999998	1.0444043405669945
TRIMETHYLAMINURIA	0.027846910000000002	1.0432803949712668
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.040691198967241
KOSAKI OVERGROWTH SYNDROME; KOGS	0.027777800000000002	1.040691198967241
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.027777800000000002	1.040691198967241
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.027777800000000002	1.040691198967241
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.027777800000000002	1.040691198967241
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.040691198967241
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.040691198967241
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.027678889999999998	1.0369855503381251
CHROMOSOME 17Q12 DELETION SYNDROME	0.027678889999999998	1.0369855503381251
7P22.1 MICRODUPLICATION SYNDROME	0.027572554	1.0330016877092134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0330016877092134
THANATOPHORIC DYSPLASIA	0.027568419	1.032846770541269
THANATOPHORIC DYSPLASIA TYPE 1	0.027568419	1.032846770541269
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.032846770541269
9Q33.3Q34.11 MICRODELETION SYNDROME	0.027568419	1.032846770541269
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.027568419	1.032846770541269
SCLEROSTEOSIS 1; SOST1	0.02754448	1.0319498994207312
RELAPSING FEVER	0.02743913	1.0280029771370658
TEMTAMY SYNDROME; TEMTYS	0.027402773000000002	1.026640867469603
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.02730194	1.0228631739278011
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0272424	1.0206325165688126
LIPOSARCOMA	0.027027	1.0125625871914845
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.027027	1.0125625871914845
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	1.0125625871914845
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0125625871914845
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0125625871914845
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	1.0125625871914845
NIPPLES, SUPERNUMERARY	0.027027	1.0125625871914845
ROTHMUND-THOMSON SYNDROME	0.027008054000000004	1.011852778082929
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.02696769	1.0103405467487299
TEMTAMY SYNDROME	0.026861354	1.0063566841198184
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.026861354	1.0063566841198184
OROFACIODIGITAL SYNDROME I; OFD1	0.026840169000000004	1.0055629912049684
ROIFMAN SYNDROME	0.026784590000000004	1.0034807321294694
CRANIOECTODERMAL DYSPLASIA 4	0.026784590000000004	1.0034807321294694
HERMANSKY-PUDLAK SYNDROME	0.026750660000000002	1.0022095496607006
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.026674119000000003	0.9993419523326132
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.026445404000000002	0.9907731784350476
OSTEOGENESIS IMPERFECTA, TYPE I	0.0263158	0.9859175836020893
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.0263158	0.9859175836020893
LOEYS-DIETZ SYNDROME	0.0263158	0.9859175836020893
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.0263158	0.9859175836020893
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0263158	0.9859175836020893
MARFANOID HYPERMOBILITY SYNDROME	0.0263158	0.9859175836020893
GLYCOGEN STORAGE DISEASE IA	0.026298750000000003	0.9852788078551838
OROFACIODIGITAL SYNDROME TYPE 1	0.026188279000000002	0.9811400280583277
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.026132700000000002	0.9790577689828286
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.026132700000000002	0.9790577689828286
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.025962644	0.9726866459085903
GALACTOSEMIA	0.025888323	0.9699022205545866
ROWLEY-ROSENBERG SYNDROME	0.025773619999999997	0.9656048894990263
HYPOPHOSPHATASIA	0.025664799000000002	0.9615279267099354
FRASIER SYNDROME	0.02564686	0.9608558447085431
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.02564686	0.9608558447085431
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.025467659	0.9541421055518738
JACOBSEN SYNDROME	0.025252163	0.9460685795486395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.025123323	0.9412416078635191
ABETA AMYLOIDOSIS, DUTCH TYPE	0.025110869	0.940775020581879
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.024967804	0.9354151113601175
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.024739944000000003	0.9268783699120304
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9265138368904824
AREGENERATIVE ANEMIA	0.024685570000000004	0.9248412559846264
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.024637819000000005	0.9230522717799059
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.9127341140274426
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.02432799	0.9114445737806107
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.02424424	0.9083068923258695
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.024221654000000002	0.907460711151699
PROPIONIC ACIDEMIA	0.024124813000000005	0.9038325773038356
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.024088054	0.9024554067653897
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.024058854	0.9013614330522143
PALLISTER-KILLIAN SYNDROME	0.024054719000000002	0.9012065158842697
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.02401301	0.899643894322529
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.02401301	0.899643894322529
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.023961063	0.8976977075938192
FETAL HYDANTOIN SYNDROME	0.023924743999999998	0.8963370215907774
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.02389484	0.8952166726209557
AICARDI-GOUTIERES SYNDROME 7	0.023814273	0.8921982417939215
KAGAMI-OGATA SYNDROME	0.023814273	0.8921982417939215
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.023811553	0.892096337393242
SIALURIA	0.023773473000000003	0.8906696757837312
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4	0.0235133	0.8809223325344853
HYPOPLASTIC LEFT HEART SYNDROME	0.0235133	0.8809223325344853
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.023507550000000002	0.8807069096286374
METHYLMALONIC ACIDURIA, CBLA TYPE	0.023472923000000003	0.8794096141571948
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02344437	0.8783398802040339
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.023419644	0.8774135242440346
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.023419644	0.8774135242440346
SILVER-RUSSELL SYNDROME	0.023379189999999998	0.8758979210730483
FATCO SYNDROME	0.023379189999999998	0.8758979210730483
LARSEN SYNDROME	0.023379189999999998	0.8758979210730483
WATSON SYNDROME	0.023379189999999998	0.8758979210730483
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.023309173000000002	0.8732747444471787
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.023309173000000002	0.8732747444471787
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.023309173000000002	0.8732747444471787
MONOSOMY 18P	0.023274514000000003	0.8719762501004339
SILVER-RUSSELL SYNDROME; SRS	0.023272854	0.8719140584441368
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.8717591412761924
COWDEN SYNDROME 6; CWS6	0.023268719	0.8717591412761924
COWDEN SYNDROME 5; CWS5	0.023268719	0.8717591412761924
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.023041473000000003	0.8632454032479645
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.02303246	0.8629077325261546
NETHERTON SYNDROME	0.023015463	0.8622709424164682
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.022959969999999996	0.8601919053183433
METHYLMALONIC ACIDURIA, CBLB TYPE	0.022931504000000002	0.8591254308074102
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.02289791	0.8578668365293138
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.022890379	0.8575846887199328
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.02287409	0.8569744237263057
JOHANSON-BLIZZARD SYNDROME; JBS	0.02287409	0.8569744237263057
MULTIPLE OSTEOCHONDROMAS	0.02287409	0.8569744237263057
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.02287409	0.8569744237263057
BETA-KETOTHIOLASE DEFICIENCY	0.022833979	0.8554716709999639
ERDHEIM-CHESTER DISEASE	0.02280269	0.8542994332084728
CURRARINO SYNDROME	0.022767754	0.852990561097394
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.022767754	0.852990561097394
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.022767754	0.852990561097394
OCCIPITAL HORN SYNDROME	0.022767754	0.852990561097394
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.022767754	0.852990561097394
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.022763619000000002	0.8528356439294495
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.022763619000000002	0.8528356439294495
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.022763619000000002	0.8528356439294495
BUERGER DISEASE	0.0227273	0.8514749579264078
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.8514749579264078
BETHLEM MYOPATHY 1	0.0227273	0.8514749579264078
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.8514749579264078
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8514749579264078
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8514749579264078
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.0227273	0.8514749579264078
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.8514749579264078
THUMB DEFORMITY	0.0227273	0.8514749579264078
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8514749579264078
CHILBLAIN LUPUS 2; CHBL2	0.0227273	0.8514749579264078
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.0227273	0.8514749579264078
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8514749579264078
ARTERIES, ANOMALIES OF	0.0227273	0.8514749579264078
PRIMARY ERYTHROMELALGIA	0.0227273	0.8514749579264078
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8514749579264078
CUTANEOUS SMALL VESSEL VASCULITIS	0.0227273	0.8514749579264078
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8514749579264078
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8514749579264078
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8514749579264078
SIRENOMELIA	0.0227273	0.8514749579264078
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.8514749579264078
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.8514749579264078
TRISOMY 13	0.022709559	0.8508102939659475
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.022686500000000002	0.8499463919162176
SPINOCEREBELLAR ATAXIA 14	0.022686500000000002	0.8499463919162176
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.022686500000000002	0.8499463919162176
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.022686500000000002	0.8499463919162176
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.022686500000000002	0.8499463919162176
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.022658983	0.8489154715509626
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.022604209	0.8468633716822821
COPPER DEFICIENCY, FAMILIAL BENIGN	0.022604209	0.8468633716822821
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8434538827176408
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8434538827176408
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8434538827176408
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8434538827176408
19P13.3 MICRODUPLICATION SYNDROME	0.022508613999999996	0.8432819190414942
POLYCYTHEMIA VERA	0.022499599999999998	0.8429442108548312
THROMBOCYTHEMIA, ESSENTIAL	0.02229256	0.8351874876501794
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.0222222	0.832551460579665
NEPHROTIC SYNDROME, TYPE 18; NPHS18	0.0222222	0.832551460579665
CARDIOMYOPATHY, DILATED, 1B; CMD1B	0.0222222	0.832551460579665
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.0222222	0.832551460579665
NEPHROTIC SYNDROME, TYPE 4	0.0222222	0.832551460579665
NEPHROTIC SYNDROME, TYPE 19; NPHS19	0.0222222	0.832551460579665
NEPHROTIC SYNDROME, TYPE 20; NPHS20	0.0222222	0.832551460579665
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.0222222	0.832551460579665
TELANGIECTASIA, HEREDITARY BENIGN	0.0222222	0.832551460579665
VASCULAR HYALINOSIS	0.0222222	0.832551460579665
CAROLI DISEASE, ISOLATED	0.0222222	0.832551460579665
FRASIER SYNDROME	0.0222222	0.832551460579665
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8	0.0222222	0.832551460579665
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7	0.0222222	0.832551460579665
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0222222	0.832551460579665
GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	0.0222222	0.832551460579665
DUANE-RADIAL RAY SYNDROME; DRRS	0.0222222	0.832551460579665
NEPHROTIC SYNDROME, TYPE 12	0.0222222	0.832551460579665
NEPHROTIC SYNDROME, TYPE 13	0.0222222	0.832551460579665
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.0222222	0.832551460579665
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9	0.0222222	0.832551460579665
CHEILITIS GLANDULARIS	0.0222222	0.832551460579665
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0222222	0.832551460579665
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.0222222	0.832551460579665
ANEURYSM OF INTERVENTRICULAR SEPTUM	0.0222222	0.832551460579665
ISOLATED POLYCYSTIC LIVER DISEASE	0.0222222	0.832551460579665
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.021977374	0.8233790904323404
PREECLAMPSIA	0.0219589	0.822686964734491
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021920273	0.8212398098502846
WHIM SYNDROME	0.021768779000000002	0.8155641093809767
CAMURATI-ENGELMANN DISEASE	0.02171339	0.8134889686275838
TIMOTHY SYNDROME; TS	0.021687283	0.812510873705328
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.021607453999999998	0.8095200919399486
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.021572010000000003	0.8081921876834491
CARNEY TRIAD	0.021519700000000003	0.8062324012130312
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.021485189999999998	0.8049394891294116
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.8008007093325556
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.8008007093325556
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299113999999997	0.7979681791070546
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.02129822	0.7979346855283019
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7974920008229978
WOLFRAM SYNDROME	0.021279019000000003	0.7972153228821829
CUTIS LAXA-MARFANOID SYNDROME	0.0212766	0.7971246954023139
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.0212766	0.7971246954023139
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.0212766	0.7971246954023139
EMPHYSEMA, HEREDITARY PULMONARY	0.0212766	0.7971246954023139
MEIER-GORLIN SYNDROME 6; MGORS6	0.0212766	0.7971246954023139
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.0212766	0.7971246954023139
ALPHA-1-ANTITRYPSIN DEFICIENCY	0.0212766	0.7971246954023139
BIRT-HOGG-DUBÉ SYNDROME	0.0212766	0.7971246954023139
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0212766	0.7971246954023139
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.0212766	0.7971246954023139
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.02125146	0.7961828289930938
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.021192350000000002	0.7939682815209774
PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	0.02105721	0.7889052812607541
SLC35A1-CDG	0.02103176	0.7879518007470446
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.020983639	0.7861489545466436
BENIGN FAMILIAL INFANTILE EPILEPSY	0.020983639	0.7861489545466436
LYNCH SYNDROME	0.020983639	0.7861489545466436
FAMILIAL COLORECTAL CANCER TYPE X	0.020983639	0.7861489545466436
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.020951428999999997	0.7849422116253634
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.780516525982771
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.780516525982771
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.780516525982771
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.780516525982771
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.780516525982771
PUPIL, EGG-SHAPED	0.0208333	0.780516525982771
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.780516525982771
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.780516525982771
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.780516525982771
CRANDALL SYNDROME	0.0208333	0.780516525982771
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.780516525982771
IMINOGLYCINURIA	0.0208333	0.780516525982771
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.780516525982771
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.780516525982771
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.780516525982771
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.780516525982771
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.780516525982771
DERMOIDS OF CORNEA	0.0208333	0.780516525982771
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.780516525982771
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.780516525982771
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.780516525982771
STICKLER SYNDROME, TYPE III	0.0208333	0.780516525982771
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.780516525982771
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.780516525982771
611426 TENTED EYEBROWS	0.0208333	0.780516525982771
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.780516525982771
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.780516525982771
UNIQUE GREEN PHENOMENON	0.0208333	0.780516525982771
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.780516525982771
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.780516525982771
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.780516525982771
FARBER DISEASE	0.020805244	0.7794654120616461
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.020772319	0.7782318817703345
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7770529003052687
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7770529003052687
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.020740849999999998	0.7770529003052687
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7770529003052687
FG SYNDROME TYPE 1	0.020529623	0.7691393117603066
WOLCOTT-RALLISON SYNDROME	0.020384369	0.7636973919749099
YELLOW NAIL SYNDROME	0.020312660000000003	0.7610108248174412
LYSOSOMAL ACID LIPASE DEFICIENCY	0.020312660000000003	0.7610108248174412
COG1-CDG	0.020312660000000003	0.7610108248174412
46,XX GONADAL DYSGENESIS	0.02025969	0.759026311543917
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.020153354000000002	0.7550424489150056
BAND HETEROTOPIA; BH	0.019954873	0.7476063873888149
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.019951149999999997	0.7474669057403849
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.01986931	0.7444007821552386
BULLOUS PEMPHIGOID	0.01986931	0.7444007821552386
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.01986931	0.7444007821552386
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.01986931	0.7444007821552386
STIFF-PERSON SYNDROME; SPS	0.019777450000000002	0.7409592607411192
GRISCELLI SYNDROME TYPE 2	0.019732479	0.7392744288282694
15Q OVERGROWTH SYNDROME	0.019676729	0.7371857632628747
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.019616359	0.7349240100757376
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.0196078	0.7346033483972765
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.0196078	0.7346033483972765
IDIOPATHIC PULMONARY FIBROSIS	0.0196078	0.7346033483972765
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4	0.0196078	0.7346033483972765
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3	0.0196078	0.7346033483972765
CYSTIC FIBROSIS	0.0196078	0.7346033483972765
IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS	0.0196078	0.7346033483972765
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.0196078	0.7346033483972765
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0196078	0.7346033483972765
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.0196078	0.7346033483972765
PETERS-PLUS SYNDROME; PTRPLS	0.019605473	0.7345161676839012
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.01955747	0.7327177423361765
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.019544620000000002	0.732236318972673
HHHH SYNDROME	0.019409319	0.7271672868710858
HEMOCHROMATOSIS, TYPE 3; HFE3	0.01934676	0.724823523120314
GLUTATHIONE SYNTHETASE DEFICIENCY	0.019312179	0.723527951032118
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.019276923999999997	0.7222071276328714
PRIMARY CILIARY DYSKINESIA	0.019265240000000003	0.7217693882881887
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.019264509	0.721742001480506
AMYLOIDOSIS VI	0.01919311	0.7190670484275263
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.01919311	0.7190670484275263
TRANSCOBALAMIN DEFICIENCY	0.019191060000000003	0.7189902454784849
GRANT SYNDROME	0.01917039	0.7182158469630281
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.01917039	0.7182158469630281
PYCNODYSOSTOSIS	0.01917039	0.7182158469630281
AREDYLD SYNDROME	0.01917039	0.7182158469630281
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.01917039	0.7182158469630281
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.01917039	0.7182158469630281
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.01917039	0.7182158469630281
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.019147764	0.7173681671947301
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.019082104	0.7149082249342129
SALT-AND-PEPPER SYNDROME	0.019082104	0.7149082249342129
HARROD SYNDROME	0.019059919	0.7140770671661721
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.01891531	0.7086593122110837
VAN DEN BOSCH SYNDROME	0.0188679	0.7068831035213012
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0188679	0.7068831035213012
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7068831035213012
HEREDITARY CHRONIC PANCREATITIS	0.0188679	0.7068831035213012
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7068831035213012
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7068831035213012
CARPAL DISPLACEMENT	0.0188679	0.7068831035213012
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7068831035213012
VESICOURETERAL REFLUX 1	0.0188679	0.7068831035213012
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7068831035213012
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7068831035213012
RAYNAUD DISEASE	0.0188679	0.7068831035213012
TRACHEOBRONCHOMEGALY	0.0188679	0.7068831035213012
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7068831035213012
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7068831035213012
OSTEOPETROSIS AND RELATED DISORDERS	0.0188679	0.7068831035213012
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7068831035213012
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7068831035213012
IVIC SYNDROME	0.0188679	0.7068831035213012
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7068831035213012
TOE, MISSHAPEN	0.0188679	0.7068831035213012
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7068831035213012
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0188679	0.7068831035213012
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7068831035213012
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7068831035213012
PUBIC BONE DYSPLASIA	0.0188679	0.7068831035213012
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7068831035213012
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0188679	0.7068831035213012
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.0188679	0.7068831035213012
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7068831035213012
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7068831035213012
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7068831035213012
KNUCKLE PADS	0.0188679	0.7068831035213012
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7068831035213012
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	0.0188679	0.7068831035213012
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7068831035213012
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	0.0188679	0.7068831035213012
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7068831035213012
THROMBOCYTOPENIA 3	0.0188679	0.7068831035213012
PYOMYOSITIS	0.0188679	0.7068831035213012
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7068831035213012
SPINAL ARACHNOIDITIS	0.0188679	0.7068831035213012
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7068831035213012
IVIC SYNDROME	0.0188679	0.7068831035213012
CHRONIC MYELOID LEUKEMIA	0.0188679	0.7068831035213012
MONOPHALANGY OF GREAT TOE	0.0188679	0.7068831035213012
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7068831035213012
RHEUMATIC FEVER	0.01881293	0.7048236605413953
PFAPA SYNDROME	0.01881293	0.7048236605413953
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.01877076	0.7032437676823335
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.018636459	0.6982122004339374
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.018629683	0.6979583385887157
JOUBERT SYNDROME WITH RENAL DEFECT	0.018629683	0.6979583385887157
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6944691244164839
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6944691244164839
THYMIC TUMOR	0.01853424	0.6943825806056129
REYNOLDS SYNDROME	0.01853282	0.6943293805140817
SHORT RIB-POLYDACTYLY SYNDROME	0.0185185	0.6937928838163876
OSTEOARTHRITIS	0.0185185	0.6937928838163876
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.0185185	0.6937928838163876
EXSTROPHY OF BLADDER	0.0185185	0.6937928838163876
THORACOMELIC DYSPLASIA	0.0185185	0.6937928838163876
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.0185185	0.6937928838163876
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0185185	0.6937928838163876
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0185185	0.6937928838163876
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0185185	0.6937928838163876
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0185185	0.6937928838163876
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0185185	0.6937928838163876
MEIER-GORLIN SYNDROME 1; MGORS1	0.0185185	0.6937928838163876
ISOLATED EPISPADIAS	0.0185185	0.6937928838163876
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.0185185	0.6937928838163876
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0185185	0.6937928838163876
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0185185	0.6937928838163876
MOEBIUS SYNDROME; MBS	0.0185185	0.6937928838163876
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.0185185	0.6937928838163876
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0185185	0.6937928838163876
ATELOSTEOGENESIS, TYPE II	0.0185185	0.6937928838163876
HYPOCHONDROPLASIA	0.0185185	0.6937928838163876
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0185185	0.6937928838163876
HYPOCHONDROPLASIA	0.0185185	0.6937928838163876
OSTEOPATHIA STRIATA-PIGMENTARY DERMOPATHY-WHITE FORELOCK SYNDROME	0.0185185	0.6937928838163876
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.018435154	0.6906703381623356
KABUKI SYNDROME	0.018431019	0.690515420994391
ADAMS-OLIVER SYNDROME	0.018329689	0.6867191074205533
PRADER-WILLI SYNDROME	0.018316568999999998	0.6862275685466881
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.018246604	0.6836063400931841
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01820571	0.682074252386794
SYSTEMIC MASTOCYTOSIS	0.01809504	0.6779280170841528
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.017893793999999998	0.6703883652388892
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01789329	0.6703694829528811
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0178896	0.6702312376446065
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.017788270000000002	0.6664349240707688
APPARENT MINERALOCORTICOID EXCESS	0.01777515	0.6659433851969037
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.017594714	0.6591833769465436
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.017542710000000003	0.657235054721202
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.017542710000000003	0.657235054721202
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.01750916	0.655978108896646
CONGENITAL TOXOPLASMOSIS	0.017455313	0.6539607389468736
YELLOW FEVER	0.017424540000000002	0.652807833019629
MYOPATHY, CONGENITAL	0.0172414	0.6459465198062404
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6459465198062404
269800 SENILE PLAQUE FORMATION	0.0172414	0.6459465198062404
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6459465198062404
PALMOMENTAL REFLEX	0.0172414	0.6459465198062404
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6459465198062404
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6459465198062404
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6459465198062404
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6459465198062404
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6459465198062404
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6459465198062404
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6459465198062404
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6459465198062404
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6459465198062404
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6459465198062404
TRANSSEXUALITY	0.0172414	0.6459465198062404
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6459465198062404
CARDIAC ARRHYTHMIA	0.0172414	0.6459465198062404
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6459465198062404
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6459465198062404
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6459465198062404
DIASTEMATOMYELIA	0.0172414	0.6459465198062404
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6459465198062404
MOSAIC TRISOMY 15	0.0172414	0.6459465198062404
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6459465198062404
ERYTHERMALGIA, PRIMARY	0.0172414	0.6459465198062404
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6459465198062404
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6459465198062404
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6459465198062404
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6459465198062404
ALCOHOL DEPENDENCE	0.0172414	0.6459465198062404
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6459465198062404
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6459465198062404
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6459465198062404
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6459465198062404
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6459465198062404
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6459465198062404
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6459465198062404
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6459465198062404
MOTION SICKNESS	0.0172414	0.6459465198062404
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6459465198062404
CERVICAL RIB	0.0172414	0.6459465198062404
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.017123259999999998	0.6415204220502629
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.017123259999999998	0.6415204220502629
WILSON DISEASE	0.01712241	0.6414885769250508
BABESIOSIS	0.01700424	0.6370613552234776
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064	0.6311727794583386
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064	0.6311727794583386
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.016674229	0.6246975415570829
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.016674229	0.6246975415570829
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.016674229	0.6246975415570829
HUNTINGTON DISEASE-LIKE 1	0.016674229	0.6246975415570829
ALZHEIMER DISEASE 3; AD	0.016674229	0.6246975415570829
ACQUIRED GENERALIZED LIPODYSTROPHY	0.01658256	0.6212631759299228
GLIOBLASTOMA	0.016556058999999998	0.6202703198555096
SAETHRE-CHOTZEN SYNDROME	0.016491739000000002	0.6178605804982686
CERNUNNOS-XLF DEFICIENCY	0.01635279	0.6126548766122408
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.016330063000000002	0.6118034128937706
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6107336789406096
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6107336789406096
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6107336789406096
AUTOSOMAL AGAMMAGLOBULINEMIA	0.01615187	0.6051274383091175
PROGRESSIVE SUPRANUCLEAR PALSY	0.01613281	0.6044133582072984
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.01613281	0.6044133582072984
ALZHEIMER DISEASE 4	0.01613281	0.6044133582072984
CORTICOBASAL SYNDROME	0.01613281	0.6044133582072984
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.01613281	0.6044133582072984
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.01613281	0.6044133582072984
ALZHEIMER DISEASE 10	0.01613281	0.6044133582072984
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.01613281	0.6044133582072984
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.01613281	0.6044133582072984
CREUTZFELDT-JAKOB DISEASE; CJD	0.01613281	0.6044133582072984
HUNTINGTON DISEASE-LIKE 2	0.01613281	0.6044133582072984
MANGANESE POISONING	0.01601464	0.5999861365057252
PITUICYTOMA	0.01601464	0.5999861365057252
PINEOCYTOMA	0.01601464	0.5999861365057252
PAPILLARY TUMOR OF THE PINEAL REGION	0.01601464	0.5999861365057252
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.015894980000000003	0.5955030921728977
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.015894980000000003	0.5955030921728977
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.015894980000000003	0.5955030921728977
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.015823363	0.5928199717819221
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.015784509000000002	0.5913643123760415
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.015472860000000001	0.5796884283439387
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.015472860000000001	0.5796884283439387
AMYLOIDOSIS, FAMILIAL VISCERAL	0.015472860000000001	0.5796884283439387
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.015472860000000001	0.5796884283439387
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.015472860000000001	0.5796884283439387
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.015472860000000001	0.5796884283439387
DENYS-DRASH SYNDROME	0.015472860000000001	0.5796884283439387
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.015472860000000001	0.5796884283439387
LIDDLE SYNDROME	0.015472860000000001	0.5796884283439387
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.015470953999999999	0.5796170203337568
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.5796170203337568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5796170203337568
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5796170203337568
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5796170203337568
CEDNIK SYNDROME	0.015437462999999998	0.578362284935539
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.015298430000000002	0.5731534340018435
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.015298430000000002	0.5731534340018435
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.015295189	0.5730320104126516
ROIFMAN SYNDROME; RFMN	0.015281944	0.5725357884321376
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.015243090000000003	0.5710801290262569
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.015243090000000003	0.5710801290262569
LEISHMANIASIS	0.015243090000000003	0.5710801290262569
KAPOSIFORM LYMPHANGIOMATOSIS	0.015243090000000003	0.5710801290262569
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.015243090000000003	0.5710801290262569
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.015243090000000003	0.5710801290262569
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.015243090000000003	0.5710801290262569
TANGIER DISEASE	0.015243090000000003	0.5710801290262569
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.015243090000000003	0.5710801290262569
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.015243090000000003	0.5710801290262569
RETICULOENDOTHELIOSIS, X-LINKED	0.015243090000000003	0.5710801290262569
MULTIPLE MYELOMA	0.015243090000000003	0.5710801290262569
INTERMEDIATE OSTEOPETROSIS	0.015243090000000003	0.5710801290262569
ACUTE ERYTHROID LEUKEMIA	0.015243090000000003	0.5710801290262569
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.015234743999999998	0.5707674473615252
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.015180260000000001	0.5687262123002703
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.015171473	0.5683970086352814
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.015171473	0.5683970086352814
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.015171473	0.5683970086352814
HENNEKAM-BEEMER SYNDROME	0.015082209000000001	0.5650527459800456
CORNELIA DE LANGE SYNDROME 1	0.015082209000000001	0.5650527459800456
LCAT DEFICIENCY	0.01505256	0.5639419505477874
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.014975873	0.561068883351134
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.014941243	0.5597714754851318
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.014941243	0.5597714754851318
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5591779198160277
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5591779198160277
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5591779198160277
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5591779198160277
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.014918959999999998	0.5589366461614781
FUNCTIONING GONADOTROPIC ADENOMA	0.014900150000000001	0.5582319322729565
DENGUE FEVER	0.014900150000000001	0.5582319322729565
AYMÉ-GRIPP SYNDROME	0.014896043999999999	0.5580781015857545
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.014891908999999998	0.5579231844178101
FLOATING-HARBOR SYNDROME	0.01482783	0.5555224740901878
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014785572999999998	0.5539393217888984
CITRULLINEMIA, CLASSIC	0.014785572999999998	0.5539393217888984
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01475377	0.5527478270628671
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.01475377	0.5527478270628671
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.01475377	0.5527478270628671
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.01473639	0.5520966879144085
PELGER-HUET ANOMALY; PHA	0.014730664000000001	0.5518821641650373
MEND SYNDROME; MEND	0.014725863	0.5517022954048676
MEND SYNDROME	0.014725863	0.5517022954048676
BARAITSER-WINTER SYNDROME 1; BRWS1	0.014725863	0.5517022954048676
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.014725863	0.5517022954048676
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.014630054	0.548112825285497
KEPPEN-LUBINSKY SYNDROME	0.014625919	0.5479579081175524
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.014540790000000001	0.5447685626302611
CASPASE 8 DEFICIENCY	0.014540790000000001	0.5447685626302611
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.014540790000000001	0.5447685626302611
IMMUNODEFICIENCY 55; IMD55	0.01450616	0.5434711547642589
RIGID SPINE SYNDROME	0.014434454000000001	0.5407847000013495
TENORIO SYNDROME; TNORS	0.014430319	0.540629782833405
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.01438535	0.5389450258502616
FAMILIAL COLD URTICARIA	0.01438535	0.5389450258502616
NIEMANN-PICK DISEASE TYPE C	0.014260423000000001	0.5342646541356774
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5336551384391139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5336551384391139
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5336551384391139
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5336551384391139
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5336551384391139
STURGE-WEBER SYNDROME	0.014240018999999998	0.5335002212711693
TRISOMY 17P	0.014184444000000001	0.531418112055083
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.014184444000000001	0.531418112055083
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.014184444000000001	0.531418112055083
3C SYNDROME	0.014184444000000001	0.531418112055083
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.014180309	0.5312631948871385
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	0.0140845	0.5276737247677679
CILIARY DYSKINESIA, PRIMARY, 33	0.0140845	0.5276737247677679
LEPTIN DEFICIENCY OR DYSFUNCTION	0.0140845	0.5276737247677679
EHLERS-DANLOS SYNDROME, TYPE VI	0.0140845	0.5276737247677679
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	0.0140845	0.5276737247677679
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	0.0140845	0.5276737247677679
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.0140845	0.5276737247677679
PULMONARY BLASTOMA	0.0140845	0.5276737247677679
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0140845	0.5276737247677679
MEIER-GORLIN SYNDROME 3; MGORS3	0.0140845	0.5276737247677679
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0140845	0.5276737247677679
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0140845	0.5276737247677679
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.0140845	0.5276737247677679
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.0140845	0.5276737247677679
EMANUEL SYNDROME	0.014073973	0.5272793322582269
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.014073973	0.5272793322582269
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.014073973	0.5272793322582269
EMANUEL SYNDROME	0.014073973	0.5272793322582269
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.013999114	0.5244747508132064
CYCLIC VOMITING SYNDROME	0.013994979	0.5243198336452619
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.013994979	0.5243198336452619
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.013994979	0.5243198336452619
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.013994979	0.5243198336452619
CARTILAGE-HAIR HYPOPLASIA	0.013987389999999999	0.5240355128743959
COFFIN-SIRIS SYNDROME 2; CSS2	0.013944783	0.5224392478744897
WITTEVEEN-KOLK SYNDROME	0.013944782999999999	0.5224392478744896
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.013888900000000001	0.5203455994836205
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.013888900000000001	0.5203455994836205
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.013888900000000001	0.5203455994836205
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.013888900000000001	0.5203455994836205
IMMUNODEFICIENCY 32B; IMD32B	0.013888900000000001	0.5203455994836205
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.013888900000000001	0.5203455994836205
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.013888900000000001	0.5203455994836205
IMMUNODEFICIENCY 13; IMD13	0.013888900000000001	0.5203455994836205
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.013888900000000001	0.5203455994836205
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.013888900000000001	0.5203455994836205
MOUNIER-KÜHN SYNDROME	0.013888900000000001	0.5203455994836205
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.013888900000000001	0.5203455994836205
215030 CHOLESTEROL PNEUMONIA	0.013888900000000001	0.5203455994836205
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.013888900000000001	0.5203455994836205
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.01385427	0.5190481916176182
LAZY LEUKOCYTE SYNDROME	0.01385427	0.5190481916176182
IMMUNODEFICIENCY 36; IMD36	0.01380979	0.5173817549476852
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5132160379213848
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.5132160379213848
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5132160379213848
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.5132160379213848
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5132160379213848
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.5132160379213848
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.5132160379213848
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.5132160379213848
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5132160379213848
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.5132160379213848
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5132160379213848
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5132160379213848
STROKE, ISCHEMIC	0.013698599999999998	0.5132160379213848
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.5132160379213848
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.013698599999999998	0.5132160379213848
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.5132160379213848
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.5132160379213848
ACYS AMYLOIDOSIS	0.013698599999999998	0.5132160379213848
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5132160379213848
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5132160379213848
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5132160379213848
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.01363889	0.510979011537354
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.01363889	0.510979011537354
PFEIFFER-PALM-TELLER SYNDROME	0.01363889	0.510979011537354
WEILL-MARCHESANI SYNDROME	0.01363889	0.510979011537354
MCDONOUGH SYNDROME	0.01363889	0.510979011537354
MUCOLIPIDOSIS III GAMMA	0.01363889	0.510979011537354
WEILL-MARCHESANI SYNDROME 3	0.01363889	0.510979011537354
TEEBI-SHALTOUT SYNDROME; TBSH	0.01363889	0.510979011537354
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.01363889	0.510979011537354
WILLIAMS-BEUREN SYNDROME (WBS)	0.01363889	0.510979011537354
WEILL-MARCHESANI SYNDROME 1; WMS1	0.01363889	0.510979011537354
POLYVALVULAR HEART DISEASE SYNDROME	0.01363889	0.510979011537354
MERRF	0.01356079	0.5080530065031417
RITSCHER-SCHINZEL SYNDROME 1	0.013532554	0.5069951489084423
OKAMOTO SYNDROME	0.013532554	0.5069951489084423
EPISODIC ATAXIA TYPE 7	0.01345356	0.5040356502954775
OCULOCEREBRORENAL SYNDROME OF LOWE	0.013397208999999998	0.5019244683533147
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.013366763	0.5007838134330636
8P11.2 DELETION SYNDROME	0.013366763	0.5007838134330636
WOLMAN DISEASE	0.013264254	0.4969433287973136
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.013245644000000003	0.4962461078794304
BANGSTAD SYNDROME	0.013241509000000002	0.49609119071148583
COG5-CDG	0.013241509000000002	0.49609119071148583
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.013241509000000002	0.49609119071148583
ACROMEGALY	0.01322858	0.49560680762458015
SOMATOMAMMOTROPINOMA	0.01322858	0.49560680762458015
CRANIOPHARYNGIOMA	0.013174723	0.4935890630262758
ACQUIRED ICHTHYOSIS	0.0131579	0.4929587918010446
MUCOUS MEMBRANE PEMPHIGOID	0.0131579	0.4929587918010446
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0131579	0.4929587918010446
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0131579	0.4929587918010446
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.0131579	0.4929587918010446
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.0131579	0.4929587918010446
INCLUSION BODY MYOSITIS	0.0131579	0.4929587918010446
PEMPHIGUS VULGARIS	0.0131579	0.4929587918010446
ALOPECIA AREATA 1	0.0131579	0.4929587918010446
LINEAR IGA DERMATOSIS	0.0131579	0.4929587918010446
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	0.0131579	0.4929587918010446
IMMUNODEFICIENCY 22; IMD22	0.0131579	0.4929587918010446
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.013135173000000002	0.4921073280825743
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.013135173000000002	0.4921073280825743
MELANOSIS, NEUROCUTANEOUS; NCMS	0.013135173000000002	0.4921073280825743
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.013135173000000002	0.4921073280825743
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.013135173000000002	0.4921073280825743
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.013135173000000002	0.4921073280825743
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.013135173000000002	0.4921073280825743
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.013135173000000002	0.4921073280825743
CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL	0.012987	0.48655604839071337
ATRIAL SEPTAL DEFECT 1	0.012987	0.48655604839071337
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.012987	0.48655604839071337
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.012987	0.48655604839071337
WEILL-MARCHESANI SYNDROME 2; WMS2	0.012987	0.48655604839071337
ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13	0.012987	0.48655604839071337
ISOTRETINOIN-LIKE SYNDROME	0.012987	0.48655604839071337
SCHEIE SYNDROME	0.012987	0.48655604839071337
XFE PROGEROID SYNDROME; XFEPS	0.01294847	0.4851125275972664
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.012908900000000001	0.4836300433565011
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.012718700000000001	0.4765042282795846
ALPHA-HEAVY CHAIN DISEASE	0.012718700000000001	0.4765042282795846
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.012718700000000001	0.4765042282795846
FETAL PARVOVIRUS SYNDROME	0.012718700000000001	0.4765042282795846
EOSINOPHILIC GASTROENTERITIS	0.012718700000000001	0.4765042282795846
HEPATOCELLULAR CARCINOMA	0.012718700000000001	0.4765042282795846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.012718700000000001	0.4765042282795846
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.012700090000000002	0.47580700736170134
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.012700090000000002	0.47580700736170134
DAHLBERG-BORER-NEWCOMER SYNDROME	0.012700090000000002	0.47580700736170134
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.012700090000000002	0.47580700736170134
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.012700090000000002	0.47580700736170134
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.012700090000000002	0.47580700736170134
CYSTINOSIS	0.012700090000000002	0.47580700736170134
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012691744	0.47549432569696964
WRINKLY SKIN SYNDROME	0.012691744	0.47549432569696964
NARP SYNDROME	0.012609713	0.47242104632486387
SPINOCEREBELLAR ATAXIA TYPE 7	0.012593754000000002	0.47182314473278975
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.012593754000000002	0.47182314473278975
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.012593754000000002	0.47182314473278975
LIG4 SYNDROME	0.012593754000000002	0.47182314473278975
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.012593754000000002	0.47182314473278975
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.012593754000000002	0.47182314473278975
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.012593754000000002	0.47182314473278975
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.012593754000000002	0.47182314473278975
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.012589619000000002	0.47166822756484517
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.012589619000000002	0.47166822756484517
SECKEL SYNDROME 1; SCKL1	0.012589619000000002	0.47166822756484517
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.012589619000000002	0.47166822756484517
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.012589619000000002	0.47166822756484517
METACHROMATIC LEUKODYSTROPHY	0.012589619000000002	0.47166822756484517
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.012589619000000002	0.47166822756484517
HYPERPROLINEMIA TYPE 1	0.012589619000000002	0.47166822756484517
KNOBLOCH SYNDROME 1; KNO1	0.012589619000000002	0.47166822756484517
NEURONAL CEROID LIPOFUSCINOSIS	0.012589619000000002	0.47166822756484517
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.012589619000000002	0.47166822756484517
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.012589619000000002	0.47166822756484517
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.012589619000000002	0.47166822756484517
EARLY-ONSET LAFORA BODY DISEASE	0.012589619000000002	0.47166822756484517
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.012589619000000002	0.47166822756484517
FETAL GAUCHER DISEASE	0.012589619000000002	0.47166822756484517
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.012589619000000002	0.47166822756484517
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.012589619000000002	0.47166822756484517
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.012589619000000002	0.47166822756484517
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.012589619000000002	0.47166822756484517
LATHOSTEROLOSIS	0.012589619000000002	0.47166822756484517
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4713555459001135
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.012536760000000001	0.46968787289002534
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.01241859	0.46526065118845217
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.01234101	0.4623541278778992
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.01234101	0.4623541278778992
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.01227979	0.46006052956555
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.012265162999999999	0.4595125311579261
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.012234674	0.45837026524898755
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.012234674	0.45837026524898755
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.012234674	0.45837026524898755
WILSON DISEASE	0.0122039	0.4572173218568897
AICARDI-GOUTIERES SYNDROME 6	0.012173454	0.45607666693663834
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.012169319	0.4559217497686939
ACUTE BILIRUBIN ENCEPHALOPATHY	0.012169319	0.4559217497686939
LOWE-KOHN-COHEN SYNDROME	0.012048200000000002	0.4513840442150607
AA AMYLOIDOSIS	0.012048200000000002	0.4513840442150607
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.012048200000000002	0.4513840442150607
MODY	0.012048200000000002	0.4513840442150607
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.012048200000000002	0.4513840442150607
FGFR2-RELATED BENT BONE DYSPLASIA	0.012048200000000002	0.4513840442150607
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.012048200000000002	0.4513840442150607
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.012048200000000002	0.4513840442150607
KURU, SUSCEPTIBILITY TO	0.012048200000000002	0.4513840442150607
WILD TYPE ATTR AMYLOIDOSIS	0.012048200000000002	0.4513840442150607
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.012048200000000002	0.4513840442150607
RENAL TUBULAR DYSGENESIS	0.012048200000000002	0.4513840442150607
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.012048200000000002	0.4513840442150607
FAMILIAL PANCREATIC CARCINOMA	0.012048200000000002	0.4513840442150607
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.012048200000000002	0.4513840442150607
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.012048200000000002	0.4513840442150607
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.012048200000000002	0.4513840442150607
WOODHOUSE-SAKATI SYNDROME	0.012048200000000002	0.4513840442150607
HYPERLIPOPROTEINEMIA, TYPE I	0.012048200000000002	0.4513840442150607
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.012048200000000002	0.4513840442150607
NEUTROPHILIA, HEREDITARY	0.012048200000000002	0.4513840442150607
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.012048200000000002	0.4513840442150607
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.012048200000000002	0.4513840442150607
DE SANCTIS-CACCHIONE SYNDROME	0.012048200000000002	0.4513840442150607
%614227 HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3	0.012048200000000002	0.4513840442150607
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.012048200000000002	0.4513840442150607
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.012048200000000002	0.4513840442150607
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.012048200000000002	0.4513840442150607
ATAXIA WITH VITAMIN E DEFICIENCY	0.012048200000000002	0.4513840442150607
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.012048200000000002	0.4513840442150607
DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY	0.012048200000000002	0.4513840442150607
PENDRED SYNDROME	0.012048200000000002	0.4513840442150607
ENAMEL-RENAL SYNDROME	0.012048200000000002	0.4513840442150607
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.012048200000000002	0.4513840442150607
ATTRV30M AMYLOIDOSIS	0.012048200000000002	0.4513840442150607
INDOMETHACIN EMBRYOFETOPATHY	0.012048200000000002	0.4513840442150607
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.012048200000000002	0.4513840442150607
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.012048200000000002	0.4513840442150607
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.012048200000000002	0.4513840442150607
RICHARDS-RUNDLE SYNDROME	0.012048200000000002	0.4513840442150607
BENT BONE DYSPLASIA SYNDROME; BBDS	0.012048200000000002	0.4513840442150607
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.012048200000000002	0.4513840442150607
OPTICOCOCHLEODENTATE DEGENERATION	0.012048200000000002	0.4513840442150607
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.012048200000000002	0.4513840442150607
SPINOCEREBELLAR ATAXIA TYPE 17	0.012048200000000002	0.4513840442150607
BECKWITH-WIEDEMANN SYNDROME	0.012048200000000002	0.4513840442150607
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.012048200000000002	0.4513840442150607
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.012048200000000002	0.4513840442150607
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.012048200000000002	0.4513840442150607
MADELUNG DEFORMITY	0.012048200000000002	0.4513840442150607
IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13	0.012048200000000002	0.4513840442150607
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012039854	0.45107136255032904
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45107136255032904
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.45107136255032904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.45107136255032904
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45107136255032904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45107136255032904
FUMARASE DEFICIENCY; FMRD	0.012039854	0.45107136255032904
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.45107136255032904
PEHO-LIKE SYNDROME; PEHOL	0.012039854	0.45107136255032904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.45107136255032904
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45107136255032904
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45107136255032904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45107136255032904
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.012039854	0.45107136255032904
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.45107136255032904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45107136255032904
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.012039854	0.45107136255032904
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45107136255032904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45107136255032904
PERLMAN SYNDROME	0.012039854	0.45107136255032904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45107136255032904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.45107136255032904
RING CHROMOSOME 14 SYNDROME	0.012039854	0.45107136255032904
RHABDOID TUMOR	0.01199589	0.4494242577446427
CITRULLINEMIA TYPE II	0.011725273	0.43928563156867056
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.011723744	0.4392283478081416
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.011723744	0.4392283478081416
NOONAN SYNDROME 9; NS9	0.011723744	0.4392283478081416
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.011723744	0.4392283478081416
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.011719608999999999	0.439073430640197
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.011719608999999999	0.439073430640197
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.011689119999999999	0.4379311647312585
CIRRHOSIS, FAMILIAL	0.011689119999999999	0.4379311647312585
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.011689119999999999	0.4379311647312585
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.0116279	0.4356375664189093
GLYCOGEN STORAGE DISEASE VII	0.0116279	0.4356375664189093
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.0116279	0.4356375664189093
SPHEROCYTOSIS, TYPE 2	0.0116279	0.4356375664189093
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.0116279	0.4356375664189093
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0116279	0.4356375664189093
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.0116279	0.4356375664189093
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.0116279	0.4356375664189093
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0116279	0.4356375664189093
ELLIPTOCYTOSIS 1; EL1	0.0116279	0.4356375664189093
SPECTRIN, BETA, ERYTHROCYTIC	0.0116279	0.4356375664189093
HEPATOERYTHROPOIETIC PORPHYRIA	0.0116279	0.4356375664189093
SPHEROCYTOSIS, AUTOSOMAL RECESSIVE	0.0116279	0.4356375664189093
GALACTOSEMIA	0.0116279	0.4356375664189093
OVALOCYTOSIS, HEREDITARY HEMOLYTIC	0.0116279	0.4356375664189093
URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIADUE TO	0.0116279	0.4356375664189093
GLUTATHIONE REDUCTASE	0.0116279	0.4356375664189093
6-@PHOSPHOGLUCONOLACTONASE DEFICIENCY	0.0116279	0.4356375664189093
SPHEROCYTOSIS, TYPE 1; SPH1	0.0116279	0.4356375664189093
PORPHYRIA, ACUTE HEPATIC	0.0116279	0.4356375664189093
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.0116279	0.4356375664189093
OVERHYDRATED HEREDITARY STOMATOCYTOSIS	0.0116279	0.4356375664189093
ELLIPTOCYTOSIS 2; EL2	0.0116279	0.4356375664189093
PYROPOIKILOCYTOSIS, HEREDITARY	0.0116279	0.4356375664189093
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0116279	0.4356375664189093
ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO	0.0116279	0.4356375664189093
GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIADUE TO	0.0116279	0.4356375664189093
RH-NULL, REGULATOR TYPE; RHNR	0.0116279	0.4356375664189093
CATEL-MANZKE SYNDROME; CATMANS	0.011613272999999999	0.43508956801128545
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.011613272999999999	0.43508956801128545
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.011613272999999999	0.43508956801128545
8Q24.3 MICRODELETION SYNDROME	0.011613272999999999	0.43508956801128545
HARTNUP DISEASE	0.011542783000000001	0.43244867050985625
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4306322620325999
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4306322620325999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4306322620325999
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4306322620325999
DESMOSTEROLOSIS	0.011494299999999999	0.4306322620325999
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4306322620325999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4306322620325999
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.01145935	0.42932286541357667
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.011424723000000001	0.42802556994213414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.011424723	0.42802556994213403
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.011424723	0.42802556994213403
GRACILE BONE DYSPLASIA; GCLEB	0.011262673	0.4219543904825426
OBESITY DUE TO SIM1 DEFICIENCY	0.011183854	0.41900144821888596
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.011179719	0.4188465310509415
CRIGLER-NAJJAR SYNDROME TYPE 1	0.011179719	0.4188465310509415
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.011179719	0.4188465310509415
CRIGLER-NAJJAR SYNDROME	0.011179719	0.4188465310509415
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.011179719	0.4188465310509415
SIFRIM-HITZ-WEISS SYNDROME	0.01117819	0.4187892472904125
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01117819	0.4187892472904125
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01117819	0.4187892472904125
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.01117819	0.4187892472904125
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01117819	0.4187892472904125
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.01117819	0.4187892472904125
DOUBLE OUTLET RIGHT VENTRICLE	0.01117819	0.4187892472904125
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.011071853999999999	0.41480538466150096
16P13.11 MICRODUPLICATION SYNDROME	0.011071853999999999	0.41480538466150096
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.011067718999999998	0.4146504674935564
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.011067718999999998	0.4146504674935564
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.010998123	0.41204306357087983
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.01098964	0.4117252492212612
DISTAL 16P11.2 MICRODELETION SYNDROME	0.010890893	0.40802570736321564
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.010883304	0.40774138659234954
X-LINKED ADRENOLEUKODYSTROPHY	0.010870850000000001	0.40727479931070965
LYMPHEDEMA, HEREDITARY, III	0.010721254000000001	0.4016702071327581
NEURAMINIDASE DEFICIENCY	0.010717119	0.40151528996481356
MYXEDEMA	0.0106383	0.39856234770115695
POSTERIOR CORTICAL ATROPHY	0.0106383	0.39856234770115695
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.0106383	0.39856234770115695
MACHADO-JOSEPH DISEASE TYPE 2	0.0106383	0.39856234770115695
MACHADO-JOSEPH DISEASE TYPE 3	0.0106383	0.39856234770115695
MACHADO-JOSEPH DISEASE TYPE 1	0.0106383	0.39856234770115695
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0106383	0.39856234770115695
SPINOCEREBELLAR ATAXIA TYPE 1	0.0106383	0.39856234770115695
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.0106383	0.39856234770115695
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0106383	0.39856234770115695
SPINOCEREBELLAR ATAXIA TYPE 27	0.0106383	0.39856234770115695
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.0106383	0.39856234770115695
SPINOCEREBELLAR ATAXIA TYPE 28	0.0106383	0.39856234770115695
SPASTIC PARAPLEGIA TYPE 7	0.0106383	0.39856234770115695
WERNICKE-KORSAKOFF SYNDROME	0.0106383	0.39856234770115695
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.0106383	0.39856234770115695
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0106383	0.39856234770115695
INFANTILE SIALIC ACID STORAGE DISEASE	0.010610783	0.3975314273359019
FREE SIALIC ACID STORAGE DISEASE	0.010610783	0.3975314273359019
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	0.010526299999999999	0.39436628414377184
OTOMANDIBULAR SYNDROME	0.010526299999999999	0.39436628414377184
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.010526299999999999	0.39436628414377184
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	0.010526299999999999	0.39436628414377184
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.010526299999999999	0.39436628414377184
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.010526299999999999	0.39436628414377184
MOSAIC TRISOMY 1	0.010526299999999999	0.39436628414377184
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.010526299999999999	0.39436628414377184
PHAVER SYNDROME	0.010526299999999999	0.39436628414377184
TRICUSPID ATRESIA	0.010526299999999999	0.39436628414377184
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.010526299999999999	0.39436628414377184
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.010526299999999999	0.39436628414377184
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.010526299999999999	0.39436628414377184
COARCTATION OF AORTA	0.010526299999999999	0.39436628414377184
CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA	0.010526299999999999	0.39436628414377184
HEMIFACIAL MICROSOMIA	0.010526299999999999	0.39436628414377184
METHIMAZOLE EMBRYOFETOPATHY	0.010526299999999999	0.39436628414377184
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.010451854	0.39157717568311934
BERNARD-SOULIER SYNDROME	0.010345339	0.3875866068454865
EPENDYMOMA	0.010345339	0.3875866068454865
RABIES	0.010345339	0.3875866068454865
SUBEPENDYMOMA	0.010345339	0.3875866068454865
EPISODIC ATAXIA, TYPE 6	0.010345339	0.3875866068454865
EPISODIC ATAXIA TYPE 6	0.010345339	0.3875866068454865
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.010345339	0.3875866068454865
CITRULLINEMIA TYPE I	0.010345339	0.3875866068454865
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.010345339	0.3875866068454865
MALAN OVERGROWTH SYNDROME	0.010345339	0.3875866068454865
ATYPICAL TERATOID RHABDOID TUMOR	0.010345339	0.3875866068454865
VIRAL HEMORRHAGIC FEVER	0.010345339	0.3875866068454865
AARSKOG-SCOTT SYNDROME	0.010341593999999999	0.38744630097028643
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.01033775	0.3873022860746205
IMMUNODEFICIENCY 46; IMD46	0.01033775	0.3873022860746205
CYCLIC NEUTROPENIA	0.01033775	0.3873022860746205
ROTHMUND-THOMSON SYNDROME TYPE 2	0.01033775	0.3873022860746205
TOXIC EPIDERMAL NECROLYSIS	0.01033775	0.3873022860746205
THROMBOCYTOPENIA 5; THC5	0.01033775	0.3873022860746205
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.010231123000000002	0.3833075211734304
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.010175700000000001	0.381231106615029
PSEUDO-TORCH SYNDROME 2	0.010065229	0.3770923268181729
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.010065229	0.3770923268181729
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.010065229	0.3770923268181729
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010065229	0.3770923268181729
HENNEKAM SYNDROME	0.010065229	0.3770923268181729
MICROHYDRANENCEPHALY; MHAC	0.00991115	0.3713197797033663
XQ12-Q13.3 DUPLICATION SYNDROME	0.00991115	0.3713197797033663
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36733591707445473
BIOTINIDASE DEFICIENCY	0.009804814	0.36733591707445473
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.36733591707445473
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.36733591707445473
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36733591707445473
KRABBE DISEASE	0.009804814	0.36733591707445473
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36733591707445473
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36733591707445473
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.36733591707445473
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36733591707445473
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36733591707445473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.36733591707445473
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36733591707445473
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36733591707445473
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.367302423495702
EPISODIC ATAXIA, TYPE 2	0.00980392	0.367302423495702
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.367302423495702
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.367302423495702
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00980392	0.367302423495702
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.367302423495702
ARACHNOIDITIS	0.00980392	0.367302423495702
FAMILIAL PAROXYSMAL ATAXIA	0.00980392	0.367302423495702
CLASSIC HODGKIN LYMPHOMA	0.00980392	0.367302423495702
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.367302423495702
LEGIONELLOSIS	0.00980392	0.367302423495702
KERION CELSI	0.00980392	0.367302423495702
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.367302423495702
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36718099990651015
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.009796039999999999	0.36700720045255736
KEIPERT SYNDROME	0.009796039999999999	0.36700720045255736
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.009796039999999999	0.36700720045255736
TRISOMY 4P	0.009796039999999999	0.36700720045255736
DISTAL TRISOMY 18Q	0.009689704	0.3630233378236458
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.009685569000000002	0.36286842065570135
KID SYNDROME	0.0096609	0.36194420019233403
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.0096609	0.36194420019233403
ENG-STROM SYNDROME	0.0096609	0.36194420019233403
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.009567399	0.3584411989541282
ALPHA-MANNOSIDOSIS	0.009554564	0.35796033756342244
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.009554564	0.35796033756342244
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.009550429	0.3578054203954779
ASPARTYLGLUCOSAMINURIA	0.009550429	0.3578054203954779
MALIGNANT PERITONEAL MESOTHELIOMA	0.00952381	0.3568081434683884
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00952381	0.3568081434683884
OVARIAN FIBROMA	0.00952381	0.3568081434683884
OVARIAN FIBROTHECOMA	0.00952381	0.3568081434683884
GRFOMA	0.00952381	0.3568081434683884
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00952381	0.3568081434683884
HEMOCHROMATOSIS, TYPE 1	0.00952381	0.3568081434683884
GALLBLADDER NEUROENDOCRINE TUMOR	0.00952381	0.3568081434683884
HEREDITARY ANGIOEDEMA	0.00952381	0.3568081434683884
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00952381	0.3568081434683884
CHYLOUS ASCITES	0.00952381	0.3568081434683884
ACQUIRED ANGIOEDEMA	0.00952381	0.3568081434683884
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00952381	0.3568081434683884
SPLENOPORTAL VASCULAR ANOMALIES	0.00952381	0.3568081434683884
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00952381	0.3568081434683884
ADENOCARCINOMA OF OVARY	0.00952381	0.3568081434683884
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00952381	0.3568081434683884
PPOMA	0.00952381	0.3568081434683884
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00952381	0.3568081434683884
BUDD-CHIARI SYNDROME	0.00952381	0.3568081434683884
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00952381	0.3568081434683884
PULMONARY ARTERIAL HYPERTENSION	0.00952381	0.3568081434683884
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00952381	0.3568081434683884
PSEUDOMYXOMA PERITONEI	0.00952381	0.3568081434683884
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00952381	0.3568081434683884
HEPATIC VENO-OCCLUSIVE DISEASE	0.00952381	0.3568081434683884
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00952381	0.3568081434683884
OVARIAN HYPERSTIMULATION SYNDROME	0.00952381	0.3568081434683884
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.009461904	0.3544888442667501
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.009351433	0.350350064469894
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.009351433	0.350350064469894
TETRASOMY 5P	0.009351433	0.350350064469894
KAGAMI-OGATA SYNDROME	0.009351433	0.350350064469894
TSH-SECRETING PITUITARY ADENOMA	0.009342419000000001	0.3500123562832309
PAINE SYNDROME	0.00925926	0.34689681655672566
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34689681655672566
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34689681655672566
CARNOSINEMIA	0.00925926	0.34689681655672566
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.34689681655672566
GAUCHER DISEASE TYPE 2	0.00925926	0.34689681655672566
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34689681655672566
HYDROXYLYSINURIA	0.00925926	0.34689681655672566
GLYCINE ENCEPHALOPATHY	0.00925926	0.34689681655672566
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34689681655672566
CARNOSINASE DEFICIENCY	0.00925926	0.34689681655672566
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34689681655672566
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.34689681655672566
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34689681655672566
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.009223120000000001	0.3455428367624052
TRISOMY 20P	0.00914415	0.3425842373059168
ROSAÏ-DORFMAN DISEASE	0.009112649	0.34140405696554904
SUSAC SYNDROME	0.00902598	0.3381570156043436
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.00900901	0.33752123704569337
PSORIASIS 1, SUSCEPTIBILITY TO	0.00900901	0.33752123704569337
WILD TYPE ABETA2M AMYLOIDOSIS	0.00900901	0.33752123704569337
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00900901	0.33752123704569337
YAO SYNDROME	0.00900901	0.33752123704569337
EOSINOPHILIC FASCIITIS	0.00900901	0.33752123704569337
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00900901	0.33752123704569337
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.00900901	0.33752123704569337
VERTICAL TALUS, CONGENITAL	0.00900901	0.33752123704569337
HEMOCHROMATOSIS, TYPE 2A	0.00900901	0.33752123704569337
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00900901	0.33752123704569337
MELORHEOSTOSIS	0.00900901	0.33752123704569337
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00900901	0.33752123704569337
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.00900901	0.33752123704569337
CINCA SYNDROME; CINCA	0.00900901	0.33752123704569337
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.00900901	0.33752123704569337
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	0.00900901	0.33752123704569337
IMMUNODEFICIENCY 61; IMD61	0.00900901	0.33752123704569337
DRACUNCULIASIS	0.00900901	0.33752123704569337
CAUDAL REGRESSION SEQUENCE	0.00891917	0.33415539463501953
APERT SYNDROME	0.00891917	0.33415539463501953
PRIMARY PROGRESSIVE FREEZING GAIT	0.00891917	0.33415539463501953
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00891635	0.3340497437490211
HURLER-SCHEIE SYNDROME	0.00891635	0.3340497437490211
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00891635	0.3340497437490211
STUVE-WIEDEMANN SYNDROME	0.00891635	0.3340497437490211
COHEN SYNDROME	0.008881723	0.33275244827757844
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.008881723	0.33275244827757844
3Q29 MICRODELETION SYNDROME	0.008810014	0.3300658811201095
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.008810014	0.3300658811201095
ADAMS-OLIVER SYNDROME 5; AOS5	0.008805878999999999	0.32991096395216496
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.008805878999999999	0.32991096395216496
FAMILIAL HYPERALDOSTERONISM TYPE III	0.008801	0.32972817293344636
ALPORT SYNDROME	0.008801	0.32972817293344636
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.008801	0.32972817293344636
FAMILIAL HYPERALDOSTERONISM TYPE II	0.008801	0.32972817293344636
FAMILIAL HYPERALDOSTERONISM TYPE I	0.008801	0.32972817293344636
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.008801	0.32972817293344636
POSTORGASMIC ILLNESS SYNDROME	0.008801	0.32972817293344636
CUSHING DISEASE	0.008801	0.32972817293344636
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.008801	0.32972817293344636
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.008801	0.32972817293344636
ACERULOPLASMINEMIA	0.0086894	0.32554709531733766
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0086894	0.32554709531733766
RAT-BITE FEVER	0.00857123	0.32111987361576455
CAMURATI-ENGELMANN DISEASE	0.00857123	0.32111987361576455
SEVERE HEMOPHILIA A	0.00857123	0.32111987361576455
DISTAL MONOSOMY 10Q	0.008450273	0.3165882373683482
DIGEORGE SYNDROME; DGS	0.008450273	0.3165882373683482
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.008450273	0.3165882373683482
HELSMOORTEL-VAN DER AA SYNDROME	0.008450273	0.3165882373683482
COFFIN-SIRIS SYNDROME 5	0.008450273	0.3165882373683482
SAUL-WILSON SYNDROME; SWILS	0.008340304	0.31246826492779395
COHEN SYNDROME	0.008336169	0.31231334775984937
ASPARTYLGLUCOSAMINURIA; AGU	0.008336169	0.31231334775984937
CARDIOMYOPATHY, DILATED, 2C; CMD2C	0.00826446	0.3096267806023804
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.00826446	0.3096267806023804
PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT	0.00826446	0.3096267806023804
CONGENITAL TRICUSPID STENOSIS	0.00826446	0.3096267806023804
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.00826446	0.3096267806023804
PULMONARY HYPERTENSION, PRIMARY, 4	0.00826446	0.3096267806023804
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.00826446	0.3096267806023804
MELNICK-NEEDLES SYNDROME	0.00826446	0.3096267806023804
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00826446	0.3096267806023804
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.00826446	0.3096267806023804
OROFACIODIGITAL SYNDROME TYPE 2	0.008239694	0.30869892604825366
1Q44 MICRODELETION SYNDROME	0.008239694	0.30869892604825366
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.008229833	0.30832948513093783
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.008229833	0.30832948513093783
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.008041974	0.3012913752753414
RABSON-MENDENHALL SYNDROME	0.007908854	0.2963040540185637
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.007908854	0.2963040540185637
SMITH-LEMLI-OPITZ SYNDROME	0.007798383000000001	0.29216527422170757
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.007798383	0.2921652742217075
PHELAN-MCDERMID SYNDROME	0.007798383	0.2921652742217075
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007798383	0.2921652742217075
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.007798383	0.2921652742217075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.007798383	0.2921652742217075
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.007798383	0.2921652742217075
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00779475	0.2920291644100648
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00779475	0.2920291644100648
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00779475	0.2920291644100648
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00769414	0.28825982553052465
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00769414	0.28825982553052465
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0076842790000000005	0.2878903846132088
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0076842790000000005	0.2878903846132088
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.284275962901613
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.284275962901613
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.284275962901613
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.007587804	0.284275962901613
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.284275962901613
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.284275962901613
W SYNDROME	0.007587804	0.284275962901613
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.284275962901613
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.284275962901613
SARCOSINEMIA	0.007587804	0.284275962901613
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.284275962901613
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2841210457336684
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2841210457336684
PYCNODYSOSTOSIS	0.00749642	0.2808522747576123
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.0073633	0.2758649535008346
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.0073633	0.2758649535008346
VELOCARDIOFACIAL SYNDROME	0.0073633	0.2758649535008346
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0072714400000000005	0.2724234320867151
MACROCEPHALY/AUTISM SYNDROME	0.007256964	0.271881090871923
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007256964	0.271881090871923
NETHERTON SYNDROME; NETH	0.007256964	0.271881090871923
JOUBERT SYNDROME 10	0.007256964	0.271881090871923
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.007256964	0.271881090871923
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.007256964	0.271881090871923
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.007256964	0.271881090871923
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.007256964	0.271881090871923
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.007256964	0.271881090871923
224250 DYSMYELINATION WITH JAUNDICE	0.007252829000000001	0.27172617370397856
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.007252829000000001	0.27172617370397856
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.007252829000000001	0.27172617370397856
PROTEUS SYNDROME	0.007252829000000001	0.27172617370397856
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.007252829000000001	0.27172617370397856
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.007252829000000001	0.27172617370397856
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.007252829000000001	0.27172617370397856
QAZI-MARKOUIZOS SYNDROME	0.007252829000000001	0.27172617370397856
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.007252829000000001	0.27172617370397856
IMMUNODEFICIENCY 37; IMD37	0.007252829000000001	0.27172617370397856
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.007252829000000001	0.27172617370397856
6Q25 MICRODELETION SYNDROME	0.007233373	0.27099725752029563
COFFIN-SIRIS SYNDROME	0.007233373	0.27099725752029563
COFFIN-SIRIS SYNDROME 4; CSS4	0.007233373	0.27099725752029563
15Q11Q13 MICRODUPLICATION SYNDROME	0.007233373	0.27099725752029563
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007233373	0.27099725752029563
49,XXXXY SYNDROME	0.007233373	0.27099725752029563
COFFIN-SIRIS SYNDROME 3; CSS3	0.007233373	0.27099725752029563
SMITH-MAGENIS SYNDROME	0.007233373	0.27099725752029563
15Q13.3 MICRODELETION SYNDROME	0.007233373	0.27099725752029563
ZTTK SYNDROME; ZTTKS	0.007233373	0.27099725752029563
RUBINSTEIN-TAYBI SYNDROME	0.007233373	0.27099725752029563
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3	0.00714286	0.26760620126342427
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00714286	0.26760620126342427
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00714286	0.26760620126342427
ADULT IDIOPATHIC NEUTROPENIA	0.00714286	0.26760620126342427
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.00714286	0.26760620126342427
IMMUNODEFICIENCY 50; IMD50	0.00714286	0.26760620126342427
BARTH SYNDROME; BTHS	0.00714286	0.26760620126342427
X-LINKED SEVERE CONGENITAL NEUTROPENIA	0.00714286	0.26760620126342427
NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA	0.00714286	0.26760620126342427
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.00714286	0.26760620126342427
IMMUNODEFICIENCY DUE TO INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE-4 DEFICIENCY	0.00714286	0.26760620126342427
DIAMOND-BLACKFAN ANEMIA 18; DBA18	0.00714286	0.26760620126342427
FELTY SYNDROME	0.00714286	0.26760620126342427
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00714286	0.26760620126342427
ISOLATED ECTOPIA LENTIS	0.0070743	0.2650376109286535
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26383686238388393
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26383686238388393
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26383686238388393
AMISH LETHAL MICROCEPHALY	0.00704225	0.26383686238388393
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26383686238388393
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26383686238388393
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26383686238388393
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26383686238388393
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26383686238388393
OLIVER SYNDROME	0.00704225	0.26383686238388393
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26383686238388393
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26383686238388393
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26383686238388393
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26383686238388393
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26383686238388393
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26383686238388393
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26383686238388393
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26383686238388393
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00684453	0.25642931161097166
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00684453	0.25642931161097166
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00671141	0.251441990354194
HISTIOCYTOSIS, FAMILIAL LIPOCHROME	0.00671141	0.251441990354194
UROCANIC ACIDURIA	0.00671141	0.251441990354194
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.00671141	0.251441990354194
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.00671141	0.251441990354194
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00671141	0.251441990354194
PSEUDODIASTROPHIC DYSPLASIA	0.00671141	0.251441990354194
GABRIELE-DE VRIES SYNDROME	0.00671141	0.251441990354194
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.00671141	0.251441990354194
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00671141	0.251441990354194
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00671141	0.251441990354194
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00671141	0.251441990354194
IMMUNE DEFICIENCY, FAMILIAL VARIABLE	0.00671141	0.251441990354194
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00671141	0.251441990354194
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00671141	0.251441990354194
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00671141	0.251441990354194
IMMUNODEFICIENCY 9; IMD9	0.00671141	0.251441990354194
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00671141	0.251441990354194
IMMUNODEFICIENCY 32A	0.00671141	0.251441990354194
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00671141	0.251441990354194
CYSTIC DISEASE OF LUNG	0.00671141	0.251441990354194
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00671141	0.251441990354194
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00671141	0.251441990354194
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00671141	0.251441990354194
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00671141	0.251441990354194
17P11.2 MICRODUPLICATION SYNDROME	0.006691954	0.2507130741705111
FLOATING-HARBOR SYNDROME	0.006691954	0.2507130741705111
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.006691954	0.2507130741705111
6Q16 MICRODELETION SYNDROME	0.006691954	0.2507130741705111
DISTAL TRISOMY 6P	0.006691954	0.2507130741705111
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.006691954	0.2507130741705111
OHDO SYNDROME	0.006687819	0.25055815700256656
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.006687819	0.25055815700256656
MICROPHTHALMIA, LENZ TYPE	0.006687819	0.25055815700256656
BARAITSER-WINTER SYNDROME 2; BRWS2	0.006687819	0.25055815700256656
ADNP SYNDROME	0.006687819	0.25055815700256656
ISOLATED SPINA BIFIDA	0.006687819	0.25055815700256656
BOWEN-CONRADI SYNDROME	0.006687819	0.25055815700256656
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.006687818999999999	0.25055815700256656
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00661955	0.2480004689400744
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.006581483000000001	0.24657429437365497
WAISMAN SYNDROME; WSMN	0.006581483000000001	0.24657429437365497
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.006581483000000001	0.24657429437365497
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.006581483000000001	0.24657429437365497
GM2-GANGLIOSIDOSIS, AB VARIANT	0.006581483000000001	0.24657429437365497
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.006581483000000001	0.24657429437365497
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.006581483000000001	0.24657429437365497
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.006581483000000001	0.24657429437365497
48,XXXY SYNDROME	0.006581483	0.24657429437365497
MONOSOMY 9P	0.006581483	0.24657429437365497
MOSAIC TRISOMY 14	0.006581483	0.24657429437365497
48,XXYY SYNDROME	0.006581483	0.24657429437365497
DUANE RETRACTION SYNDROME	0.006581483	0.24657429437365497
L1 SYNDROME	0.006463313	0.24214707267208183
OPTIC PATHWAY GLIOMA	0.006463313	0.24214707267208183
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0061464	0.23027397365278204
MONOSOMY 5P	0.0061464	0.23027397365278204
FRONTONASAL DYSPLASIA	0.0061464	0.23027397365278204
MOSAIC TRISOMY 8	0.0061464	0.23027397365278204
ACROCRANIOFACIAL DYSOSTOSIS	0.0061464	0.23027397365278204
MESOMELIA-SYNOSTOSES SYNDROME	0.0061464	0.23027397365278204
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.0061464	0.23027397365278204
NEUROFACIODIGITORENAL SYNDROME	0.0061464	0.23027397365278204
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.0061464	0.23027397365278204
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.0061464	0.23027397365278204
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.0061464	0.23027397365278204
MCDONOUGH SYNDROME	0.0061464	0.23027397365278204
CAMPOMELIC DYSPLASIA	0.0061464	0.23027397365278204
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0061464	0.23027397365278204
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0061464	0.23027397365278204
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.0061464	0.23027397365278204
LAURENCE-MOON SYNDROME	0.0061464	0.23027397365278204
THALIDOMIDE EMBRYOPATHY	0.0061464	0.23027397365278204
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0061464	0.23027397365278204
TRISOMY 18P	0.0061464	0.23027397365278204
ERYTHROKERATODERMIA VARIABILIS	0.0061464	0.23027397365278204
DISTAL MONOSOMY 10P	0.0061464	0.23027397365278204
MONOSOMY 13Q14	0.0061464	0.23027397365278204
FEMORAL-FACIAL SYNDROME	0.0061464	0.23027397365278204
X-LINKED EHLERS-DANLOS SYNDROME	0.0061464	0.23027397365278204
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.0061464	0.23027397365278204
LARYNX ATRESIA	0.0061464	0.23027397365278204
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0061464	0.23027397365278204
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.006040064	0.22629011102387048
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.006040064	0.22629011102387048
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.006040064	0.22629011102387048
ROBERTS SYNDROME	0.006040064	0.22629011102387048
TARP SYNDROME; TARPS	0.006040064	0.22629011102387048
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.006040064	0.22629011102387048
DISTAL MONOSOMY 9P	0.006040064	0.22629011102387048
HYDROCEPHALUS, NORMAL-PRESSURE	0.006040064	0.22629011102387048
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.006040064	0.22629011102387048
TRISOMY 8Q	0.006040064	0.22629011102387048
OROFACIODIGITAL SYNDROME TYPE 4	0.006040064	0.22629011102387048
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.006040064	0.22629011102387048
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.006040064	0.22629011102387048
WEAVER SYNDROME	0.006040064	0.22629011102387048
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.006035929000000001	0.22613519385592593
FLYNN-AIRD SYNDROME	0.006035929000000001	0.22613519385592593
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.006035929000000001	0.22613519385592593
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.006035929000000001	0.22613519385592593
FLYNN-AIRD SYNDROME	0.006035929000000001	0.22613519385592593
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.006035929000000001	0.22613519385592593
HUNTINGTON DISEASE; HD	0.006035929000000001	0.22613519385592593
KALLMANN SYNDROME	0.006035929000000001	0.22613519385592593
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.006035929000000001	0.22613519385592593
DISTAL TRISOMY 15Q	0.006035929000000001	0.22613519385592593
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.006035929000000001	0.22613519385592593
KUFOR-RAKEB SYNDROME	0.006035929000000001	0.22613519385592593
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.006035929000000001	0.22613519385592593
JUVENILE HUNTINGTON DISEASE	0.006035929000000001	0.22613519385592593
ACROCALLOSAL SYNDROME; ACLS	0.006035929000000001	0.22613519385592593
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.006035929000000001	0.22613519385592593
ADRENOLEUKODYSTROPHY	0.006035929000000001	0.22613519385592593
CHOREOATHETOSIS, FAMILIAL INVERTED	0.006035929000000001	0.22613519385592593
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.006035929000000001	0.22613519385592593
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006035929000000001	0.22613519385592593
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006035929000000001	0.22613519385592593
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.006028230000000001	0.22584675195120893
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0059218940000000005	0.22186288932229728
HYDROXYKYNURENINURIA	0.0059218940000000005	0.22186288932229728
LHERMITTE-DUCLOS DISEASE	0.005917759	0.22170797215435276
LUJO HEMORRHAGIC FEVER	0.005917759	0.22170797215435276
PARIETAL FORAMINA	0.005917759	0.22170797215435276
CENTRAL DIABETES INSIPIDUS	0.005917759	0.22170797215435276
EBOLA HEMORRHAGIC FEVER	0.005917759	0.22170797215435276
PAPILLOMA OF CHOROID PLEXUS	0.005917759	0.22170797215435276
RIFT VALLEY FEVER	0.005917759	0.22170797215435276
NIPAH VIRUS DISEASE	0.005917759	0.22170797215435276
CRANIOSYNOSTOSIS 2	0.005917759	0.22170797215435276
PROLACTINOMA	0.005917759	0.22170797215435276
ACQUIRED METHEMOGLOBINEMIA	0.005917759	0.22170797215435276
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.005917759	0.22170797215435276
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.005917759	0.22170797215435276
POSTENCEPHALITIC PARKINSONISM	0.005917759	0.22170797215435276
NEUROFIBROMATOSIS, TYPE II	0.005917759	0.22170797215435276
LASSA FEVER	0.005917759	0.22170797215435276
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00549451	0.2058510105061414
DEMENTIA, LEWY BODY; DLB	0.00549451	0.2058510105061414
PHENYLKETONURIA	0.00549451	0.2058510105061414
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.00549451	0.2058510105061414
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.2058510105061414
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00549451	0.2058510105061414
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00549451	0.2058510105061414
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00549451	0.2058510105061414
SCHISIS ASSOCIATION	0.00549451	0.2058510105061414
CAMPOMELIA, CUMMING TYPE	0.00549451	0.2058510105061414
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00549451	0.2058510105061414
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00549451	0.2058510105061414
HEART-HAND SYNDROME TYPE 2	0.00549451	0.2058510105061414
184705 STEINFELD SYNDROME	0.00549451	0.2058510105061414
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.2058510105061414
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00549451	0.2058510105061414
BARTSOCAS-PAPAS SYNDROME	0.00549451	0.2058510105061414
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00549451	0.2058510105061414
NAGER SYNDROME	0.00549451	0.2058510105061414
HUNTINGTON DISEASE	0.00549451	0.2058510105061414
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.00549451	0.2058510105061414
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.2058510105061414
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00549451	0.2058510105061414
MARSHALL-SMITH SYNDROME	0.00549451	0.2058510105061414
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00549451	0.2058510105061414
NEUROFERRITINOPATHY	0.00549451	0.2058510105061414
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00549451	0.2058510105061414
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00549451	0.2058510105061414
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00549451	0.2058510105061414
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.2058510105061414
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.00549451	0.2058510105061414
ALZHEIMER DISEASE 2	0.00549451	0.2058510105061414
ALZHEIMER DISEASE	0.00549451	0.2058510105061414
ACHONDROGENESIS	0.00549451	0.2058510105061414
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00549451	0.2058510105061414
ACHONDROGENESIS TYPE 2	0.00549451	0.2058510105061414
ACHONDROGENESIS TYPE 1B	0.00549451	0.2058510105061414
ACHONDROGENESIS TYPE 1A	0.00549451	0.2058510105061414
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00549451	0.2058510105061414
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.00549451	0.2058510105061414
ACALVARIA	0.00549451	0.2058510105061414
HYDROLETHALUS	0.00549451	0.2058510105061414
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00549451	0.2058510105061414
HOLZGREVE SYNDROME	0.00549451	0.2058510105061414
15Q26 OVERGROWTH SYNDROME	0.00549451	0.2058510105061414
SPINOCEREBELLAR ATAXIA TYPE 2	0.00549451	0.2058510105061414
SPINOCEREBELLAR ATAXIA TYPE 12	0.00549451	0.2058510105061414
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.2058510105061414
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00549451	0.2058510105061414
PRIMARY DYSTONIA, DYT4 TYPE	0.00549451	0.2058510105061414
EARLY-ONSET ALZHEIMER DISEASE WITH CEREBRAL AMYLOID ANGIOPATHY	0.00549451	0.2058510105061414
FRANK-TER HAAR SYNDROME; FTHS	0.00549451	0.2058510105061414
ISOLATED HEMIHYPERPLASIA	0.00549451	0.2058510105061414
FRASER SYNDROME	0.00549451	0.2058510105061414
MAST SYNDROME	0.00549451	0.2058510105061414
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00549451	0.2058510105061414
ADULT POLYGLUCOSAN BODY DISEASE	0.00549451	0.2058510105061414
RENAL AGENESIS, BILATERAL	0.00549451	0.2058510105061414
AUROCEPHALOSYNDACTYLY	0.00549451	0.2058510105061414
WAARDENBURG SYNDROME TYPE 1	0.00549451	0.2058510105061414
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00549451	0.2058510105061414
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.00549451	0.2058510105061414
HUNTINGTON DISEASE-LIKE 2	0.00549451	0.2058510105061414
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00549451	0.2058510105061414
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00549451	0.2058510105061414
AXENFELD-RIEGER SYNDROME	0.00549451	0.2058510105061414
SPINOCEREBELLAR ATAXIA 12	0.00549451	0.2058510105061414
HUNTINGTON DISEASE-LIKE 1	0.00549451	0.2058510105061414
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00549451	0.2058510105061414
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00549451	0.2058510105061414
POPLITEAL PTERYGIUM SYNDROME	0.00549451	0.2058510105061414
TRISOMY 18-LIKE SYNDROME	0.00549451	0.2058510105061414
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00549451	0.2058510105061414
DEMENTIA, FAMILIAL DANISH	0.00549451	0.2058510105061414
MACHADO-JOSEPH DISEASE; MJD	0.00549451	0.2058510105061414
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00549451	0.2058510105061414
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00549451	0.2058510105061414
PERRY SYNDROME	0.00549451	0.2058510105061414
ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL	0.00549451	0.2058510105061414
AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA	0.00549451	0.2058510105061414
LEBER OPTIC ATROPHY AND DYSTONIA	0.00549451	0.2058510105061414
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00549451	0.2058510105061414
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00549451	0.2058510105061414
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.2058510105061414
CAMPOMELIC DYSPLASIA	0.00549451	0.2058510105061414
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00549451	0.2058510105061414
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00549451	0.2058510105061414
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00549451	0.2058510105061414
INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	0.00549451	0.2058510105061414
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00549451	0.2058510105061414
SEMANTIC DEMENTIA	0.00549451	0.2058510105061414
VACTERL WITH HYDROCEPHALUS	0.00549451	0.2058510105061414
PRESENILE DEMENTIA, KRAEPELIN TYPE	0.00549451	0.2058510105061414
NEU-LAXOVA SYNDROME	0.00549451	0.2058510105061414
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00549451	0.2058510105061414
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.00549451	0.2058510105061414
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00549451	0.2058510105061414
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.2058510105061414
KUFOR-RAKEB SYNDROME	0.00549451	0.2058510105061414
UNVERRICHT-LUNDBORG DISEASE	0.00549451	0.2058510105061414
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00549451	0.2058510105061414
FACIOSCAPULOHUMERAL DYSTROPHY	0.00549451	0.2058510105061414
FAMILIAL VISCERAL MYOPATHY	0.00549451	0.2058510105061414
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.00549451	0.2058510105061414
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00549451	0.2058510105061414
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00549451	0.2058510105061414
PARKINSON DISEASE, LATE-ONSET; PD	0.00549451	0.2058510105061414
MYOPATHY AND DIABETES MELLITUS	0.00549451	0.2058510105061414
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.00549451	0.2058510105061414
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005388502999999999	0.20187947381392957
CORNELIA DE LANGE SYNDROME 3	0.005388502999999999	0.20187947381392957
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005388502999999999	0.20187947381392957
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.005388502999999999	0.20187947381392957
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.20142378880456824
BRUNNER SYNDROME; BRNRS	0.00537634	0.20142378880456824
CUTANEOUS MASTOCYTOSIS	0.00537634	0.20142378880456824
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.20142378880456824
PITUITARY CARCINOMA	0.00537634	0.20142378880456824
MARSILI SYNDROME; MARSIS	0.00537634	0.20142378880456824
EPISODIC ATAXIA, TYPE 3	0.00537634	0.20142378880456824
IDIOPATHIC PANUVEITIS	0.00537634	0.20142378880456824
SOLAR URTICARIA	0.00537634	0.20142378880456824
PARKES WEBER SYNDROME	0.00537634	0.20142378880456824
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.20142378880456824
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.20142378880456824
PARATHYROID CARCINOMA	0.00537634	0.20142378880456824
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.20142378880456824
SYDENHAM CHOREA	0.00537634	0.20142378880456824
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.20142378880456824
HODGKIN LYMPHOMA	0.00537634	0.20142378880456824
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.20142378880456824
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.20142378880456824
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.20142378880456824
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00537634	0.20142378880456824
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.20142378880456824
PERINEURAL CYST	0.00537634	0.20142378880456824
CHIARI MALFORMATION TYPE I	0.00537634	0.20142378880456824
CUTANEOUS MASTOCYTOMA	0.00537634	0.20142378880456824
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.20142378880456824
CENTRAL NEUROCYTOMA	0.00537634	0.20142378880456824
PRIMARY PARATHYROID HYPERPLASIA	0.00537634	0.20142378880456824
MARBURG HEMORRHAGIC FEVER	0.00537634	0.20142378880456824
TURCOT SYNDROME WITH POLYPOSIS	0.00537634	0.20142378880456824
CROUZON DISEASE	0.00537634	0.20142378880456824
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00537634	0.20142378880456824
HEMANGIOBLASTOMA	0.00537634	0.20142378880456824
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.20142378880456824
EPISODIC ATAXIA TYPE 1	0.00537634	0.20142378880456824
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.20142378880456824
TYPHOID	0.00537634	0.20142378880456824
PONTIAC FEVER	0.00537634	0.20142378880456824
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00537634	0.20142378880456824
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.004933753	0.1848423318253505
TRISOMY 18	0.004847084	0.18159529046414508
DYSTONIA 28, CHILDHOOD-ONSET	0.004847084	0.18159529046414508
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.004847084	0.18159529046414508
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.004847084	0.18159529046414508
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.004842949	0.18144037329620055
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.004842949	0.18144037329620055
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.004842949	0.18144037329620055
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.004842949	0.18144037329620055
NOONAN SYNDROME 7; NS7	0.004842948999999999	0.18144037329620052
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.004842948999999999	0.18144037329620052
GM2 GANGLIOSIDOSIS, AB VARIANT	0.004842948999999999	0.18144037329620052
ZELLWEGER SYNDROME	0.004842948999999999	0.18144037329620052
XERODERMA PIGMENTOSUM	0.004842948999999999	0.18144037329620052
ATAXIA-TELANGIECTASIA	0.004842948999999999	0.18144037329620052
DISTAL MONOSOMY 3P	0.004842948999999999	0.18144037329620052
CANAVAN DISEASE	0.004736613000000001	0.17745651066728899
TRISOMY X	0.004736613000000001	0.17745651066728899
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004736613000000001	0.17745651066728899
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.004736613000000001	0.17745651066728899
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.004736613000000001	0.17745651066728899
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.004736613000000001	0.17745651066728899
FOIX-CHAVANY-MARIE SYNDROME	0.004736613000000001	0.17745651066728899
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.004736613000000001	0.17745651066728899
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004736613000000001	0.17745651066728899
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.004736613000000001	0.17745651066728899
DYSTONIA-APHONIA SYNDROME	0.004736613000000001	0.17745651066728899
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.004736613000000001	0.17745651066728899
CONGENITAL HYPOTHYROIDISM	0.004622104	0.17316644779324783
POPOV-CHANG SYNDROME; POPCHAS	0.004622104	0.17316644779324783
SENIOR-LOKEN SYNDROME	0.004622104	0.17316644779324783
HURLER SYNDROME	0.004622104	0.17316644779324783
NEUROFIBROMATOSIS, TYPE I	0.0046179689999999995	0.17301153062530328
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.004511633	0.1690276679963917
XQ21 MICRODELETION SYNDROME	0.004511633	0.1690276679963917
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.004392334	0.164558148475566
FAMILIAL BENIGN COPPER DEFICIENCY	0.004388199000000001	0.1644032313076215
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.004388199000000001	0.1644032313076215
21Q22.11Q22.12 MICRODELETION SYNDROME	0.004388199000000001	0.1644032313076215
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.004388199000000001	0.1644032313076215
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00430153	0.161156189946416
HIDROTIC ECTODERMAL DYSPLASIA	0.00430153	0.161156189946416
CONGENITAL SHORT BOWEL SYNDROME	0.00430153	0.161156189946416
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00430153	0.161156189946416
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00430153	0.161156189946416
SECKEL SYNDROME 4	0.00430153	0.161156189946416
LEPRECHAUNISM	0.00430153	0.161156189946416
DISTAL MONOSOMY 13Q	0.00430153	0.161156189946416
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00430153	0.161156189946416
VOGT-KOYANAGI-HARADA DISEASE	0.00430153	0.161156189946416
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00430153	0.161156189946416
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00430153	0.161156189946416
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00430153	0.161156189946416
SECKEL SYNDROME	0.00430153	0.161156189946416
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00430153	0.161156189946416
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00430153	0.161156189946416
LAMELLAR ICHTHYOSIS	0.00430153	0.161156189946416
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00430153	0.161156189946416
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00430153	0.161156189946416
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00430153	0.161156189946416
MUCOLIPIDOSIS TYPE III	0.00430153	0.161156189946416
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00430153	0.161156189946416
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004281863	0.16041936867870987
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.004281863	0.16041936867870987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.004281863	0.16041936867870987
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.004281863	0.16041936867870987
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.004281863	0.16041936867870987
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.004281863	0.16041936867870987
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.004281863	0.16041936867870987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.004281863	0.16041936867870987
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.004195194	0.15717232731750447
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.004195194	0.15717232731750447
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA 5; SCA5	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.004195194	0.15717232731750447
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.004195194	0.15717232731750447
DUCHENNE MUSCULAR DYSTROPHY	0.004195194	0.15717232731750447
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.004195194	0.15717232731750447
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004195194	0.15717232731750447
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.004195194	0.15717232731750447
BARDET-BIEDL SYNDROME 17; BBS17	0.004195194	0.15717232731750447
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.004195194	0.15717232731750447
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA TYPE 29	0.004195194	0.15717232731750447
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004195194	0.15717232731750447
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.004195194	0.15717232731750447
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.004195194	0.15717232731750447
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.004195194	0.15717232731750447
BARDET-BIEDL SYNDROME 8; BBS8	0.004195194	0.15717232731750447
JOUBERT SYNDROME 31; JBTS31	0.004195194	0.15717232731750447
BARDET-BIEDL SYNDROME 16; BBS16	0.004195194	0.15717232731750447
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.004195194	0.15717232731750447
ENDOCARDIAL FIBROELASTOSIS	0.0041910590000000005	0.15701741014955992
CRISPONI SYNDROME	0.0041910590000000005	0.15701741014955992
PHAKOMATOSIS PIGMENTOVASCULARIS	0.0041910590000000005	0.15701741014955992
BENIGN FAMILIAL NEONATAL EPILEPSY	0.0041910590000000005	0.15701741014955992
MUSCLE-EYE-BRAIN DISEASE	0.0041910590000000005	0.15701741014955992
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0041910590000000005	0.15701741014955992
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.0041910590000000005	0.15701741014955992
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.0041910590000000005	0.15701741014955992
SYMMETRICAL THALAMIC CALCIFICATIONS	0.0041910590000000005	0.15701741014955992
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0041910590000000005	0.15701741014955992
ONDINE SYNDROME	0.0041910590000000005	0.15701741014955992
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0041910590000000005	0.15701741014955992
WORSTER-DROUGHT SYNDROME	0.0041910590000000005	0.15701741014955992
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.0041910590000000005	0.15701741014955992
PAPILLOMA OF CHOROID PLEXUS	0.0041910590000000005	0.15701741014955992
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0041910590000000005	0.15701741014955992
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0041910590000000005	0.15701741014955992
ALG2-CDG	0.0041910590000000005	0.15701741014955992
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0041910590000000005	0.15701741014955992
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0041910590000000005	0.15701741014955992
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0041910590000000005	0.15701741014955992
MPDU1-CDG	0.0041910590000000005	0.15701741014955992
LEIGH SYNDROME	0.0041910590000000005	0.15701741014955992
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0041910590000000005	0.15701741014955992
ALG9-CDG	0.0041910590000000005	0.15701741014955992
NAIL-PATELLA-LIKE RENAL DISEASE	0.00407655	0.1527273472755188
JUVENILE PAGET DISEASE	0.00407655	0.1527273472755188
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00407655	0.1527273472755188
BARDET-BIEDL SYNDROME	0.00407655	0.1527273472755188
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00407655	0.1527273472755188
STIFF SKIN SYNDROME	0.00407655	0.1527273472755188
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00407655	0.1527273472755188
HUNTER-MACDONALD SYNDROME	0.00407655	0.1527273472755188
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.003970214	0.14874348464660717
JOUBERT SYNDROME 14	0.003970214	0.14874348464660717
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003970214	0.14874348464660717
MERCURY POISONING	0.003966079	0.14858856747866264
FAMILIAL DYSAUTONOMIA	0.003966079	0.14858856747866264
ALEXANDER DISEASE	0.003966079	0.14858856747866264
CLASSIC HOMOCYSTINURIA	0.003966079	0.14858856747866264
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.003966079	0.14858856747866264
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003966079	0.14858856747866264
PORPHYRIA	0.003966079	0.14858856747866264
PREECLAMPSIA/ECLAMPSIA 1	0.003966079	0.14858856747866264
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.003966079	0.14858856747866264
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00384678	0.14411904795783695
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00384678	0.14411904795783695
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00384678	0.14411904795783695
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00384678	0.14411904795783695
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00384678	0.14411904795783695
JOHANSON-BLIZZARD SYNDROME	0.00384678	0.14411904795783695
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003740444	0.14013518532892533
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.003740444	0.14013518532892533
HEREDITARY OROTIC ACIDURIA	0.003740444	0.14013518532892533
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.003740444	0.14013518532892533
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.003740444	0.14013518532892533
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.003740444	0.14013518532892533
NEPHRONOPHTHISIS 11; NPHP11	0.003740444	0.14013518532892533
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.003740444	0.14013518532892533
DERMOTRICHIC SYNDROME	0.003736309	0.1399802681609808
CRONKHITE-CANADA SYNDROME	0.003736309	0.1399802681609808
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.003736309	0.1399802681609808
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.003736309	0.1399802681609808
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.003736309	0.1399802681609808
HYPOPHOSPHATASIA, INFANTILE	0.003736309	0.1399802681609808
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00364964	0.1367332267997754
EARLY-ONSET SCHIZOPHRENIA	0.00364964	0.1367332267997754
PRUNE BELLY SYNDROME	0.00364964	0.1367332267997754
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00364964	0.1367332267997754
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00364964	0.1367332267997754
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00364964	0.1367332267997754
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00364964	0.1367332267997754
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00364964	0.1367332267997754
SPINOCEREBELLAR ATAXIA TYPE 21	0.00364964	0.1367332267997754
SPINOCEREBELLAR ATAXIA TYPE 14	0.00364964	0.1367332267997754
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00364964	0.1367332267997754
SCHIZOPHRENIA 19; SCZD19	0.00364964	0.1367332267997754
DK1-CDG	0.00364964	0.1367332267997754
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00364964	0.1367332267997754
NON-DISTAL TRISOMY 13Q	0.00364964	0.1367332267997754
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00364964	0.1367332267997754
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00364964	0.1367332267997754
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00364964	0.1367332267997754
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.1367332267997754
COWCHOCK SYNDROME; COWCK	0.00364964	0.1367332267997754
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.00364964	0.1367332267997754
MONOAMINE OXIDASE A DEFICIENCY	0.00364964	0.1367332267997754
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00364964	0.1367332267997754
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00364964	0.1367332267997754
RHIZOMELIC SYNDROME, URBACH TYPE	0.00364964	0.1367332267997754
DEAFNESS-HYPOGONADISM SYNDROME	0.00364964	0.1367332267997754
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00364964	0.1367332267997754
SPINOCEREBELLAR ATAXIA TYPE 32	0.00364964	0.1367332267997754
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00364964	0.1367332267997754
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00364964	0.1367332267997754
JOUBERT SYNDROME 4	0.00364964	0.1367332267997754
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00364964	0.1367332267997754
NON-DISTAL MONOSOMY 10Q	0.00364964	0.1367332267997754
SPINOCEREBELLAR ATAXIA 1	0.00364964	0.1367332267997754
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00364964	0.1367332267997754
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00364964	0.1367332267997754
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00364964	0.1367332267997754
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00364964	0.1367332267997754
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00364964	0.1367332267997754
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00364964	0.1367332267997754
MONILETHRIX	0.00364964	0.1367332267997754
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00364964	0.1367332267997754
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00364964	0.1367332267997754
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00364964	0.1367332267997754
KERATODERMA HEREDITARIUM MUTILANS	0.00364964	0.1367332267997754
DYSTONIA 16; DYT16	0.00364964	0.1367332267997754
SPINOCEREBELLAR ATAXIA 42	0.00364964	0.1367332267997754
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00364964	0.1367332267997754
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00364964	0.1367332267997754
RING CHROMOSOME 1 SYNDROME	0.00364964	0.1367332267997754
ISOLATED CLOVERLEAF SKULL SYNDROME	0.00364964	0.1367332267997754
ISOLATED KLIPPEL-FEIL SYNDROME	0.00364964	0.1367332267997754
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00364964	0.1367332267997754
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.1367332267997754
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00364964	0.1367332267997754
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.00364964	0.1367332267997754
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00364964	0.1367332267997754
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00364964	0.1367332267997754
PACHYONYCHIA CONGENITA	0.00364964	0.1367332267997754
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00364964	0.1367332267997754
BARDET-BIEDL SYNDROME 5; BBS5	0.00364964	0.1367332267997754
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00364964	0.1367332267997754
BARDET-BIEDL SYNDROME 10; BBS10	0.00364964	0.1367332267997754
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00364964	0.1367332267997754
ISOTRETINOIN SYNDROME	0.00364964	0.1367332267997754
BARDET-BIEDL SYNDROME 18; BBS18	0.00364964	0.1367332267997754
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00342466	0.12830438412887812
POSTERIOR URETHRAL VALVE	0.00342466	0.12830438412887812
POLYCYSTIC KIDNEY DISEASE 2	0.00342466	0.12830438412887812
LIDDLE SYNDROME 3; LIDLS3	0.00342466	0.12830438412887812
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00342466	0.12830438412887812
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00342466	0.12830438412887812
ACTH-DEPENDENT CUSHING SYNDROME	0.00342466	0.12830438412887812
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00342466	0.12830438412887812
ACTH-INDEPENDENT CUSHING SYNDROME	0.00342466	0.12830438412887812
PRIMARY LIPODYSTROPHY	0.00342466	0.12830438412887812
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00342466	0.12830438412887812
LONG QT SYNDROME 13; LQT13	0.00342466	0.12830438412887812
GANGLIONEUROMA	0.00342466	0.12830438412887812
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00342466	0.12830438412887812
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12830438412887812
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00342466	0.12830438412887812
SCALP-EAR-NIPPLE SYNDROME	0.00342466	0.12830438412887812
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00342466	0.12830438412887812
OCHOA SYNDROME	0.00342466	0.12830438412887812
RENAL AGENESIS	0.00342466	0.12830438412887812
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12830438412887812
CONGENITAL ADRENAL HYPERPLASIA	0.00342466	0.12830438412887812
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00342466	0.12830438412887812
NELSON SYNDROME	0.00342466	0.12830438412887812
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00342466	0.12830438412887812
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00342466	0.12830438412887812
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00342466	0.12830438412887812
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12830438412887812
LIDDLE SYNDROME 1; LIDLS1	0.00342466	0.12830438412887812
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00342466	0.12830438412887812
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00342466	0.12830438412887812
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00342466	0.12830438412887812
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00342466	0.12830438412887812
LIDDLE SYNDROME 2; LIDLS2	0.00342466	0.12830438412887812
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00342466	0.12830438412887812
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00342466	0.12830438412887812
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.00342466	0.12830438412887812
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12830438412887812
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00342466	0.12830438412887812
FIBRONECTIN GLOMERULOPATHY	0.00342466	0.12830438412887812
INFANT BOTULISM	0.00342466	0.12830438412887812
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00342466	0.12830438412887812
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00342466	0.12830438412887812
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00342466	0.12830438412887812
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00342466	0.12830438412887812
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00342466	0.12830438412887812
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00342466	0.12830438412887812
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00342466	0.12830438412887812
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00342466	0.12830438412887812
TETANUS	0.00342466	0.12830438412887812
NEPHROBLASTOMA	0.00342466	0.12830438412887812
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.00342466	0.12830438412887812
CATECHOLAMINE-PRODUCING TUMOR	0.00342466	0.12830438412887812
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00342466	0.12830438412887812
PARAGANGLIOMAS 6	0.00342466	0.12830438412887812
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.00342466	0.12830438412887812
ALKAPTONURIA	0.00342466	0.12830438412887812
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00342466	0.12830438412887812
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00342466	0.12830438412887812
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00342466	0.12830438412887812
ADRENOCORTICAL CARCINOMA	0.00342466	0.12830438412887812
CUSHING SYNDROME	0.00342466	0.12830438412887812
DIAMOND-BLACKFAN ANEMIA-LIKE; DBAL	0.00319489	0.11969608481119627
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00319489	0.11969608481119627
SENIOR-LOKEN SYNDROME 1	0.00319489	0.11969608481119627
DIAMOND-BLACKFAN ANEMIA 9	0.00319489	0.11969608481119627
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00319489	0.11969608481119627
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00319489	0.11969608481119627
BAZEX SYNDROME	0.00319489	0.11969608481119627
NEPHRONOPHTHISIS	0.00319489	0.11969608481119627
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00319489	0.11969608481119627
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY	0.00319489	0.11969608481119627
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.00319489	0.11969608481119627
HEMOGLOBIN E-BETA-THALASSEMIA SYNDROME	0.00319489	0.11969608481119627
X-LINKED SIDEROBLASTIC ANEMIA	0.00319489	0.11969608481119627
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.00319489	0.11969608481119627
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.00319489	0.11969608481119627
EOSINOPHILIA, FAMILIAL	0.00319489	0.11969608481119627
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00319489	0.11969608481119627
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00319489	0.11969608481119627
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.00319489	0.11969608481119627
CASTLEMAN DISEASE	0.00319489	0.11969608481119627
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00319489	0.11969608481119627
CONGENITAL FACTOR II DEFICIENCY	0.00319489	0.11969608481119627
PEARSON SYNDROME	0.00319489	0.11969608481119627
HYDATIDIFORM MOLE	0.00319489	0.11969608481119627
HB BART'S HYDROPS FETALIS	0.00319489	0.11969608481119627
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00319489	0.11969608481119627
TUFTED ANGIOMA	0.00319489	0.11969608481119627
SANDIFER SYNDROME	0.00319489	0.11969608481119627
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.00319489	0.11969608481119627
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.00319489	0.11969608481119627
LYMPHATIC MALFORMATION 7; LMPHM7	0.00319489	0.11969608481119627
HEMOCHROMATOSIS, TYPE 2B	0.00319489	0.11969608481119627
PEUTZ-JEGHERS SYNDROME	0.00319489	0.11969608481119627
X-LINKED LYMPHOPROLIFERATIVE DISEASE	0.00319489	0.11969608481119627
DIAMOND-BLACKFAN ANEMIA 20; DBA20	0.00319489	0.11969608481119627
DIAMOND-BLACKFAN ANEMIA 16	0.00319489	0.11969608481119627
HYDROPS FETALIS, NONIMMUNE	0.00319489	0.11969608481119627
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00319489	0.11969608481119627
WEISMANN-NETTER SYNDROME	0.00319489	0.11969608481119627
SENIOR-LOKEN SYNDROME 4; SLSN4	0.00319489	0.11969608481119627
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00319489	0.11969608481119627
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00319489	0.11969608481119627
FAMILIAL LONG QT SYNDROME	0.00319489	0.11969608481119627
HEMOGLOBIN--DELTA LOCUS	0.00319489	0.11969608481119627
DIAMOND-BLACKFAN ANEMIA 17	0.00319489	0.11969608481119627
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00319489	0.11969608481119627
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00319489	0.11969608481119627
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00319489	0.11969608481119627
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00319489	0.11969608481119627
OLLIER DISEASE	0.00319489	0.11969608481119627
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00319489	0.11969608481119627
GENERALIZED DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00319489	0.11969608481119627
LESCH-NYHAN SYNDROME	0.00319489	0.11969608481119627
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00319489	0.11969608481119627
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00319489	0.11969608481119627
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00319489	0.11969608481119627
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.00319489	0.11969608481119627
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00319489	0.11969608481119627
FETAL CYTOMEGALOVIRUS SYNDROME	0.00319489	0.11969608481119627
DOHLE BODIES AND LEUKEMIA	0.00319489	0.11969608481119627
ACUTE MYELOMONOCYTIC LEUKEMIA	0.00319489	0.11969608481119627
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001738863	0.06514624701415422
DISTAL MONOSOMY 1Q	0.001738863	0.06514624701415422
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001738863	0.06514624701415422
INFANTILE REFSUM DISEASE	0.001738863	0.06514624701415422
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001738863	0.06514624701415422
PRADER-WILLI-LIKE SYNDROME	0.001738863	0.06514624701415422
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001738863	0.06514624701415422
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.001738863	0.06514624701415422
OROFACIODIGITAL SYNDROME TYPE 6	0.001738863	0.06514624701415422
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.001738863	0.06514624701415422
15Q14 MICRODELETION SYNDROME	0.001738863	0.06514624701415422
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001738863	0.06514624701415422
SPINOCEREBELLAR ATAXIA TYPE 13	0.001738863	0.06514624701415422
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001738863	0.06514624701415422
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001738863	0.06514624701415422
COFFIN-SIRIS SYNDROME 1; CSS1	0.001738863	0.06514624701415422
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001738863	0.06514624701415422
KBG SYNDROME	0.001738863	0.06514624701415422
16P13.2 MICRODELETION SYNDROME	0.001738863	0.06514624701415422
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001738863	0.06514624701415422
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001738863	0.06514624701415422
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.001738863	0.06514624701415422
NEPHROGENIC DIABETES INSIPIDUS	0.001738863	0.06514624701415422
XQ25 MICRODUPLICATION SYNDROME	0.001738863	0.06514624701415422
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001738863	0.06514624701415422
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001738863	0.06514624701415422
GENITOPATELLAR SYNDROME	0.001738863	0.06514624701415422
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001738863	0.06514624701415422
MEVALONIC ACIDURIA	0.001738863	0.06514624701415422
PRADER-WILLI SYNDROME; PWS	0.001738863	0.06514624701415422
15Q24 MICRODELETION SYNDROME	0.001738863	0.06514624701415422
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001738863	0.06514624701415422
PITUITARY STALK INTERRUPTION SYNDROME	0.001738863	0.06514624701415422
KOOLEN-DE VRIES SYNDROME	0.001738863	0.06514624701415422
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001738863	0.06514624701415422
20P12.3 MICRODELETION SYNDROME	0.001738863	0.06514624701415422
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.001738863	0.06514624701415422
WILSON-TURNER SYNDROME	0.001738863	0.06514624701415422
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001738863	0.06514624701415422
1Q21.1 MICRODELETION SYNDROME	0.001738863	0.06514624701415422
MICRO SYNDROME	0.001738863	0.06514624701415422
2Q31.1 MICRODELETION SYNDROME	0.001738863	0.06514624701415422
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001738863	0.06514624701415422
17Q12 MICRODELETION SYNDROME	0.001738863	0.06514624701415422
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001738863	0.06514624701415422
KBG SYNDROME	0.001738863	0.06514624701415422
C SYNDROME	0.001738863	0.06514624701415422
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001738863	0.06514624701415422
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001738863	0.06514624701415422
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001738863	0.06514624701415422
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001738863	0.06514624701415422
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001738863	0.06514624701415422
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001738863	0.06514624701415422
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001738863	0.06514624701415422
VICI SYNDROME	0.001738863	0.06514624701415422
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001738863	0.06514624701415422
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001738863	0.06514624701415422
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001738863	0.06514624701415422
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001738863	0.06514624701415422
PIERPONT SYNDROME	0.001738863	0.06514624701415422
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.001738863	0.06514624701415422
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001738863	0.06514624701415422
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001738863	0.06514624701415422
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001738863	0.06514624701415422
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001738863	0.06514624701415422
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001738863	0.06514624701415422
LUSCAN-LUMISH SYNDROME; LLS	0.001738863	0.06514624701415422
BOHRING-OPITZ SYNDROME	0.001738863	0.06514624701415422
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001738863	0.06514624701415422
CHROMOSOME 1P35 DELETION SYNDROME	0.001738863	0.06514624701415422
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001738863	0.06514624701415422
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001738863	0.06514624701415422
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001738863	0.06514624701415422
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.001738863	0.06514624701415422
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001738863	0.06514624701415422
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001738863	0.06514624701415422
SCHAAF-YANG SYNDROME; SHFYNG	0.001738863	0.06514624701415422
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001738863	0.06514624701415422
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001738863	0.06514624701415422
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001738863	0.06514624701415422
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001738863	0.06514624701415422
HOLOPROSENCEPHALY 1; HPE1	0.001738863	0.06514624701415422
GLYCEROL KINASE DEFICIENCY; GKD	0.001738863	0.06514624701415422
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001738863	0.06514624701415422
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001738863	0.06514624701415422
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001738863	0.06514624701415422
WIEACKER-WOLFF SYNDROME	0.001738863	0.06514624701415422
HARTNUP DISORDER	0.001738863	0.06514624701415422
CODAS SYNDROME	0.001738863	0.06514624701415422
CHROMOSOME 2Q37 DELETION SYNDROME	0.001738863	0.06514624701415422
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001738863	0.06514624701415422
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001738863	0.06514624701415422
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001738863	0.06514624701415422
XQ25 DUPLICATION SYNDROME	0.001738863	0.06514624701415422
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001738863	0.06514624701415422
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001738863	0.06514624701415422
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001738863	0.06514624701415422
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001738863	0.06514624701415422
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001738863	0.06514624701415422
LISSENCEPHALY 4	0.001738863	0.06514624701415422
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001738863	0.06514624701415422
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001738863	0.06514624701415422
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001738863	0.06514624701415422
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001738863	0.06514624701415422
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001738863	0.06514624701415422
GLASS SYNDROME	0.001738863	0.06514624701415422
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001738863	0.06514624701415422
CHROMOSOME 10Q26 DELETION SYNDROME	0.001738863	0.06514624701415422
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001738863	0.06514624701415422
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001738863	0.06514624701415422
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001738863	0.06514624701415422
17Q11.2 MICRODUPLICATION SYNDROME	0.001738863	0.06514624701415422
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001738863	0.06514624701415422
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001738863	0.06514624701415422
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001738863	0.06514624701415422
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001738863	0.06514624701415422
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001738863	0.06514624701415422
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001738863	0.06514624701415422
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001738863	0.06514624701415422
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001738863	0.06514624701415422
AL KAISSI SYNDROME; ALKAS	0.001738863	0.06514624701415422
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001738863	0.06514624701415422
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001738863	0.06514624701415422
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001738863	0.06514624701415422
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001738863	0.06514624701415422
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001738863	0.06514624701415422
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001197444	0.0448620636643697
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.001197444	0.0448620636643697
NOONAN SYNDROME 3; NS3	0.001197444	0.0448620636643697
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.001197444	0.0448620636643697
14Q22Q23 MICRODELETION SYNDROME	0.001197444	0.0448620636643697
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001197444	0.0448620636643697
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.001197444	0.0448620636643697
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001197444	0.0448620636643697
2Q32Q33 MICRODELETION SYNDROME	0.001197444	0.0448620636643697
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001197444	0.0448620636643697
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.001197444	0.0448620636643697
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.001197444	0.0448620636643697
CARDIOFACIOCUTANEOUS SYNDROME	0.001197444	0.0448620636643697
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.001197444	0.0448620636643697
SEPTOOPTIC DYSPLASIA	0.001197444	0.0448620636643697
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001197444	0.0448620636643697
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.001197444	0.0448620636643697
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.001197444	0.0448620636643697
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.001197444	0.0448620636643697
MCKUSICK-KAUFMAN SYNDROME	0.001197444	0.0448620636643697
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.001197444	0.0448620636643697
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.001197444	0.0448620636643697
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001197444	0.0448620636643697
FORSYTHE-WAKELING SYNDROME; FWS	0.001197444	0.0448620636643697
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001197444	0.0448620636643697
CODAS SYNDROME	0.001197444	0.0448620636643697
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.001197444	0.0448620636643697
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.001197444	0.0448620636643697
NOONAN SYNDROME 11; NS11	0.001197444	0.0448620636643697
LARSEN-LIKE SYNDROME	0.001197444	0.0448620636643697
CHROMOSOME 18P DELETION SYNDROME	0.001197444	0.0448620636643697
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001197444	0.0448620636643697
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001197444	0.0448620636643697
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.001197444	0.0448620636643697
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001197444	0.0448620636643697
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001197444	0.0448620636643697
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001197444	0.0448620636643697
16P11.2P12.2 MICRODELETION SYNDROME	0.001197444	0.0448620636643697
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001197444	0.0448620636643697
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.001197444	0.0448620636643697
STEEL SYNDROME; STLS	0.001197444	0.0448620636643697
TYSHCHENKO SYNDROME	0.001197444	0.0448620636643697
FRIAS SYNDROME	0.001197444	0.0448620636643697
XQ27.3Q28 DUPLICATION SYNDROME	0.001197444	0.0448620636643697
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001197444	0.0448620636643697
HADZISELIMOVIC SYNDROME	0.001197444	0.0448620636643697
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001197444	0.0448620636643697
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.001197444	0.0448620636643697
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001197444	0.0448620636643697
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001197444	0.0448620636643697
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.001197444	0.0448620636643697
NOONAN SYNDROME 6; NS6	0.001197444	0.0448620636643697
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001197444	0.0448620636643697
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.001197444	0.0448620636643697
COSTELLO SYNDROME; CSTLO	0.001197444	0.0448620636643697
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.001197444	0.0448620636643697
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.001197444	0.0448620636643697
JOUBERT SYNDROME 26	0.001197444	0.0448620636643697
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001197444	0.0448620636643697
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.001197444	0.0448620636643697
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001197444	0.0448620636643697
MEIER-GORLIN SYNDROME 7	0.001197444	0.0448620636643697
THYROID HYPOPLASIA	0.001197444	0.0448620636643697
FAMILIAL THYROID DYSHORMONOGENESIS	0.001197444	0.0448620636643697
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.001197444	0.0448620636643697
ATHYREOSIS	0.001197444	0.0448620636643697
THYROID ECTOPIA	0.001197444	0.0448620636643697
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.001197444	0.0448620636643697
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.001197444	0.0448620636643697
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.001197444	0.0448620636643697
HOLMES-GANG SYNDROME	0.001197444	0.0448620636643697
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001197444	0.0448620636643697
OROFACIODIGITAL SYNDROME VI	0.001197444	0.0448620636643697
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.001197444	0.0448620636643697
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.001197444	0.0448620636643697
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.001197444	0.0448620636643697
TOLUENE EMBRYOPATHY	0.001197444	0.0448620636643697
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001197444	0.0448620636643697
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001197444	0.0448620636643697
ALAZAMI-YUAN SYNDROME	0.001197444	0.0448620636643697
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001197444	0.0448620636643697
COFFIN-SIRIS SYNDROME 6; CSS6	0.001197444	0.0448620636643697
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001197444	0.0448620636643697
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001197444	0.0448620636643697
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.001197444	0.0448620636643697
GERMAN SYNDROME	0.001197444	0.0448620636643697
MARINESCO-SJOGREN SYNDROME; MSS	0.001197444	0.0448620636643697
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001197444	0.0448620636643697
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.001197444	0.0448620636643697
DE BARSY SYNDROME	0.001197444	0.0448620636643697
OXOGLUTARIC ACIDURIA	0.001197444	0.0448620636643697
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.001197444	0.0448620636643697
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001197444	0.0448620636643697
RAINE SYNDROME	0.001197444	0.0448620636643697
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001197444	0.0448620636643697
COLE-CARPENTER SYNDROME	0.001197444	0.0448620636643697
SAY-BARBER-MILLER SYNDROME	0.001197444	0.0448620636643697
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001197444	0.0448620636643697
OPTIC ATROPHY 11; OPA11	0.001197444	0.0448620636643697
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.001197444	0.0448620636643697
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.001197444	0.0448620636643697
DUPLICATION OF THE PITUITARY GLAND	0.001197444	0.0448620636643697
CEREBROFACIOARTICULAR SYNDROME	0.001197444	0.0448620636643697
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001197444	0.0448620636643697
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001197444	0.0448620636643697
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.001197444	0.0448620636643697
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.001197444	0.0448620636643697
MENTAL RETARDATION, X-LINKED 99	0.001197444	0.0448620636643697
OTOFACIOCERVICAL SYNDROME	0.001197444	0.0448620636643697
PERMANENT CONGENITAL HYPOTHYROIDISM	0.001197444	0.0448620636643697
PRIMARY CONGENITAL HYPOTHYROIDISM	0.001197444	0.0448620636643697
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001197444	0.0448620636643697
CEREBELLOFACIODENTAL SYNDROME	0.001197444	0.0448620636643697
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.001197444	0.0448620636643697
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.001197444	0.0448620636643697
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.001197444	0.0448620636643697
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001197444	0.0448620636643697
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.001197444	0.0448620636643697
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001197444	0.0448620636643697
CULLER-JONES SYNDROME; CJS	0.001197444	0.0448620636643697
MICROPHTHALMIA, SYNDROMIC 3	0.001197444	0.0448620636643697
CRANIOFRONTONASAL SYNDROME; CFNS	0.001197444	0.0448620636643697
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001197444	0.0448620636643697
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.001197444	0.0448620636643697
NOONAN SYNDROME 5; NS5	0.001197444	0.0448620636643697
SECKEL SYNDROME 8; SCKL8	0.001197444	0.0448620636643697
OCULO-PALATO-CEREBRAL SYNDROME	0.001197444	0.0448620636643697
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001197444	0.0448620636643697
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001197444	0.0448620636643697
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001197444	0.0448620636643697
COFFIN-SIRIS SYNDROME 7; CSS7	0.001197444	0.0448620636643697
SECKEL SYNDROME 9; SCKL9	0.001197444	0.0448620636643697
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.001197444	0.0448620636643697
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001197444	0.0448620636643697
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001197444	0.0448620636643697
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.001197444	0.0448620636643697
PSEUDOAMINOPTERIN SYNDROME	0.001197444	0.0448620636643697
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.001193309	0.044707146496425175
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001193309	0.044707146496425175
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001193309	0.044707146496425175
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.001193309	0.044707146496425175
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.001193309	0.044707146496425175
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.001193309	0.044707146496425175
CROME SYNDROME	0.001193309	0.044707146496425175
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001193309	0.044707146496425175
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001193309	0.044707146496425175
SPINOCEREBELLAR ATAXIA 47; SCA47	0.001193309	0.044707146496425175
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001193309	0.044707146496425175
1Q41Q42 MICRODELETION SYNDROME	0.001193309	0.044707146496425175
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.001193309	0.044707146496425175
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.001193309	0.044707146496425175
PERRAULT SYNDROME 3	0.001193309	0.044707146496425175
MICROFORM HOLOPROSENCEPHALY	0.001193309	0.044707146496425175
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001193309	0.044707146496425175
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.001193309	0.044707146496425175
FOUNTAIN SYNDROME	0.001193309	0.044707146496425175
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.001193309	0.044707146496425175
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.001193309	0.044707146496425175
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.001193309	0.044707146496425175
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001193309	0.044707146496425175
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001193309	0.044707146496425175
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.001193309	0.044707146496425175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.001193309	0.044707146496425175
GM1 GANGLIOSIDOSIS	0.001193309	0.044707146496425175
TEMPLE-BARAITSER SYNDROME	0.001193309	0.044707146496425175
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.001193309	0.044707146496425175
MOMO SYNDROME	0.001193309	0.044707146496425175
MOYNAHAN SYNDROME	0.001193309	0.044707146496425175
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.001193309	0.044707146496425175
XP22.13P22.2 DUPLICATION SYNDROME	0.001193309	0.044707146496425175
DDOST-CDG	0.001193309	0.044707146496425175
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.001193309	0.044707146496425175
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001193309	0.044707146496425175
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.001193309	0.044707146496425175
CORNELIA DE LANGE SYNDROME	0.001193309	0.044707146496425175
2Q33.1 DELETION SYNDROME	0.001193309	0.044707146496425175
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.001193309	0.044707146496425175
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001193309	0.044707146496425175
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.001193309	0.044707146496425175
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001193309	0.044707146496425175
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001193309	0.044707146496425175
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.001193309	0.044707146496425175
RETT SYNDROME	0.001193309	0.044707146496425175
ADRENOMYODYSTROPHY	0.001193309	0.044707146496425175
HYPOPHOSPHATASIA, CHILDHOOD	0.001193309	0.044707146496425175
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.001193309	0.044707146496425175
SANJAD-SAKATI SYNDROME	0.001193309	0.044707146496425175
GURRIERI SYNDROME	0.001193309	0.044707146496425175
SMITH-FINEMAN-MYERS SYNDROME	0.001193309	0.044707146496425175
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001193309	0.044707146496425175
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.001193309	0.044707146496425175
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001193309	0.044707146496425175
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001193309	0.044707146496425175
EPILEPSY-TELANGIECTASIA SYNDROME	0.001193309	0.044707146496425175
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.001193309	0.044707146496425175
SJOGREN-LARSSON SYNDROME; SLS	0.001193309	0.044707146496425175
MOWAT-WILSON SYNDROME	0.001193309	0.044707146496425175
FOUNTAIN SYNDROME	0.001193309	0.044707146496425175
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.001193309	0.044707146496425175
SIALIDOSIS TYPE 1	0.001193309	0.044707146496425175
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001193309	0.044707146496425175
AYME-GRIPP SYNDROME; AYGRP	0.001193309	0.044707146496425175
COFFIN-LOWRY SYNDROME; CLS	0.001193309	0.044707146496425175
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.001193309	0.044707146496425175
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.001193309	0.044707146496425175
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.001193309	0.044707146496425175
COFFIN-LOWRY SYNDROME	0.001193309	0.044707146496425175
2Q23.1 MICRODELETION SYNDROME	0.001193309	0.044707146496425175
ATKIN-FLAITZ SYNDROME	0.001193309	0.044707146496425175
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.001193309	0.044707146496425175
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.001193309	0.044707146496425175
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001193309	0.044707146496425175
5Q35 MICRODUPLICATION SYNDROME	0.001193309	0.044707146496425175
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001193309	0.044707146496425175
TRIPLE A SYNDROME	0.001193309	0.044707146496425175
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001193309	0.044707146496425175
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001193309	0.044707146496425175
LOWE OCULOCEREBRORENAL SYNDROME	0.001193309	0.044707146496425175
DYSEQUILIBRIUM SYNDROME	0.001193309	0.044707146496425175
HALL-RIGGS SYNDROME	0.001193309	0.044707146496425175
MENKES DISEASE	0.001193309	0.044707146496425175
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001193309	0.044707146496425175
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.001193309	0.044707146496425175
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.001193309	0.044707146496425175
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001193309	0.044707146496425175
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.040723283867513574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040723283867513574
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.040723283867513574
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.040723283867513574
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.040723283867513574
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040723283867513574
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.040723283867513574
DESANTO-SHINAWI SYNDROME	0.001086973	0.040723283867513574
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.040723283867513574
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.040723283867513574
DISTAL TRISOMY 17Q	0.001086973	0.040723283867513574
ANGELMAN SYNDROME	0.001086973	0.040723283867513574
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.040723283867513574
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040723283867513574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001086973	0.040723283867513574
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.040723283867513574
20Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040723283867513574
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040723283867513574
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040723283867513574
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.040723283867513574
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.040723283867513574
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040723283867513574
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040723283867513574
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.040723283867513574
19P13.13 MICRODELETION SYNDROME	0.001086973	0.040723283867513574
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040723283867513574
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040723283867513574
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040723283867513574
FUCOSIDOSIS	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.040723283867513574
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.001086973	0.040723283867513574
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001086973	0.040723283867513574
ARGININEMIA	0.001086973	0.040723283867513574
WALKER-WARBURG SYNDROME	0.001086973	0.040723283867513574
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.040723283867513574
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040723283867513574
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.040723283867513574
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001086973	0.040723283867513574
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.040723283867513574
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040723283867513574
RUVALCABA SYNDROME	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.040723283867513574
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040723283867513574
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.040723283867513574
LEIGH SYNDROME; LS	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.040723283867513574
LISSENCEPHALY 8; LIS8	0.001086973	0.040723283867513574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.040723283867513574
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001086973	0.040723283867513574
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.040723283867513574
XQ28 (MECP2) DUPLICATION	0.001086973	0.040723283867513574
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.040723283867513574
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.040723283867513574
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.040723283867513574
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.040723283867513574
KETOADIPICACIDURIA	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.040723283867513574
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.040723283867513574
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040723283867513574
MACDERMOT-WINTER SYNDROME	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.040723283867513574
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.040723283867513574
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040723283867513574
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.040723283867513574
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040723283867513574
VICI SYNDROME; VICIS	0.001086973	0.040723283867513574
SEVERE CANAVAN DISEASE	0.001086973	0.040723283867513574
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040723283867513574
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040723283867513574
HEART AND BRAIN MALFORMATION SYNDROME	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.040723283867513574
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040723283867513574
FILIPPI SYNDROME	0.001086973	0.040723283867513574
WEAVER SYNDROME	0.001086973	0.040723283867513574
STT3A-CDG	0.001086973	0.040723283867513574
SULFOCYSTEINURIA	0.001086973	0.040723283867513574
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.040723283867513574
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.040723283867513574
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.040723283867513574
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040723283867513574
MEHMO SYNDROME; MEHMO	0.001086973	0.040723283867513574
ISOVALERIC ACIDEMIA	0.001086973	0.040723283867513574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001086973	0.040723283867513574
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040723283867513574
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.040723283867513574
ELEJALDE DISEASE	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.040723283867513574
PEHO SYNDROME; PEHO	0.001086973	0.040723283867513574
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001086973	0.040723283867513574
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.040723283867513574
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001086973	0.040723283867513574
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.040723283867513574
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040723283867513574
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.040723283867513574
DISTAL MONOSOMY 19P13.3	0.001086973	0.040723283867513574
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.040723283867513574
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.001086973	0.040723283867513574
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.001086973	0.040723283867513574
STT3B-CDG	0.001086973	0.040723283867513574
SSR4-CDG	0.001086973	0.040723283867513574
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.040723283867513574
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.040723283867513574
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.040723283867513574
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040723283867513574
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040723283867513574
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040723283867513574
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040723283867513574
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040723283867513574
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040723283867513574
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001086973	0.040723283867513574
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040723283867513574
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.040723283867513574
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001086973	0.040723283867513574
LISSENCEPHALY 1; LIS1	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.040723283867513574
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.001086973	0.040723283867513574
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.040723283867513574
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040723283867513574
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040723283867513574
MONOSOMY 9Q22.3	0.001086973	0.040723283867513574
JOUBERT SYNDROME	0.001086973	0.040723283867513574
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040723283867513574
PYRUVATE DEHYDROGENASE DEFICIENCY	0.001086973	0.040723283867513574
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.001086973	0.040723283867513574
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.040723283867513574
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.040723283867513574
MONOSOMY 22Q13.3	0.001086973	0.040723283867513574
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.040723283867513574
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.040723283867513574
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.040723283867513574
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040723283867513574
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040723283867513574
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040723283867513574
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040723283867513574
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.040723283867513574
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040723283867513574
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001086973	0.040723283867513574
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.040723283867513574
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.040723283867513574
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040723283867513574
HOLOPROSENCEPHALY 7	0.001086973	0.040723283867513574
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.040723283867513574
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040723283867513574
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040723283867513574
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001086973	0.040723283867513574
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040723283867513574
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001086973	0.040723283867513574
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040723283867513574
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040723283867513574
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.040723283867513574
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040723283867513574
MAPLE SYRUP URINE DISEASE	0.001086973	0.040723283867513574
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001086973	0.040723283867513574
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.040723283867513574
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040723283867513574
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.040723283867513574
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.040723283867513574
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040723283867513574
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040723283867513574
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001086973	0.040723283867513574
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040723283867513574
SCHINDLER DISEASE, TYPE I	0.001086973	0.040723283867513574
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.040723283867513574
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.040723283867513574
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.040723283867513574
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.040723283867513574
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.040723283867513574
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.040723283867513574
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.040723283867513574
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040723283867513574
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.040723283867513574
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040723283867513574
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040723283867513574
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.040723283867513574
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.040723283867513574
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040723283867513574
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.040723283867513574
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.040723283867513574
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040723283867513574
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.040723283867513574
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040723283867513574
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.040723283867513574
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.040723283867513574
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.040723283867513574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.040723283867513574
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040723283867513574
PETTIGREW SYNDROME	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040723283867513574
HSD10 DISEASE	0.001086973	0.040723283867513574
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.040723283867513574
DPAGT1-CDG	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.040723283867513574
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040723283867513574
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.040723283867513574
MAN1B1-CDG	0.001086973	0.040723283867513574
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.040723283867513574
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.040723283867513574
SALLA DISEASE	0.001086973	0.040723283867513574
LATHOSTEROLOSIS	0.001086973	0.040723283867513574
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.040723283867513574
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.040723283867513574
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.001086973	0.040723283867513574
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.040723283867513574
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040723283867513574
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.040723283867513574
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.040723283867513574
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.040723283867513574
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.040723283867513574
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.040723283867513574
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.040723283867513574
MUENKE SYNDROME	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.040723283867513574
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040723283867513574
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040723283867513574
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.040723283867513574
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040723283867513574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.040723283867513574
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040723283867513574
GRISCELLI SYNDROME TYPE 1	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.040723283867513574
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.040723283867513574
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.040723283867513574
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.040723283867513574
SCHIZENCEPHALY	0.001086973	0.040723283867513574
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040723283867513574
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.040723283867513574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.040723283867513574
11Q22.2Q22.3 MICRODELETION SYNDROME	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.040723283867513574
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040723283867513574
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.040723283867513574
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001086973	0.040723283867513574
ALG3-CDG	0.001086973	0.040723283867513574
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.040723283867513574
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040723283867513574
CK SYNDROME	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040723283867513574
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040723283867513574
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.040723283867513574
PITT-HOPKINS SYNDROME	0.001086973	0.040723283867513574
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040723283867513574
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001086973	0.040723283867513574
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040723283867513574
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001086973	0.040723283867513574
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001086973	0.040723283867513574
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.040723283867513574
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.040723283867513574
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.040723283867513574
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040723283867513574
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.040723283867513574
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.040723283867513574
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.040723283867513574
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.040723283867513574
19P13.12 MICRODELETION SYNDROME	0.001086973	0.040723283867513574
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.040723283867513574
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.040723283867513574
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.040723283867513574
2P21 MICRODELETION SYNDROME	0.001086973	0.040723283867513574
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040723283867513574
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040723283867513574
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.040723283867513574
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.040723283867513574
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.040723283867513574
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001086973	0.040723283867513574
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.040723283867513574
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040723283867513574
TARP SYNDROME	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.040723283867513574
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040723283867513574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.040723283867513574
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.040723283867513574
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.040723283867513574
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040723283867513574
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.040723283867513574
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040723283867513574
EAST SYNDROME	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.040723283867513574
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.040723283867513574
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.040723283867513574
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001086973	0.040723283867513574
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.040723283867513574
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.040723283867513574
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.040723283867513574
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040723283867513574
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.040723283867513574
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040723283867513574
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040723283867513574
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040723283867513574
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001086973	0.040723283867513574
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040723283867513574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040723283867513574
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040723283867513574
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.040723283867513574
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.040723283867513574
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040723283867513574
DONNAI-BARROW SYNDROME	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.040723283867513574
RING CHROMOSOME 22 SYNDROME	0.001086973	0.040723283867513574
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040723283867513574
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001086973	0.040723283867513574
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040723283867513574
XP21 MICRODELETION SYNDROME	0.001086973	0.040723283867513574
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.040723283867513574
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.040723283867513574
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040723283867513574
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.040723283867513574
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001086973	0.040723283867513574
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.040723283867513574
ALG11-CDG	0.001086973	0.040723283867513574
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00065189	0.02442296314664065
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00065189	0.02442296314664065
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00065189	0.02442296314664065
BRUCK SYNDROME 2	0.00065189	0.02442296314664065
CEREBROCOSTOMANDIBULAR SYNDROME	0.00065189	0.02442296314664065
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00065189	0.02442296314664065
DYSOSTOSIS WITH BRACHYDACTYLY	0.00065189	0.02442296314664065
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00065189	0.02442296314664065
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00065189	0.02442296314664065
OSTEOGENESIS IMPERFECTA	0.00065189	0.02442296314664065
COXOAURICULAR SYNDROME	0.00065189	0.02442296314664065
CATEL-MANZKE SYNDROME	0.00065189	0.02442296314664065
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00065189	0.02442296314664065
HYALURONIDASE DEFICIENCY	0.00065189	0.02442296314664065
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.02442296314664065
CORNEODERMATOOSSEOUS SYNDROME	0.00065189	0.02442296314664065
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00065189	0.02442296314664065
BIEMOND SYNDROME II	0.00065189	0.02442296314664065
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00065189	0.02442296314664065
EIKEN SYNDROME	0.00065189	0.02442296314664065
MASA SYNDROME	0.00065189	0.02442296314664065
SECKEL SYNDROME 2; SCKL2	0.00065189	0.02442296314664065
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00065189	0.02442296314664065
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00065189	0.02442296314664065
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00065189	0.02442296314664065
TARSAL-CARPAL COALITION SYNDROME	0.00065189	0.02442296314664065
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00065189	0.02442296314664065
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00065189	0.02442296314664065
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00065189	0.02442296314664065
608028 THAI SYMPHALANGISM SYNDROME	0.00065189	0.02442296314664065
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00065189	0.02442296314664065
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00065189	0.02442296314664065
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00065189	0.02442296314664065
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.02442296314664065
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00065189	0.02442296314664065
NIEMANN-PICK DISEASE, TYPE B	0.00065189	0.02442296314664065
BIEMOND SYNDROME TYPE 2	0.00065189	0.02442296314664065
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00065189	0.02442296314664065
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.02442296314664065
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00065189	0.02442296314664065
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00065189	0.02442296314664065
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00065189	0.02442296314664065
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00065189	0.02442296314664065
SPONDYLOOCULAR SYNDROME; SOS	0.00065189	0.02442296314664065
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00065189	0.02442296314664065
CLEIDOCRANIAL DYSPLASIA	0.00065189	0.02442296314664065
RING CHROMOSOME 7 SYNDROME	0.00065189	0.02442296314664065
CEREBROFACIOTHORACIC DYSPLASIA	0.00065189	0.02442296314664065
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00065189	0.02442296314664065
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00065189	0.02442296314664065
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00065189	0.02442296314664065
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00065189	0.02442296314664065
RING CHROMOSOME 6 SYNDROME	0.00065189	0.02442296314664065
PFEIFFER SYNDROME	0.00065189	0.02442296314664065
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00065189	0.02442296314664065
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.02442296314664065
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00065189	0.02442296314664065
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00065189	0.02442296314664065
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.02442296314664065
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00065189	0.02442296314664065
SAGLIKER SYNDROME	0.00065189	0.02442296314664065
MELNICK-NEEDLES SYNDROME	0.00065189	0.02442296314664065
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00065189	0.02442296314664065
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00065189	0.02442296314664065
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00065189	0.02442296314664065
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00065189	0.02442296314664065
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00065189	0.02442296314664065
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00065189	0.02442296314664065
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.02442296314664065
HAIRY ELBOWS	0.00065189	0.02442296314664065
BARTTER SYNDROME	0.00065189	0.02442296314664065
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00065189	0.02442296314664065
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.02442296314664065
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00065189	0.02442296314664065
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00065189	0.02442296314664065
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.02442296314664065
BRANCHIOGENIC DEAFNESS SYNDROME	0.00065189	0.02442296314664065
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00065189	0.02442296314664065
AROMATASE EXCESS SYNDROME	0.00065189	0.02442296314664065
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00065189	0.02442296314664065
AURICULOOSTEODYSPLASIA	0.00065189	0.02442296314664065
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00065189	0.02442296314664065
BRACHYDACTYLY, TYPE E2; BDE2	0.00065189	0.02442296314664065
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00065189	0.02442296314664065
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.02442296314664065
TEMPLE SYNDROME	0.00065189	0.02442296314664065
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00065189	0.02442296314664065
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00065189	0.02442296314664065
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00065189	0.02442296314664065
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00065189	0.02442296314664065
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00065189	0.02442296314664065
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00065189	0.02442296314664065
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00065189	0.02442296314664065
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.02442296314664065
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00065189	0.02442296314664065
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00065189	0.02442296314664065
HYPOPHOSPHATEMIC BONE DISEASE	0.00065189	0.02442296314664065
FEINGOLD SYNDROME 2; FGLDS2	0.00065189	0.02442296314664065
STICKLER SYNDROME, TYPE V; STL5	0.00065189	0.02442296314664065
HYPERTELORISM, TEEBI TYPE; TBHS	0.00065189	0.02442296314664065
SECKEL SYNDROME 5; SCKL5	0.00065189	0.02442296314664065
MARTSOLF SYNDROME	0.00065189	0.02442296314664065
ALOPECIA ANTIBODY DEFICIENCY	0.00065189	0.02442296314664065
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00065189	0.02442296314664065
MULIBREY NANISM	0.00065189	0.02442296314664065
FRAXE INTELLECTUAL DISABILITY	0.00065189	0.02442296314664065
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00065189	0.02442296314664065
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00065189	0.02442296314664065
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00065189	0.02442296314664065
METAPHYSEAL ANADYSPLASIA	0.00065189	0.02442296314664065
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00065189	0.02442296314664065
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00065189	0.02442296314664065
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00065189	0.02442296314664065
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00065189	0.02442296314664065
ACROGERIA	0.00065189	0.02442296314664065
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00065189	0.02442296314664065
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00065189	0.02442296314664065
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00065189	0.02442296314664065
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00065189	0.02442296314664065
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00065189	0.02442296314664065
EXOSTOSES, MULTIPLE, TYPE II	0.00065189	0.02442296314664065
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00065189	0.02442296314664065
EXOSTOSES, MULTIPLE, TYPE I	0.00065189	0.02442296314664065
MULTIMINICORE MYOPATHY	0.00065189	0.02442296314664065
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00065189	0.02442296314664065
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00065189	0.02442296314664065
SHELDON-HALL SYNDROME	0.00065189	0.02442296314664065
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00065189	0.02442296314664065
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00065189	0.02442296314664065
NOONAN SYNDROME 4; NS4	0.00065189	0.02442296314664065
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.00065189	0.02442296314664065
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00065189	0.02442296314664065
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00065189	0.02442296314664065
ACROCAPITOFEMORAL DYSPLASIA	0.00065189	0.02442296314664065
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00065189	0.02442296314664065
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00065189	0.02442296314664065
LATERAL MENINGOCELE SYNDROME	0.00065189	0.02442296314664065
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00065189	0.02442296314664065
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00065189	0.02442296314664065
MIRROR POLYDACTYLY-VERTEBRAL SEGMENTATION-LIMBS DEFECTS SYNDROME	0.00065189	0.02442296314664065
STIFF SKIN SYNDROME	0.00065189	0.02442296314664065
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00065189	0.02442296314664065
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00065189	0.02442296314664065
MACS SYNDROME	0.00065189	0.02442296314664065
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00065189	0.02442296314664065
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00065189	0.02442296314664065
ATKIN-FLAITZ SYNDROME	0.00065189	0.02442296314664065
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00065189	0.02442296314664065
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00065189	0.02442296314664065
THREE M SYNDROME 2; 3M2	0.00065189	0.02442296314664065
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00065189	0.02442296314664065
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00065189	0.02442296314664065
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00065189	0.02442296314664065
BALLER-GEROLD SYNDROME	0.00065189	0.02442296314664065
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00065189	0.02442296314664065
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00065189	0.02442296314664065
BLOOM SYNDROME	0.00065189	0.02442296314664065
BONNEMANN-MEINECKE-REICH SYNDROME	0.00065189	0.02442296314664065
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00065189	0.02442296314664065
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00065189	0.02442296314664065
MARSHALL SYNDROME	0.00065189	0.02442296314664065
BRANCHIO-OCULO-FACIAL SYNDROME	0.00065189	0.02442296314664065
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00065189	0.02442296314664065
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.02442296314664065
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00065189	0.02442296314664065
MULTIPLE METAPHYSEAL DYSPLASIA	0.00065189	0.02442296314664065
HURLER-SCHEIE SYNDROME	0.00065189	0.02442296314664065
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00065189	0.02442296314664065
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00065189	0.02442296314664065
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00065189	0.02442296314664065
CHUDLEY-LOWRY-HOAR SYNDROME	0.00065189	0.02442296314664065
JUBERG-MARSIDI SYNDROME	0.00065189	0.02442296314664065
CARPENTER-WAZIRI SYNDROME	0.00065189	0.02442296314664065
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00065189	0.02442296314664065
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00065189	0.02442296314664065
SPONDYLOPERIPHERAL DYSPLASIA	0.00065189	0.02442296314664065
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00065189	0.02442296314664065
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00065189	0.02442296314664065
SONODA SYNDROME	0.00065189	0.02442296314664065
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00065189	0.02442296314664065
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00065189	0.02442296314664065
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00065189	0.02442296314664065
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00065189	0.02442296314664065
SACCHAROPINURIA	0.00065189	0.02442296314664065
RODRIGUES BLINDNESS	0.00065189	0.02442296314664065
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00065189	0.02442296314664065
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00065189	0.02442296314664065
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00065189	0.02442296314664065
DISTAL TRISOMY 5Q	0.00065189	0.02442296314664065
WERNER SYNDROME; WRN	0.00065189	0.02442296314664065
BRACHYDACTYLY TYPE A4	0.00065189	0.02442296314664065
THORACOPELVIC DYSOSTOSIS	0.00065189	0.02442296314664065
BRACHYDACTYLY TYPE A1	0.00065189	0.02442296314664065
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00065189	0.02442296314664065
MENTAL RETARDATION, X-LINKED 84	0.00065189	0.02442296314664065
MENTAL RETARDATION, X-LINKED 45	0.00065189	0.02442296314664065
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00065189	0.02442296314664065
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00065189	0.02442296314664065
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.00065189	0.02442296314664065
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00065189	0.02442296314664065
MENTAL RETARDATION, X-LINKED 2	0.00065189	0.02442296314664065
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00065189	0.02442296314664065
ABRUZZO-ERICKSON SYNDROME	0.00065189	0.02442296314664065
EEC SYNDROME	0.00065189	0.02442296314664065
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00065189	0.02442296314664065
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00065189	0.02442296314664065
FETAL METHYLMERCURY SYNDROME	0.00065189	0.02442296314664065
BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.02442296314664065
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00065189	0.02442296314664065
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00065189	0.02442296314664065
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00065189	0.02442296314664065
DENT DISEASE 1	0.00065189	0.02442296314664065
PELVISCAPULAR DYSPLASIA	0.00065189	0.02442296314664065
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.00065189	0.02442296314664065
BRACHYDACTYLY TYPE C	0.00065189	0.02442296314664065
BRACHYDACTYLY TYPE E	0.00065189	0.02442296314664065
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.02442296314664065
RAPADILINO SYNDROME	0.00065189	0.02442296314664065
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00065189	0.02442296314664065
PYGMY	0.00065189	0.02442296314664065
MUCOLIPIDOSIS III ALPHA/BETA	0.00065189	0.02442296314664065
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00065189	0.02442296314664065
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00065189	0.02442296314664065
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00065189	0.02442296314664065
FRYNS-SMEETS-THIRY SYNDROME	0.00065189	0.02442296314664065
NEUTRAL LIPID STORAGE MYOPATHY	0.00065189	0.02442296314664065
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00065189	0.02442296314664065
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00065189	0.02442296314664065
CAT-EYE SYNDROME (TYPE I)	0.00065189	0.02442296314664065
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00065189	0.02442296314664065
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00065189	0.02442296314664065
MYOTONIA PERMANENS	0.00065189	0.02442296314664065
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00065189	0.02442296314664065
GEMIGNANI SYNDROME	0.00065189	0.02442296314664065
3MC SYNDROME 3	0.00065189	0.02442296314664065
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00065189	0.02442296314664065
245800 LAURENCE-MOON SYNDROME	0.00065189	0.02442296314664065
GLAUCOMA-ECTOPIA LENTIS-MICROSPHEROPHAKIA-STIFF JOINTS-SHORT STATURE SYNDROME	0.00065189	0.02442296314664065
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00065189	0.02442296314664065
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00065189	0.02442296314664065
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00065189	0.02442296314664065
ACROCRANIOFACIAL DYSOSTOSIS	0.00065189	0.02442296314664065
ERMINE PHENOTYPE	0.00065189	0.02442296314664065
FREEMAN-SHELDON SYNDROME	0.00065189	0.02442296314664065
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00065189	0.02442296314664065
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.00065189	0.02442296314664065
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00065189	0.02442296314664065
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00065189	0.02442296314664065
GLYCOGEN STORAGE DISEASE IXB	0.00065189	0.02442296314664065
260150 PALANT CLEFT PALATE SYNDROME	0.00065189	0.02442296314664065
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.02442296314664065
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00065189	0.02442296314664065
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00065189	0.02442296314664065
PRIMROSE SYNDROME; PRIMS	0.00065189	0.02442296314664065
OROFACIODIGITAL SYNDROME IV; OFD4	0.00065189	0.02442296314664065
SMITH-MAGENIS SYNDROME	0.00065189	0.02442296314664065
OCULOPALATOCEREBRAL SYNDROME	0.00065189	0.02442296314664065
FEMUR-FIBULA-ULNA COMPLEX	0.00065189	0.02442296314664065
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00065189	0.02442296314664065
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00065189	0.02442296314664065
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00065189	0.02442296314664065
FIBROCHONDROGENESIS	0.00065189	0.02442296314664065
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00065189	0.02442296314664065
22Q11.2 DISTAL DELETION SYNDROME	0.00065189	0.02442296314664065
15Q24 RECURRENT MICRODELETION SYNDROME	0.00065189	0.02442296314664065
NASODIGITOACOUSTIC SYNDROME	0.00065189	0.02442296314664065
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00065189	0.02442296314664065
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00065189	0.02442296314664065
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00065189	0.02442296314664065
CHROMOSOME XP11.3 DELETION SYNDROME	0.00065189	0.02442296314664065
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00065189	0.02442296314664065
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00065189	0.02442296314664065
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00065189	0.02442296314664065
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00065189	0.02442296314664065
THUMB DEFORMITY AND ALOPECIA	0.00065189	0.02442296314664065
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00065189	0.02442296314664065
KENNERKNECHT SYNDROME	0.00065189	0.02442296314664065
600736 VELOFACIOSKELETAL SYNDROME	0.00065189	0.02442296314664065
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00065189	0.02442296314664065
SATOYOSHI SYNDROME	0.00065189	0.02442296314664065
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00065189	0.02442296314664065
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00065189	0.02442296314664065
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00065189	0.02442296314664065
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00065189	0.02442296314664065
WARBURG MICRO SYNDROME 1	0.00065189	0.02442296314664065
EIKEN SYNDROME	0.00065189	0.02442296314664065
DISTAL MONOSOMY 17Q	0.00065189	0.02442296314664065
WIDOW'S PEAK SYNDROME	0.00065189	0.02442296314664065
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.02442296314664065
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00065189	0.02442296314664065
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.00065189	0.02442296314664065
SPASTIC PARAPARESIS AND DEAFNESS	0.00065189	0.02442296314664065
DYSSPONDYLOENCHONDROMATOSIS	0.00065189	0.02442296314664065
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00065189	0.02442296314664065
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00065189	0.02442296314664065
MAFFUCCI SYNDROME	0.00065189	0.02442296314664065
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00065189	0.02442296314664065
SPINAL DYSPLASIA, ANHALT TYPE	0.00065189	0.02442296314664065
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00065189	0.02442296314664065
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.02442296314664065
LEGG-CALVÉ-PERTHES DISEASE	0.00065189	0.02442296314664065
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00065189	0.02442296314664065
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00065189	0.02442296314664065
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00065189	0.02442296314664065
CONGENITAL LARYNGEAL WEB	0.00065189	0.02442296314664065
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00065189	0.02442296314664065
COOPER-JABS SYNDROME	0.00065189	0.02442296314664065
RHYNS SYNDROME; RHYNS	0.00065189	0.02442296314664065
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00065189	0.02442296314664065
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00065189	0.02442296314664065
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00065189	0.02442296314664065
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00065189	0.02442296314664065
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00065189	0.02442296314664065
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00065189	0.02442296314664065
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00065189	0.02442296314664065
COXOAURICULAR SYNDROME	0.00065189	0.02442296314664065
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00065189	0.02442296314664065
CRANIODIAPHYSEAL DYSPLASIA	0.00065189	0.02442296314664065
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.02442296314664065
CRANIOFACIAL DYSSYNOSTOSIS	0.00065189	0.02442296314664065
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00065189	0.02442296314664065
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00065189	0.02442296314664065
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00065189	0.02442296314664065
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00065189	0.02442296314664065
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00065189	0.02442296314664065
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00065189	0.02442296314664065
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00065189	0.02442296314664065
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00065189	0.02442296314664065
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.02442296314664065
X-LINKED HYPOPHOSPHATEMIA	0.00065189	0.02442296314664065
AURICULOOSTEODYSPLASIA	0.00065189	0.02442296314664065
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.02442296314664065
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00065189	0.02442296314664065
FRONTOFACIONASAL DYSPLASIA	0.00065189	0.02442296314664065
PERIPHERAL DYSOSTOSIS	0.00065189	0.02442296314664065
DYSOSTOSIS, STANESCU TYPE	0.00065189	0.02442296314664065
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00065189	0.02442296314664065
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00065189	0.02442296314664065
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00065189	0.02442296314664065
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00065189	0.02442296314664065
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00065189	0.02442296314664065
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00065189	0.02442296314664065
MENTAL RETARDATION, X-LINKED 92	0.00065189	0.02442296314664065
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00065189	0.02442296314664065
LOWRY-WOOD SYNDROME	0.00065189	0.02442296314664065
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.02442296314664065
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00065189	0.02442296314664065
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.02442296314664065
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00065189	0.02442296314664065
WAGR SYNDROME	0.00065189	0.02442296314664065
DYSOSTEOSCLEROSIS	0.00065189	0.02442296314664065
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00065189	0.02442296314664065
FOCAL DERMAL HYPOPLASIA; FDH	0.00065189	0.02442296314664065
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00065189	0.02442296314664065
XP22.3 MICRODELETION SYNDROME	0.00065189	0.02442296314664065
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00065189	0.02442296314664065
ISOLATED OSTEOPOIKILOSIS	0.00065189	0.02442296314664065
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00065189	0.02442296314664065
ODONTOCHONDRODYSPLASIA	0.00065189	0.02442296314664065
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00065189	0.02442296314664065
ARGININOSUCCINIC ACIDURIA	0.00065189	0.02442296314664065
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00065189	0.02442296314664065
TOWNES-BROCKS SYNDROME	0.00065189	0.02442296314664065
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00065189	0.02442296314664065
TRISOMY XQ28	0.00065189	0.02442296314664065
NATIVE AMERICAN MYOPATHY	0.00065189	0.02442296314664065
BRACHYDACTYLY, TYPE A6	0.00065189	0.02442296314664065
MASA SYNDROME	0.00065189	0.02442296314664065
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00065189	0.02442296314664065
CHARGE-LIKE SYNDROME, X-LINKED	0.00065189	0.02442296314664065
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00065189	0.02442296314664065
TRISOMY 5P	0.00065189	0.02442296314664065
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00065189	0.02442296314664065
TETRASOMY 12P	0.00065189	0.02442296314664065
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00065189	0.02442296314664065
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00065189	0.02442296314664065
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00065189	0.02442296314664065
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00065189	0.02442296314664065
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00065189	0.02442296314664065
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00065189	0.02442296314664065
HIRSCHSPRUNG DISEASE	0.00065189	0.02442296314664065
SAY SYNDROME	0.00065189	0.02442296314664065
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00065189	0.02442296314664065
ULNAR-MAMMARY SYNDROME	0.00065189	0.02442296314664065
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00065189	0.02442296314664065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00065189	0.02442296314664065
GORDON SYNDROME	0.00065189	0.02442296314664065
GOLDENHAR SYNDROME	0.00065189	0.02442296314664065
RUVALCABA SYNDROME	0.00065189	0.02442296314664065
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00065189	0.02442296314664065
XYLT1-CDG	0.00065189	0.02442296314664065
ACRODERMATITIS ENTEROPATHICA	0.00065189	0.02442296314664065
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00065189	0.02442296314664065
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00065189	0.02442296314664065
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00065189	0.02442296314664065
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00065189	0.02442296314664065
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00065189	0.02442296314664065
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00065189	0.02442296314664065
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00065189	0.02442296314664065
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00065189	0.02442296314664065
SHOX-RELATED SHORT STATURE	0.00065189	0.02442296314664065
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00065189	0.02442296314664065
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00065189	0.02442296314664065
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00065189	0.02442296314664065
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00065189	0.02442296314664065
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00065189	0.02442296314664065
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00065189	0.02442296314664065
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00065189	0.02442296314664065
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00065189	0.02442296314664065
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00065189	0.02442296314664065
COSTELLO SYNDROME	0.00065189	0.02442296314664065
NATHALIE SYNDROME	0.00065189	0.02442296314664065
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00065189	0.02442296314664065
LEGG-CALVE-PERTHES DISEASE	0.00065189	0.02442296314664065
13Q12.3 MICRODELETION SYNDROME	0.00065189	0.02442296314664065
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00065189	0.02442296314664065
OVARIAN DYSGENESIS 5; ODG5	0.00065189	0.02442296314664065
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00065189	0.02442296314664065
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00065189	0.02442296314664065
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00065189	0.02442296314664065
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.02442296314664065
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00065189	0.02442296314664065
SATOYOSHI SYNDROME	0.00065189	0.02442296314664065
LOEYS-DIETZ SYNDROME 5	0.00065189	0.02442296314664065
ANAUXETIC DYSPLASIA 2; ANXD2	0.00065189	0.02442296314664065
PROGEROID SYNDROME, PETTY TYPE	0.00065189	0.02442296314664065
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00065189	0.02442296314664065
RICHIERI COSTA-DA SILVA SYNDROME	0.00065189	0.02442296314664065
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00065189	0.02442296314664065
GMS SYNDROME	0.00065189	0.02442296314664065
SHPRINTZEN OMPHALOCELE SYNDROME	0.00065189	0.02442296314664065
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00065189	0.02442296314664065
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.00065189	0.02442296314664065
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00065189	0.02442296314664065
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00065189	0.02442296314664065
OVARIAN DYSGENESIS 4; ODG4	0.00065189	0.02442296314664065
RUIJS-AALFS SYNDROME; RJALS	0.00065189	0.02442296314664065
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00065189	0.02442296314664065
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00065189	0.02442296314664065
PRECOCIOUS PUBERTY, CENTRAL	0.00065189	0.02442296314664065
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00065189	0.02442296314664065
PARANA HARD SKIN SYNDROME	0.00065189	0.02442296314664065
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00065189	0.02442296314664065
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.02442296314664065
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00065189	0.02442296314664065
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00065189	0.02442296314664065
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00065189	0.02442296314664065
STÜVE-WIEDEMANN SYNDROME	0.00065189	0.02442296314664065
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.02442296314664065
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00065189	0.02442296314664065
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00065189	0.02442296314664065
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00065189	0.02442296314664065
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00065189	0.02442296314664065
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00065189	0.02442296314664065
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00065189	0.02442296314664065
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.02442296314664065
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00065189	0.02442296314664065
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00065189	0.02442296314664065
OROFACIODIGITAL SYNDROME XVII	0.00065189	0.02442296314664065
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00065189	0.02442296314664065
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00065189	0.02442296314664065
9P13 MICRODELETION SYNDROME	0.00065189	0.02442296314664065
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00065189	0.02442296314664065
SHORT STATURE, BRUSSELS TYPE	0.00065189	0.02442296314664065
CLASSIC MULTIMINICORE MYOPATHY	0.00065189	0.02442296314664065
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00065189	0.02442296314664065
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00065189	0.02442296314664065
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00065189	0.02442296314664065
RADIAL-RENAL SYNDROME	0.00065189	0.02442296314664065
BRUCK SYNDROME	0.00065189	0.02442296314664065
TEMPLE SYNDROME	0.00065189	0.02442296314664065
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00065189	0.02442296314664065
CHITAYAT SYNDROME	0.00065189	0.02442296314664065
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00065189	0.02442296314664065
IMMUNODEFICIENCY 58; IMD58	0.00065189	0.02442296314664065
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00065189	0.02442296314664065
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00065189	0.02442296314664065
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00065189	0.02442296314664065
NEURALGIC AMYOTROPHY	0.00065189	0.02442296314664065
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00065189	0.02442296314664065
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00065189	0.02442296314664065
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00065189	0.02442296314664065
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00065189	0.02442296314664065
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00065189	0.02442296314664065
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00065189	0.02442296314664065
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00065189	0.02442296314664065
MICROTRIPLICATION 11Q24.1	0.00065189	0.02442296314664065
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00065189	0.02442296314664065
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00065189	0.02442296314664065
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00065189	0.02442296314664065
VELO-FACIAL-SKELETAL SYNDROME	0.00065189	0.02442296314664065
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00065189	0.02442296314664065
URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.02442296314664065
STIMMLER SYNDROME	0.00065189	0.02442296314664065
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00065189	0.02442296314664065
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00065189	0.02442296314664065
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00065189	0.02442296314664065
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00065189	0.02442296314664065
ACROOTOOCULAR SYNDROME	0.00065189	0.02442296314664065
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00065189	0.02442296314664065
PSEUDOPROGERIA SYNDROME	0.00065189	0.02442296314664065
HYPOPHOSPHATEMIC RICKETS	0.00065189	0.02442296314664065
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00065189	0.02442296314664065
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00065189	0.02442296314664065
RING CHROMOSOME Y SYNDROME	0.00065189	0.02442296314664065
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00065189	0.02442296314664065
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00065189	0.02442296314664065
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00065189	0.02442296314664065
PELVIS-SHOULDER DYSPLASIA	0.00065189	0.02442296314664065
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00065189	0.02442296314664065
NOONAN SYNDROME 8; NS8	0.00065189	0.02442296314664065
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00065189	0.02442296314664065
JOUBERT SYNDROME 28	0.000545554	0.020439100517729052
CHAR SYNDROME	0.000545554	0.020439100517729052
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020439100517729052
ISOLATED PLAGIOCEPHALY	0.000545554	0.020439100517729052
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.020439100517729052
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020439100517729052
TRISOMY 9P	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020439100517729052
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020439100517729052
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.020439100517729052
N SYNDROME	0.000545554	0.020439100517729052
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020439100517729052
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020439100517729052
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020439100517729052
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020439100517729052
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020439100517729052
CDAGS SYNDROME	0.000545554	0.020439100517729052
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020439100517729052
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020439100517729052
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020439100517729052
JOUBERT SYNDROME 27	0.000545554	0.020439100517729052
ALG6-CDG	0.000545554	0.020439100517729052
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.020439100517729052
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020439100517729052
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.020439100517729052
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020439100517729052
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020439100517729052
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020439100517729052
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020439100517729052
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020439100517729052
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020439100517729052
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020439100517729052
AL-RAQAD SYNDROME; ARS	0.000545554	0.020439100517729052
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.020439100517729052
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.020439100517729052
LATERAL MENINGOCELE SYNDROME	0.000545554	0.020439100517729052
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020439100517729052
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020439100517729052
CURRY-JONES SYNDROME	0.000545554	0.020439100517729052
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.020439100517729052
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020439100517729052
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020439100517729052
MECKEL SYNDROME 13; MKS13	0.000545554	0.020439100517729052
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020439100517729052
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020439100517729052
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020439100517729052
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020439100517729052
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020439100517729052
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020439100517729052
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020439100517729052
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020439100517729052
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.020439100517729052
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020439100517729052
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020439100517729052
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020439100517729052
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020439100517729052
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020439100517729052
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020439100517729052
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020439100517729052
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020439100517729052
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020439100517729052
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020439100517729052
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020439100517729052
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.020439100517729052
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.020439100517729052
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020439100517729052
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020439100517729052
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020439100517729052
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020439100517729052
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020439100517729052
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020439100517729052
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020439100517729052
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020439100517729052
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.020439100517729052
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020439100517729052
JOUBERT SYNDROME 15	0.000545554	0.020439100517729052
FRONTOOCULAR SYNDROME	0.000545554	0.020439100517729052
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020439100517729052
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020439100517729052
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020439100517729052
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020439100517729052
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020439100517729052
MOSAIC TRISOMY 9	0.000545554	0.020439100517729052
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020439100517729052
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.020439100517729052
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020439100517729052
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020439100517729052
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020439100517729052
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020439100517729052
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020439100517729052
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.020439100517729052
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020439100517729052
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020439100517729052
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.020439100517729052
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020439100517729052
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
EVEN-PLUS SYNDROME	0.000545554	0.020439100517729052
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020439100517729052
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020439100517729052
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020439100517729052
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020439100517729052
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020439100517729052
TREACHER-COLLINS SYNDROME	0.000545554	0.020439100517729052
HYPERTRICHOSIS CUBITI	0.000545554	0.020439100517729052
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020439100517729052
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020439100517729052
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020439100517729052
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020439100517729052
LAMB-SHAFFER SYNDROME	0.000545554	0.020439100517729052
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.020439100517729052
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020439100517729052
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020439100517729052
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020439100517729052
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020439100517729052
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020439100517729052
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.020439100517729052
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.020439100517729052
BARATELA-SCOTT SYNDROME	0.000545554	0.020439100517729052
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.020439100517729052
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020439100517729052
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020439100517729052
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.020439100517729052
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020439100517729052
2P15P16.1 MICRODELETION SYNDROME	0.000545554	0.020439100517729052
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.020439100517729052
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020439100517729052
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020439100517729052
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020439100517729052
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020439100517729052
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.020439100517729052
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.020439100517729052
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.020439100517729052
FRIED SYNDROME	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020439100517729052
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.020439100517729052
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020439100517729052
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.020439100517729052
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020439100517729052
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020439100517729052
AUSTRALIA ANTIGEN	0.000545554	0.020439100517729052
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.020439100517729052
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020439100517729052
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020439100517729052
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.020439100517729052
LOWRY-MACLEAN SYNDROME	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020439100517729052
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020439100517729052
AU-KLINE SYNDROME; AUKS	0.000545554	0.020439100517729052
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020439100517729052
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020439100517729052
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000545554	0.020439100517729052
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020439100517729052
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020439100517729052
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020439100517729052
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020439100517729052
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020439100517729052
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020439100517729052
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020439100517729052
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020439100517729052
JOUBERT SYNDROME 25	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020439100517729052
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020439100517729052
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020439100517729052
USHER SYNDROME TYPE 1	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020439100517729052
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020439100517729052
BRESEK SYNDROME	0.000545554	0.020439100517729052
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020439100517729052
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.020439100517729052
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.020439100517729052
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020439100517729052
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020439100517729052
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020439100517729052
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020439100517729052
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020439100517729052
JOUBERT SYNDROME 1	0.000545554	0.020439100517729052
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020439100517729052
JOUBERT SYNDROME 24	0.000545554	0.020439100517729052
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.020439100517729052
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020439100517729052
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020439100517729052
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020439100517729052
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020439100517729052
3MC SYNDROME 2	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020439100517729052
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020439100517729052
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020439100517729052
XIA-GIBBS SYNDROME	0.000545554	0.020439100517729052
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.020439100517729052
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020439100517729052
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020439100517729052
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.020439100517729052
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020439100517729052
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.020439100517729052
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020439100517729052
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.020439100517729052
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020439100517729052
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020439100517729052
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020439100517729052
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.020439100517729052
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020439100517729052
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020439100517729052
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.020439100517729052
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020439100517729052
MONOSOMY 13Q34	0.000545554	0.020439100517729052
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020439100517729052
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020439100517729052
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020439100517729052
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.020439100517729052
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020439100517729052
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020439100517729052
JAWAD SYNDROME	0.000545554	0.020439100517729052
RAHMAN SYNDROME	0.000545554	0.020439100517729052
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020439100517729052
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.020439100517729052
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 6	0.000545554	0.020439100517729052
OPITZ G/BBB SYNDROME	0.000545554	0.020439100517729052
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020439100517729052
PELLAGRA-LIKE SYNDROME	0.000545554	0.020439100517729052
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020439100517729052
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020439100517729052
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020439100517729052
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 8	0.000545554	0.020439100517729052
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020439100517729052
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020439100517729052
CHAR SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 21	0.000545554	0.020439100517729052
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.020439100517729052
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.020439100517729052
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020439100517729052
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.020439100517729052
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020439100517729052
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020439100517729052
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.020439100517729052
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020439100517729052
MIETENS SYNDROME	0.000545554	0.020439100517729052
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.020439100517729052
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020439100517729052
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020439100517729052
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020439100517729052
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020439100517729052
JOUBERT SYNDROME 7	0.000545554	0.020439100517729052
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020439100517729052
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.020439100517729052
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020439100517729052
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020439100517729052
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020439100517729052
ZEBRA BODY MYOPATHY	0.000545554	0.020439100517729052
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020439100517729052
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020439100517729052
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020439100517729052
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020439100517729052
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020439100517729052
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020439100517729052
ATELOSTEOGENESIS TYPE III	0.000545554	0.020439100517729052
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020439100517729052
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.020439100517729052
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020439100517729052
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020439100517729052
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020439100517729052
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020439100517729052
MARDEN-WALKER SYNDROME	0.000545554	0.020439100517729052
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.020439100517729052
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.020439100517729052
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020439100517729052
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.020439100517729052
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.020439100517729052
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020439100517729052
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.020439100517729052
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020439100517729052
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.020439100517729052
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.020439100517729052
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
BARDET-BIEDL SYNDROME 2	0.000545554	0.020439100517729052
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.020439100517729052
THYROID HEMIAGENESIS	0.000545554	0.020439100517729052
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020439100517729052
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020439100517729052
ZECHI-CEIDE SYNDROME	0.000545554	0.020439100517729052
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020439100517729052
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020439100517729052
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020439100517729052
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020439100517729052
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020439100517729052
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.020439100517729052
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020439100517729052
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020439100517729052
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020439100517729052
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.020439100517729052
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020439100517729052
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020439100517729052
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.020439100517729052
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020439100517729052
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020439100517729052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.020439100517729052
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.020439100517729052
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020439100517729052
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020439100517729052
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020439100517729052
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020439100517729052
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020439100517729052
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020439100517729052
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020439100517729052
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.020439100517729052
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020439100517729052
HOLOPROSENCEPHALY 11	0.000545554	0.020439100517729052
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020439100517729052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020439100517729052
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020439100517729052
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020439100517729052
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020439100517729052
AURICULOCONDYLAR SYNDROME	0.000545554	0.020439100517729052
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020439100517729052
DISTAL MONOSOMY 6P	0.000545554	0.020439100517729052
TURNPENNY-FRY SYNDROME; TPFS	0.000545554	0.020439100517729052
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020439100517729052
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020439100517729052
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020439100517729052
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.020439100517729052
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020439100517729052
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020284183349784525
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020284183349784525
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.020284183349784525
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020284183349784525
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020284183349784525
RENPENNING SYNDROME	0.000541419	0.020284183349784525
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020284183349784525
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020284183349784525
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020284183349784525
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.020284183349784525
ISOLATED BILIARY ATRESIA	0.000541419	0.020284183349784525
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020284183349784525
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020284183349784525
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020284183349784525
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020284183349784525
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020284183349784525
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.020284183349784525
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020284183349784525
ATYPICAL RETT SYNDROME	0.000541419	0.020284183349784525
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020284183349784525
CLARK-BARAITSER SYNDROME	0.000541419	0.020284183349784525
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020284183349784525
1P36 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020284183349784525
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020284183349784525
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020284183349784525
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020284183349784525
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020284183349784525
RAMON SYNDROME	0.000541419	0.020284183349784525
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020284183349784525
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020284183349784525
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020284183349784525
CYSTATHIONINURIA	0.000541419	0.020284183349784525
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020284183349784525
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020284183349784525
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020284183349784525
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020284183349784525
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020284183349784525
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020284183349784525
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020284183349784525
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020284183349784525
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020284183349784525
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020284183349784525
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020284183349784525
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.020284183349784525
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020284183349784525
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020284183349784525
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020284183349784525
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020284183349784525
ALEXANDER DISEASE	0.000541419	0.020284183349784525
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020284183349784525
8P INVERTED DUPLICATION/DELETION SYNDROME	0.000541419	0.020284183349784525
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020284183349784525
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020284183349784525
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020284183349784525
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020284183349784525
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020284183349784525
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.020284183349784525
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020284183349784525
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020284183349784525
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020284183349784525
HYPERPROLINEMIA, TYPE II	0.000541419	0.020284183349784525
NON-DISTAL MONOSOMY 20Q	0.000541419	0.020284183349784525
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020284183349784525
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020284183349784525
HADDAD SYNDROME	0.000541419	0.020284183349784525
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020284183349784525
COG8-CDG	0.000541419	0.020284183349784525
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020284183349784525
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020284183349784525
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020284183349784525
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020284183349784525
MARDEN-WALKER SYNDROME	0.000541419	0.020284183349784525
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020284183349784525
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020284183349784525
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.020284183349784525
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020284183349784525
FILIPPI SYNDROME; FLPIS	0.000541419	0.020284183349784525
THREONINEMIA	0.000541419	0.020284183349784525
PARTINGTON SYNDROME	0.000541419	0.020284183349784525
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.020284183349784525
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020284183349784525
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020284183349784525
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020284183349784525
CONGENITAL HYDROCEPHALUS	0.000541419	0.020284183349784525
FRONTAL ENCEPHALOCELE	0.000541419	0.020284183349784525
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020284183349784525
FRYNS SYNDROME	0.000541419	0.020284183349784525
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020284183349784525
PHENYLKETONURIA	0.000541419	0.020284183349784525
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020284183349784525
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020284183349784525
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.020284183349784525
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020284183349784525
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020284183349784525
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020284183349784525
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000541419	0.020284183349784525
SECONDARY SYRINGOMYELIA	0.000541419	0.020284183349784525
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020284183349784525
PORENCEPHALY	0.000541419	0.020284183349784525
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020284183349784525
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020284183349784525
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020284183349784525
KIFAFA SEIZURE DISORDER	0.000541419	0.020284183349784525
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020284183349784525
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020284183349784525
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020284183349784525
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020284183349784525
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020284183349784525
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020284183349784525
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020284183349784525
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020284183349784525
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.020284183349784525
XYLOSIDASE DEFICIENCY	0.000541419	0.020284183349784525
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020284183349784525
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020284183349784525
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020284183349784525
20P13 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020284183349784525
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020284183349784525
GITELMAN SYNDROME	0.000541419	0.020284183349784525
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020284183349784525
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020284183349784525
HYPER-BETA-ALANINEMIA	0.000541419	0.020284183349784525
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020284183349784525
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020284183349784525
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020284183349784525
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000541419	0.020284183349784525
LISSENCEPHALY 3; LIS3	0.000541419	0.020284183349784525
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020284183349784525
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.020284183349784525
OCULODENTODIGITAL DYSPLASIA	0.000541419	0.020284183349784525
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020284183349784525
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020284183349784525
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020284183349784525
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020284183349784525
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020284183349784525
DIAMINOPENTANURIA	0.000541419	0.020284183349784525
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020284183349784525
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020284183349784525
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020284183349784525
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020284183349784525
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020284183349784525
LIPOID PROTEINOSIS	0.000541419	0.020284183349784525
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020284183349784525
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020284183349784525
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020284183349784525
BETA-MANNOSIDOSIS	0.000541419	0.020284183349784525
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.020284183349784525
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020284183349784525
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020284183349784525
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020284183349784525
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020284183349784525
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020284183349784525
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020284183349784525
AICA-RIBOSIDURIA	0.000541419	0.020284183349784525
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020284183349784525
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020284183349784525
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020284183349784525
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020284183349784525
STURGE-WEBER SYNDROME	0.000541419	0.020284183349784525
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020284183349784525
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020284183349784525
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020284183349784525
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020284183349784525
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020284183349784525
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020284183349784525
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020284183349784525
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020284183349784525
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020284183349784525
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020284183349784525
DYSOSTEOSCLEROSIS	0.000541419	0.020284183349784525
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020284183349784525
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.020284183349784525
CENTRONUCLEAR MYOPATHY	0.000541419	0.020284183349784525
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020284183349784525
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020284183349784525
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020284183349784525
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020284183349784525
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020284183349784525
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020284183349784525
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020284183349784525
EPILEPSY, READING	0.000541419	0.020284183349784525
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020284183349784525
PITT-HOPKINS SYNDROME	0.000541419	0.020284183349784525
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020284183349784525
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020284183349784525
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020284183349784525
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020284183349784525
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020284183349784525
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020284183349784525
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020284183349784525
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020284183349784525
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020284183349784525
LISSENCEPHALY 5; LIS5	0.000541419	0.020284183349784525
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020284183349784525
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020284183349784525
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020284183349784525
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.020284183349784525
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.020284183349784525
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020284183349784525
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020284183349784525
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020284183349784525
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020284183349784525
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020284183349784525
14Q12 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020284183349784525
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.020284183349784525
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020284183349784525
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020284183349784525
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020284183349784525
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020284183349784525
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020284183349784525
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020284183349784525
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020284183349784525
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020284183349784525
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020284183349784525
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020284183349784525
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020284183349784525
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020284183349784525
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020284183349784525
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020284183349784525
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020284183349784525
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020284183349784525
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020284183349784525
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020284183349784525
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.020284183349784525
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.000541419	0.020284183349784525
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020284183349784525
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020284183349784525
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020284183349784525
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020284183349784525
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020284183349784525
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020284183349784525
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020284183349784525
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020284183349784525
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020284183349784525
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020284183349784525
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020284183349784525
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020284183349784525
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020284183349784525
ROMANO-WARD SYNDROME	0.000541419	0.020284183349784525
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020284183349784525
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020284183349784525
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020284183349784525
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020284183349784525
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020284183349784525
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020284183349784525
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020284183349784525
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020284183349784525
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020284183349784525
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020284183349784525
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020284183349784525
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020284183349784525
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020284183349784525
CAMOS SYNDROME	0.000541419	0.020284183349784525
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.020284183349784525
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020284183349784525
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020284183349784525
MEHMO SYNDROME	0.000541419	0.020284183349784525
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020284183349784525
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020284183349784525
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020284183349784525
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020284183349784525
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020284183349784525
2Q24 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020284183349784525
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020284183349784525
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020284183349784525
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020284183349784525
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.020284183349784525
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020284183349784525
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020284183349784525
AUTISM	0.000541419	0.020284183349784525
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.020284183349784525
KNOBLOCH SYNDROME	0.000541419	0.020284183349784525
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020284183349784525
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020284183349784525
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020284183349784525
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020284183349784525
47,XYY SYNDROME	0.000541419	0.020284183349784525
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020284183349784525
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020284183349784525
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020284183349784525
PORPHYRIA VARIEGATA	0.000541419	0.020284183349784525
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020284183349784525
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020284183349784525
TYROSINEMIA TYPE 2	0.000541419	0.020284183349784525
EPILEPSY-TELANGIECTASIA	0.000541419	0.020284183349784525
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020284183349784525
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020284183349784525
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020284183349784525
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.000541419	0.020284183349784525
IMMUNODEFICIENCY 47	0.000541419	0.020284183349784525
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020284183349784525
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020284183349784525
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020284183349784525
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020284183349784525
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020284183349784525
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020284183349784525
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020284183349784525
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020284183349784525
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020284183349784525
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020284183349784525
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.020284183349784525
DUPLICATION/INVERSION 15Q11	0.000541419	0.020284183349784525
TETRASOMY 18P	0.000541419	0.020284183349784525
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020284183349784525
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020284183349784525
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020284183349784525
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020284183349784525
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020284183349784525
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.000541419	0.020284183349784525
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020284183349784525
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020284183349784525
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020284183349784525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020284183349784525
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020284183349784525
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020284183349784525
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.000541419	0.020284183349784525
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020284183349784525
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020284183349784525
FRYNS SYNDROME; FRNS	0.000541419	0.020284183349784525
DARIER-WHITE DISEASE; DAR	0.000541419	0.020284183349784525
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020284183349784525
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020284183349784525
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020284183349784525
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020284183349784525
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020284183349784525
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020284183349784525
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020284183349784525
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020284183349784525
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020284183349784525
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020284183349784525
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020284183349784525
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020284183349784525
ANGELMAN SYNDROME	0.000541419	0.020284183349784525
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020284183349784525
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020284183349784525
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020284183349784525
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020284183349784525
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020284183349784525
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020284183349784525
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020284183349784525
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020284183349784525
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020284183349784525
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020284183349784525
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020284183349784525
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.020284183349784525
CROUZON SYNDROME	0.000541419	0.020284183349784525
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020284183349784525
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020284183349784525
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020284183349784525
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020284183349784525
CHIME SYNDROME	0.000541419	0.020284183349784525
MOGS-CDG	0.000541419	0.020284183349784525
PAPILLORENAL SYNDROME	0.000541419	0.020284183349784525
DPM1-CDG	0.000541419	0.020284183349784525
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020284183349784525
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020284183349784525
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020284183349784525
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020284183349784525
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020284183349784525
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020284183349784525
GALACTOSIALIDOSIS	0.000541419	0.020284183349784525
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020284183349784525
HEREDITARY COPROPORPHYRIA	0.000541419	0.020284183349784525
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020284183349784525
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020284183349784525
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020284183349784525
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020284183349784525
EPISODIC ATAXIA TYPE 3	0.000541419	0.020284183349784525
DEND SYNDROME	0.000541419	0.020284183349784525
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020284183349784525
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020284183349784525
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020284183349784525
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020284183349784525
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020284183349784525
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020284183349784525
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020284183349784525
4Q21 MICRODELETION SYNDROME	0.000541419	0.020284183349784525
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020284183349784525
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020284183349784525
